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Three strategies addressed to give further scope on to the antimicrobial photodynamic therapy field 
comprise the first part of the thesis. In a f irst approach, six cationic photosensitisers varying in the net 
electrical charge and structure have been characterised in solution and their photoinactivation skills have 
been tested against different types of microorganisms. In a s econd approach, conjugates between a 
photosensitiser and the antimicrobial peptide Apidaecin 1b have been analysed in a photophysical and 
mechanistic way, and their properties have been correlated with their bacterial photoinactivation ability. 
In the last approach, two fluorescent proteins –namely TagRFP and miniSOG- have been expressed in E. 
coli and their phototoxicity has been studied and characterised mechanistically. Moreover, the capacity of 
miniSOG to photosensitise singlet oxygen formation has been revisited and studied in detail. 
In the second part of the thesis, focus has been shifted towards singlet oxygen detection. In the first 
section, the probing ability of a new dyad comprising a naphthoxazole moiety plus a singlet oxygen 
chemical trap has been evaluated in solution. In the last section, we develop, test, and discuss the 
feasibility of a polyacrylamide nanoparticle scaffold as a potential platform for singlet oxygen detection 
in intracellular systems. 
RESUMEN 
 
Tres estrategias destinadas a aportar una mayor perspectiva en el campo de la terapia fotodinámica 
antimicrobiana componen la primera parte de la tesis. En una primera aproximación, seis 
fotosensibilizadores catiónicos, con distinta carga eléctrica neta y estructura, han sido 
caracterizados en disolución y sus propiedades fotoinactivadoras probadas contra diferentes tipos 
de microorganismos. En una segunda aproximación, conjugados entre un fotosensibilizador y el 
péptido antimicrobiano Apidaecina 1b han sido analizados fotofísica y mecanísticamente, y sus 
propiedades correlacionadas con su habilidad fotosensibilizadora en bacterias. En la última 
aproximación, dos proteínas fluorescentes –TagRFP y miniSOG- han sido expresadas en E. coli y 
se ha estudiado su fototoxicidad así como su mecanismo de acción. Además, se ha reevaluado y 
estudiado en detalle la capacidad de miniSOG para fotosensibilizar la formación de oxígeno 
singlete. 
 
En la segunda parte de la tesis, el interés se ha centrado en la detección de oxígeno singlete. En la 
primera sección, se ha evaluado la capacidad de detección en disolución de una nueva díada 
compuesta por un naftoxazol y una trampa química de oxígeno singlete. En la última sección, se 
desarrolla, prueba y discute la viabilidad de nanopartículas de poliacrilamida como plataforma 






ADPA   9,10-anthracene dipropionic acid 
AMP   antimicrobial peptide 
(a)PDT   (antimicrobial) photodynamic therapy 
a.u.   arbitrary units 
BHI   brain-heart infusion 
BSA   bovine serum albumin 
CALI   chromophore-assisted light inactivation 
CD   circular dichroism 
CFU   colony forming units 
(d)PBS   (deuterated) phosphate buffered saline 
DABCO  1,4-diazabicyclo[2.2.2]octane 
DMSO   dimethylsulfoxide 
EDC   1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride 
EM   electron microscopy 
FACS   fluorescence-activated cell sorting 
FP   fluorescent protein 
GFP   green fluorescence protein 
Gdn HCl  guanidinium hydrochloride 
His   histidine 
IM   inner membrane 
IPTG   isopropyl β-D-1-thiogalactopyranoside 
IR   infrared 
IRF   instrument’s response function 
LB   lysogeny broth 
MDR   multridrug-resistant 
MeOH   methanol 
Met   methionine 
miniSOG  mini singlet oxygen generator 
MRSA   methicillin-resistant Staphylococcus aureus 
m-THPP  5,10,15,20-tetrakis(m-hydroxyphenyl)-21H,23H-porphine 
NaN3   sodium azide 
NDM-1   New Delhi metallo-beta lactamase 
NHS   N-hydroxysuccinimide 
NMB   new methylene blue 
NMe3MeO-TBPo 2,7,12-tris(trimethyl-p-tolyl)–17-(p-(methoxymethyl)phenyl)porphycene 
NPN   1-N-phenylnaphthylamine 
NPs   nanoparticles 
1O2 (1∆g)   singlet oxygen 
OD   optical density 
OM   outer membrane 
PDI   photodynamic inactivation 
PDR   pandrug-resistant 
PDT   photodynamic therapy 
PN(S)   phenalenone (-2-sulfonate) 
PS   photosensitiser 
Py3MeO-TBPo  2,7,12-tris(α-pyridinio-p-tolyl)–17-(p-(methoxymethyl)phenyl)porphycene 
RFP   red fluorescent protein 
ROS   reactive oxygen species 
rt   room temperature 
SOSG   singlet oxygen sensor green 
Spp   species 
TCSPC   time-correlated single photon counting 
THF   tetrahydrofuran 
TMPyP   5,10,15,20-tetrakis(N-methyl-4-pyridyl)-21H,23H-porphine 
TPP   5,10,15,20-Tetraphenyl-21H,23H-porphine 
TPPo   2,7,12,17-tetraphenylporphycene 
TPPS   meso-tetrakis(4-sulfonatophenyl)-porphyrin 
Trp   tryptophan 
TRPD   time-resolved phosphorescence detection 
TSB   tryptic soy broth 
Tyr  tyrosine 
UA uric acid 
UV   ultraviolet 
VIS   visible 
XDR   extensively-drug resistant 
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Living in a microbial world 
 
“The number of these animals in the scurf of a man’s teeth, are so many 
that I believe they exceed the number of men in a kingdom. […] Some of these 
are so exceedingly small that millions of millions might be contained in a 
single drop of water. I was much surprised at this wonderful spectacle, having 
never seen any living creature comparable to those for smallness; nor could I 
indeed imagine that nature had afforded instances of so exceedingly minute 
animal proportions.” 
-Antony van Leeuwenhoek  
(1684; letter to the Royal Society of London)  
 
Bacteria have been encountered on every recondite surface on Earth, and almost all bacteria possess 
at least one alternative energy-generating system if the preferred route is unavailable. Ecologists have 
discovered bacteria in places no one thought a creature could live, and not only do they tolerate these 
places, but they thrive. Extremophiles live in environments of extraordinary harshness to human standards 
(very high/low temperatures, huge salt concentrations, etc.) where few other living beings can survive.1,2  
Though tiny, bacteria occupy the Earth in enormous numbers. The total population of bacteria is 
estimated to reach 1030 and the mass of these cells approaches 1 × 1015 kg. Of these, the overwhelming 
majority lives in the soil. Just to provide a couple of extra figures and as an update of van Leeuwenhoek 
comparison, the number of microorganisms in a teaspoon of soil can be compared to the number of 
humans currently living in Africa. Or, in another rough estimation, dental plaque is so densely packed that 
one gram will contain namely the same number of humans that have ever populated the Earth!3  
We are microbe magnets since we are born. Evolutionarily, we are meant to attract these bugs 
because that's the initial signal to activate our immune system.4 Although animals and bacteria have 
different forms and lifestyles, they recognise one another and are able to coexist. Most organisms have 
about 1/3 of their genes in common. For instance, in the human genome 37% genes are similar to those in 




bacteria and archaea. Another 28% are similar to genes in unicellular eukaryotes. Thus, a full 65% of 
human genes show similarity to those of microbes.5  
 
Figure 1. Human genomic signature through phylogenetic analysis. Drawing (from ref 5) sorts out human genes 
relative to percentage of the genome that arose at a series of stages in biological evolution. 
The human body is, thus, both an organism and a complex ecosystem, whose inhabitants comprise 
ca. 1000 different species belonging to 200 genera. The human microbiota (the collection of microbes 
that live on and inside us) consists of about 100 trillion microbial cells that outnumber our ‘‘human’’ cells 
10 to 1, and that provide a wide range of metabolic functions that we lack.6 If we consider ourselves as 
supraorganisms encompassing these microbial symbionts, by far the majority of genes in the system are 
microbial (over 23,000 genes constitute the human genome while ca. 8,000,000 genes present in the 
human microbiome –which refers to the collective genomes of the microbes that colonise a determined 










“Ce qui est vrai pour le colibacille est vrai pour l’éléphant”  
-Jacques Monod 
 (Biologist; Nobel Prize 1965) 
 
Bacteria are self-sufficient packets of life, the smallest independently living creatures on Earth. Most 
bacteria are between 0.5 and 1.5 μm in diameter and 1 to 2 μm long, bacterial volumes ranging, thus, 
from 0.02 to 400 μm3.8 Still, extreme cases appear: huge Thiomargarita namibiensis reaches 750 μm 
while Francisella tularensis is as small as 0.2 μm.9,10  One of many advantages in being small involves 
the ability to sense environmental changes with an immediacy that large multicellular organisms lack. 
Bacteria need only be big enough to hold their vital enzymes, proteins, and genetic machinery. Its simple 
architecture allows for rapid reproduction, which aids adaptation. Bacterial metabolism is a model of 
efficiency because of a large surface-to-volume ratio that the aforementioned smallness creates.8 No part 
of a bacterial cell is very far from the surface where nutrients enter and undesired products exit. Finally, 
small size contributes to massive bacterial populations that dwarf the populations of any other biota. On 
the other hand, microbiology’s slow acceptance was partly due to the minuscule dimensions of microbes. 
Antony van Leewenhok reported the first thorough pictures of the ‘very little animalcules’ in the end of 
XVIIth century; but not until the naissance of electron and fluorescence microscopy did their inner 
structures (nucleoids, ribosomes, cell walls and membranes, flagella) become discernible.11 
In a microscope, bacteria exhibit several different shapes: spheres (coccus), rods (bacillus), spirals 
(spirillum), corkscrews (spirochaete), and boomerangs (vibrio). When bacteria grow, the cell wall 
prevents any increase in size contrary to multicellular organisms.12,13 
 Bacteria grow by splitting into two new cells by binary fission. Bacteria do not always live as free-
floating specimens. As cell numbers increase, certain species align or form clusters. Furthermore, if 
bacterial populations find a surface with a little moisture and some nutrients they settle and form thin, flat 




sheets and swarm forming what we call bacterial biofilms (Figure 2).14,15 Thus, they tend to form 
communities which display attributes of multicelullarity, with a vast diversity in population, architecture 
and activities. These groups of cells are held in place by an extracellular matrix and can use intercellular 
signaling for communication.16 
 
Figure 2. Biofilms formed by Bacillus subtilis (strain NCIB 3610). Image from reference 5. 
Until the late 1970s, microbiologists identified bacteria through enzyme activities, end products, 
nutrient needs, and morphology. In 1977 C arl Woese proposed a classification based on the use of 
ribosomal ribonucleic acid (rRNA) fragments. Because the genetic information in rRNA is unique to each 
species, it can act as a type of bacterial fingerprint. This analysis led to a new hierarchy of living things 
with bacteria, archaea, and eukaryotes comprising the three domains shown in Figure 3b that substituted 
classical kingdom-like phylogeny tree (Figure 3a).17,18  
 
Figure 3. Classical (a) and molecular (b) phylogenia representation. Adapted from ref 19 and 






In a different approach, bacteria are usually classified in two main categories regarding their 
differences in structure. Gram-positive bacteria (Figure 4 right) are surrounded by an outer wall, which is 
separated from the plasma membrane by a p eriplasmic space. This 20-80 nm thick wall acts as a 
protective mesh constituted mainly by peptidoglycan layers, which are traversed by negatively charged 
lipoteichoic and teichuronic acids anchored in the membrane. This architecture doesn’t act strictly as a 
permeability barrier, since macromolecules with molecular weight up to 60,000 Da can diffuse through 
the inner membrane (IM). On the other hand, Gram-negative bacteria (Figure 4 left) are endowed with an 
additional 10-15 nm thick densely packed structural layer, external to the peptidoglycan network, whose 
constituents (e.g., lipoproteins, lipopolysaccharides) confer the outer surface highly negative charges. 
This highly organised system –called outer membrane (OM)- inhibits the penetration of compounds with 
molecular weight larger than 600-700 Da.20  
 
 
Figure 4. Gram-positive and Gram-negative bacteria structure. Image from ref  20. 
 





Bad bugs, no drugs 
 
“Bacteria have been around for billions of years. Then we steal some 
antibacterial drugs from fungi and think we can do us in for good.”  
 
-Stephen Jay Gould 
(1941-2002; Evolutionary biologist) 
 
There is a p reconceived concept that associates bacteria with pathogenesis and, in the end, with 
deleterious effects (e.g. bioterrorism, infections concomitant to natural catastrophes, organisms resistant 
to antibiotics, etc.). However, the vast majority of microorganisms are not necessarily bad, indeed.  
Besides oxygenating the early Earth, loads of bacterial activities shape the ecology of the planet, 
thus helping to sustain human life. In soil, several bacteria replenish nitrogen that higher organisms need 
or regulate the carbon cycle through the Earth’s organic and inorganic matter; they help metabolise food, 
block dangerous pathogens and even help develop the immune response.21,22  Humans and animals also 
come with a full complement of gut flora that sometimes provides the host living system with metabolic 
capabilities that do n ot possess by themselves.23-25 In addition to aiding our digestive system, gut 
microorganisms also influence distant parts of the body, including the brain.5 
Moreover, our understanding of microbes has allowed us to use their features in our profit. Among 
others, we can track disease outbreaks or monitor pollution; we can use them to clean up our wastes and 
decontaminate (sulfide removal, oil spills…);26,27 they can provide important and useful chemical 
compounds;28-31 preparation of many daily products (food and beverages) are aided by microbes;32 they 
have enabled the development of revolutionary tools for bioengineering such as PCR;33 or we now 
manage that medically important compounds such as human insulin can be processed in large scale by 
recombinant bacteria.34 
Despite we have exemplified in the previous paragraphs that bacteria are not always to be related 
with deleterious effects, the truth is that pathogenic microorganisms have become a u niversal threat. 
Today infectious disease is the second most important killer in the world, number three in developed 




nations and fourth in the USA. It is the third leading cause of death in Europe and despite existing 
antibiotic therapies and vaccines, infectious diseases remain the leading cause of mortality and morbidity. 
Worldwide, 17 million people die each year from bacterial infections.35  
In total, there are ca. 1,400 known species of human pathogens (including viruses, bacteria, fungi, 
protozoa and helminths), but they account for much less than 1% of the total number of microbial species 
on the planet.3 The issue of prevention and control of infectious diseases remains open and a series of 
highly virulent pathogens are emerging both in and beyond the hospital setting. Penicillin and subsequent 
development and synthesis of other antibiotics were one of the most sounded scientific highlights of the 
20th century as a tool of prevention and control of infectious diseases worldwide. Fleming’s first paper on 
penicillin was published in 1929. Penicillin was put into common use in the early 1940s but by 1944 half 
of all clinical Staphylococci species (hereafter spp) isolates were resistant to this proclaimed “miracle 
drug.” Still, by the 1980s, pharmaceutical companies were convinced that there were enough antibiotics 
and that it was about time to shift focus to more threatening clinical problems such as cancer, diabetes and 
heart or degenerative diseases.  
Paradoxically, concomitant with the rise of antibiotic-resistant bacteria, approval of new antibiotics 
has dramatically slowed (Figure 5). And not on only that: the number of truly novel compounds with new 
mechanism of action remains small.36 Of great significance, nearly all major pharmaceutical companies 
have withdrawn from or greatly downsized their antibiotic research and development (R+D) programs 
over the past two decades, and the egress from the market is actively continuing. 





Figure 5. Number of antibacterial agents approved by the US FDA per 5-year period (from reference 37) 
 
Microorganisms, however, had a different opinion. The extensive and inappropriate use of 
antibiotics gradually has led to a worrying resurgence of morbidity and mortality from new and old 




Figure 6. Stop to the abuse of antibiotics usage. Image adapted from http://www.flickr.com/photos/mbradbury/1847123974/ 
(retrieved April 2013) 
 
The problem of antimicrobial resistance is not specific to bacteria. Medically important viruses (e.g., 
HIV, influenza), fungi (e.g., Candida, Aspergillus), and parasites (e.g., malaria) also develop resistance. 
However, a unique convergence of events has created an enormous public health concern regarding 
antibiotic resistance in bacteria making it the primary focus of most research in the field. Today, many 
bacteria are already resistant to common antibiotics. Antimicrobial resistance is a co nsequence of 




continued misuse and overuse of antibiotics (both in humans and animals, Figure 6) combined with the 
natural and constant growth of resistance over time and the remarkable genetic plasticity of bacteria.36,38,39  
Harmonised definitions with which to describe and classify the different patterns of bacterial 
resistance found in healthcare-associated environments comprise three categories: multidrug-resistant 
(MDR), extensively-drug resistant (XDR) and pandrug-resistant (PDR) bacteria.40 Up to date, The 
naiscement of the so called “superbugs” or ESKAPE pathogens (Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, Escherichia coli and 
Enterobacter spp) cause serious and life-threatening infections. Indeed, they are extremely difficult and in 
many cases impossible to effectively treat.41  
 
Figure 7. SEM micrographs depicting ESKAPE pathogens. Images were obtained from the Public Health Image 
Library of the centers for disease control and prevention (http://phil.cdc.gov/Phil/default.asp; retrieved April 2013). 
 
Ten years ago, concern was centred on Gram-positive bacteria, particularly methicillin-resistant S. 
aureus and vancomycin-resistant Enterococcus spp. Now, however, consensus exist that MDR Gram-
negative bacteria pose the greatest risk. Not only is the increase in resistance of Gram-negative bacteria 
faster than in Gram-positive bacteria, but also there are fewer new and developmental antibiotics active 
against Gram-negative bacteria. The increase in resistance of Gram-negative bacteria is mainly due to 
mobile genes on plasmids that can readily spread through bacterial populations.42 




Therapeutic options for ESKAPE pathogens are extremely limited such that clinicians are often 
forced to use obsolete drugs, such as colistin, that are associated with significant toxicity and for which 
there is a lack of robust data to guide dosage regimen or duration of therapy.43 For example, more people 
now die of MRSA infection in U.S.A. than of HIV/AIDS, emphysema, Parkinson’s disease and homicide 
together.37 XDR Klebsiella or XDR Acinetobacter bacteria kill up to 50% of infected patients despite 
treatment with last resort drugs, and resistance rates for these pathogens continue to climb. As a final 
threatening example, all strains of Klebsiella and E. coli containing the New Delhi metallo-beta-lactamase 
(NDM-1) enzyme are resistant to all antibiotics except colistin and tigecycline, and 10% of these strains 
are even resistant to these drugs, making them truly pan resistant. XDR Acinetobacter strains that are 
resistant to colistin are now being reported.42  
We must increase our efforts to preserve the activity of available antibiotics, or at least expand as 
much as possible the period of their use, whilst intense research efforts should be focused on the 








“I don't understand it Dr. von Tappeiner, the paramecia were all wiggling 
just fine a minute ago, but now these over by the window seem to be dead.” 
-Oscar Raab (1900) 
 
The origin of photosensitisation as a science is usually attributed to the work of Oscar Raab at the 
end of 19th century. Although there are several accounts of photosensitisation reactions in the writings of 
the Egyptians, Indians and Chinese dating to at least 30 centuries ago, the modern era is conveniently 
recognised to begin in the year 1900. 
Oscar Raab was a medical student of Hermann von Tappeiner at the Ludwig-Maximilian University 
in Munich. Raab was involved in a study of the toxicity of acridine towards paramecia. In the winter 
semester of 1897-98, Raab found that the apparent toxicity that he measured depended on the time of day 
when he performed his experiment. Near midday the toxicity was the greatest. Raab realised that one of 
the variables in his work was the amount of light in the laboratory, and he subsequently demonstrated that 
paramecia in acridine solutions were inactivated more effectively if the solutions were kept near a bright 
window, than if they were prevented from light. The surprising result was published in 1900 a nd 
stimulated further activity in the field. It was the first report regarding what they called “photodynamic 
action”. Since then, a lot has been learnt about this effect ant the development of its use in therapies is a 
fact.44  
The photodynamic therapy (PDT) concept comprises the action of three components: a 
photosensitiser (PS), a light source of appropriate wavelength, and oxygen. The interaction between light 
and the PS leads to the generation of reactive oxygen species (ROS), e.g. singlet oxygen (1O2), by two 
possible mechanisms involving either the interaction of the PS with the oxidizable substrate (e.g., by 
electron-transfer) -type I- or with oxygen (by energy- or electron-transfer) -type II- reactions.  Almost 
every cell component is a potential target for these ROS, as they react readily with proteins, 
carbohydrates, cell-membrane components, and nucleic acids resulting in cytotoxicity.45 PDT is a highly 




selective modality as (a) hyperproliferating cells selectively uptake PSs and (b) cell death is spatially 
limited to regions where light of the appropriate wavelength is applied. 
Every PS molecule participates in multiple cycles of oxygen activation so that low doses are 
required so as to achieve the therapeutic effect. Excited species are generated by photon absorptions and, 
generally, they exhibit very short lifetimes limiting this way the possible reactions that occur. There are 
different pathways of returning the energy delivered by irradiation. Either through radiative means 
(fluorescence, phosphorescence) or thermal pathways (intersystem crossing (ISC), internal conversion, 
etc.); but they can also react with neighbouring compounds. In this second scenario, another classification 
can be also done. When energy transfer is mediated through proton or electron with the biological 
substrate it is known as Type I mechanism; on the contrary, if oxygen is the primary acceptor this process 
is called Type II mechanism (see Scheme 2). Both mechanisms occur simultaneously and the efficiency 
of each process hinges on the respective value relative to oxygen and substrate concentration and to the 
reaction constant rates and also on the triplet state deactivation kinetics.46  
 
Scheme 1. Photophysical ROS generation cycle. 
 
 
PDT was established and remains a successful modality for a varied pool of malignancies ranging 





diseases.47,48 But photodynamic inactivation (PDI) has been transformed recently to an antimicrobial 
discovery and development platform. 
We have described the PS as the agent able to generate the ROS that will lead to the desired 
therapeutical effect. Despite their clinical application, several problems aroused from the first generation 
PSs. For instance, porfimer sodium (Photofrin®; the first clinically approved PS) provoked severe 
dermatological photosensitivity for several weeks due to its low selectivity; also the photosensitising drug 
was an inseparable mixture of porphyrin oligomeric compounds with the subsequent chemical 
characterisation difficulties. Based on these and other problems encountered in the clinical use of 
Photofrin and other first generation PSs, several ideal features were regarded for the ideal PS:  
• Pure chemical compound and photochemical stability. 
• Preferential location and selective retention at the target tissue. 
• Single compound, with known and constant composition whose synthesis is affordable, high 
performance and scalable. 
• Effective generator of 1O2 and other ROS. 
• Appropriate photophysical properties: e.g. high quantum yield of triplet formation (ΦT), high 
quantum yield of 1O2 formation (Φ∆) and high triplet state energy (enough to achieve 1O2 
formation). 
• Low toxicity and negligible dark cytotoxicity. 
• Rapid drug clearance in healthy tissue and minimal skin photosensitivity. 
• High coefficient of absorption in the red / near infrared in order to achieve maximum penetration 
into tissues. 
• Soluble in biological fluids (allowing administration via parenteral). If not, easy to incorporate into 
a hydrophilic transport system capable of circulating in the bloodstream. 
• Susceptible to become drug through a simple and stable formulation. 
 
 





Scheme 2. Summary of desired properties for an ideal PS. 
Trying to improve the properties of their predecessors in compliance with the aforementioned 
properties new families of PSs have been born: the so-called 2nd generation PSs. Among them stand 
porphycenes, porphyrins, chlorins, bacteriochlorins, phthalocyanines, aza-porphyrins, naphthocyanines, 






Scheme 3. Families of 2nd generation PSs. 1) Porphycene, 2) Porphyrin, 3) Chlorin, 4) Bacteriochlorin, 5) 
Phthalocyanine, 6) Azaporphyrin, 7) Naphthalocyanine, 8) Texaphyrin, 9) Purpurin 





Molecular oxygen (O2) is a ubiquitous and often adventitious participant in organic photochemical 
reactions. O2 is ubiquitous because samples are saturated with air, which means that unless purged, they 
contain a certain concentration of dissolved O2 that at room temperature (rt) and 1 atm of air typically 
falls in the order of ~ millimolar. O2 is adventitious because attempts of purging it may not succeeded 
completely, thus leading to unexpected reactions. 
Singlet oxygen (1O2) is defined as the lowest excited electronic state of molecular oxygen and has 
been present in the scientific community for over 80 years. Its intrinsically atypical but appealing 
physico-chemical properties and behaviour (due to the unique electronic structure of the dioxygen 
molecule with a spin triplet in its ground state), makes 1O2 remain at the forefront of research in different 
disciplines.50,51 1O2 is definitely of great interest. Firstly, due to its high reactivity toward organic 
substrates as a synthetic reagent.52 Secondly, as an intermediate in oxygenation reactions of polymers.53 
Thirdly, and probably the most appealing up to date, as a member of the ROS family that takes active part 
in a range of biological events. A great variety of biological molecules (i.e. proteins, DNA and lipids) can 
suffer oxidation processes by 1O2, leading to a plethora of deleterious effects that can ultimately result in 
cell death, degenerative diseases, etc.54 Over the years, insight has been gained in the rules that control 
1O2 generation, the characters involved and the energy requirements. More recent studies have focused on 
assessing the 1O2 involvement during cellular signaling upon its generation in sub-lethal amounts, 
studying its role in cell regulation events (i.e. mediation of immune response, cell transduction or gene 
expression). Also, we are learning how to use it in our profit, for instance, destroying malignant cells as a 
therapy (i.e. PDT).48 Still many gaps are to be closed and better understanding about 1O2 is needed. In this 
sense, delivering the proper amount of 1O2 within a therapy is crucial for its success, but it is  not 
something we can fully control nor monitor yet.  
As mentioned in the previous paragraph, the ground state of O2 is a triplet, paramagnetic because of 
two parallel electronic spins. When excited, oxygen gets to two different metastable electronically excited 
singlet states. The higher-energy state (1Σg) is deactivated to the so called 1∆g stated very rapidly. So 





thus allowing for interaction and reactivity. 1O2 lies ca. 94 kJ·mol-1 above the ground state, energy 
corresponding to an infrared wavelength of 1270 nm, where it emits light (Scheme 4). 
 
Scheme 4. Energetic representation of 1O2 excited singlet states. 
Because 1O2 in solution deactivates by transferring its electronic energy to solvent vibrations, its 
lifetime depends strongly on the medium. Thus, solvents with high vibrational frequencies provide the 
most efficient relaxation. It is for this reason that the lifetime is shortest in water (which has a strong OH 
vibration) followed by solvents with CH groups. In deuterated solvents the quenching rate constant 
decreases by approximately an order of magnitude because the corresponding vibrations shift to lower 
frequency. This results in lifetimes increasing from 3-4 µs in water up to 65 µs in D2O. 
There are two major sources of 1O2: photochemical and “chemical”. One of the most common 
sources of 1O2 requires energy transfer (ET) from an excited PS, as seen in Scheme 5.  
 
Scheme 5. Representation of 1O2 formation through energy transfer with an excited 3PS. 




The role of the PS is to absorb the light and be converted to an electronically excited state (usually 
the first excited triplet state, T1); then transfers its energy to molecular oxygen, producing 1O2 and 
regenerating the PS as we previously showed in detail in Scheme 1. Three are the requirements for a 
molecule to be able to photosensitise the production of 1O2 efficiently: (A) have a good ability to populate 
the excited triplet state (high ISC quantum yield), (B) the energy of its triplet state must be higher than 94 
kJ·mol-1.and (C) energy transfer must occur efficiently. 
Although not included in Schemes 1 and 5 for the sake of simplicity, 1O2 can also be generated from 
the fluorescent (singlet, S1) state of a PS. This phenomenon is less frequent and requires that the S1–T1 
energy gap exceeds the excitation energy of 1O2 (94 kJ·mol-1) so that oxygen can elicit this spin allowed 
intersystem crossing.50,51 This discovery led to the finding that it is possible to achieve Φ∆ values higher 
than unity if both S1-T1 and T1-S0 energy gaps of the PS are around 94 kJ·mol-1. For instance, rubrene is 
reported to have a Φ∆ value of 1.8 in toluene and oxygen pressure of 10 atm. Perylene, pyrene or 1,3-
diphneylisobenzofuran are other examples.50 Still, most PSs do not have such a large S1-T1 energy gap 
and the utterly high oxygen pressure requirements make their feasibility in PDT unviable. 
Hence, for most PSs, the role of oxygen quenching of S1 is limited to enhancement of the triplet 
quantum yield, and the main pathway of 1O2 generation is oxygen quenching of T1. Because the 
intramolecular T1  S0 transition is spin-forbidden, T1 states generally have long lifetimes, allowing 
mostly for complete quenching by ground-state oxygen in air-saturated solution. From now on, we will 
focus only in this majority event when dealing with  photosensitised 1O2 formation. 
Chemical sources of 1O2 are quite diverse (Scheme 6). The oldest is the reaction of HClO with 
H2O2, which produces 1O2 in nearly quantitative yields. Other sources of 1O2 are phosphite ozonides 
(produced by reaction of ozone with phosphites) and decomposition of hydrotrioxides. Peroxomolybdates 
are also able to produce 1O2 in good yields. One of the cleanest methods of producing 1O2 without other 
reactive oxidants is the decomposition of aromatic (particularly substituted naphthalene) endoperoxides. 







Scheme 6. Chemical sources of singlet oxygen. 
 
A drawback of chemical sources is that many substrates do not trap 1O2 efficiently, so that a large 
excess of the reagent must be used to obtain appreciable substrate conversions. Moreover, since many of 
the sources use strong oxidising agents, undesired side reactions may also occur. Still, this system renders 
useful whenever light cannot be used or just for mechanistic purposes. 
 
Due to the characteristic reactivity of 1O2, photooxygenation is a valuable complement of oxidation 
methods. 1O2 is a synthetically useful electrophilic reagent which, in many cases, allows stereospecific 
and regiospecific introduction of O2 into organic substrates. In industry, the reaction is applied to 
production of perfumes and aromas by oxidation of terpenes or terpenols. The singlet spin multiplicity 
significantly increases reactivity with respect to triplet (ground state) oxygen. Main reactions are briefly 
summarised in the following paragraphs. 
[4+2] cycloaddition: 1O2 reacts with the s-cis conformations of 1,3-dienes to form endoperoxides. The 
reactions are characterised by a negligible solvent effect and they can be stereospecific. The synthetic 
importance of this reaction relies on the great variety of transformations available to the endoperoxide 
products.  
Ene reaction: In this reaction, olefins with allylic hydrogens are oxidised to allylic hydroperoxides 
concomitant with a s hift of the double bond. These allylic hydroperoxides can be easily converted to 
allylic alochols, key intermediates in several synthetic transformations. The synthetic utility of the ene 




reaction is increased by tits unique stereochemistry and regiochemistry since the double bond always 
shifts to the allylic position. 
[2+2] cycloaddition: [2+2] cycloadditions with 1O2 occur with electron-rich substrates or with olefins in 
which the competing ene reactions are structurally precluded. The products are dioxetanes, characteristic 
by their ability to decompose with light emission. 
Sulfide photooxidation: The photooxidative behaviour of sulphides was examined more than 50 years 
ago and reported as a new method of making sulfoxides. The quantum efficiency of product formation is 
sensitive to both temperature and the identity of the solvent. While pretty efficient in methanol it does not 
proceed properly in benzene. But efficiency in aprotic solvents, however, increases as the temperature is 
lowered. 
Reactivity towards aminoacids: Biomolecules react in the same way other molecules do, but many of 
the initial products are unstable and cannot be isolated. Special attention has been gained since the 
obvious use of 1O2 in biological media as we will later see. 
 
 






Aside from 1O2 deactivation through chemical reaction (i.e. reaction with chemical traps as we will 
see in chapter IV) physical pathways are very common for deactivation of 1O2. Hereafter we will refer as 
“quenching” to the concept of deactivation of an excited molecule to its ground state without chemical 
reaction with the deactivating molecule (quencher). In some case, competition between chemical and 
physical deactivation pathways occur. There are two major mechanisms of physical quenching: 
Energy transfer: this process is typified by carotenes. Carotenes participate in a reverse reaction of that 
by which 1O2 is formed by the PS. Carotene’s triplet excitation energy lies below that of 1O2 so that the 
reaction is exothermic. Moreover, the rate constant for this reaction is in the diffusional limit rate, that is, 
in the order of 1·1010 M-1·s-1, meaning that reaction occurs with every collision. Thus, carotene family 
become extremely efficient physical 1O2 quenchers. This quenching may be the reason for the very 
important role played by carotenes in protecting against oxidative photodamage in photosynthetic 
systems. 
carotene + 1O2  3carotene + 3O2 
Charge transfer: electron-rich compounds make up the second class of physical quenching molecules. 
Partial charge transfer from these compounds appears to catalyse the intersystem crossing of 1O2 to the 
ground state. Complete electron transfer to 1O2 has been observed but only with extremely strong electron 
donors. However, complete transfer is not a requirement for quenching. 
Q + 1O2  +Q--O2-  Q + 3O2 
Sodium azide (NaN3) and DABCO (diazabicyclo[2.2.2]octane) are examples of charge-transfer 
quenchers. DABCO has a particularly low oxidation potential for an amine and quenches 1O2 very 
efficiently without itself undergoing any reaction. Hydrazines also are very efficient quenchers. Finally, 
NaN3 is a water soluble quencher which has been frequently used in biological studies; however, it is not 
as inert chemical and it can undergo reactions itself via the azido radical; it is also a potent 
metalloenzyme poison, which limits its usefulness in biological systems. Certain reactive phenols do also 
undergo a mixture of reaction and quenching; vitamin E (α-tocopherol) is a particularly reactive example 
and the ratio of reaction/quenching hinges on the solvent. 









AIM OF THE STUDY 
In the present study we aim at two main objectives: 
• The study of different novel approaches towards antimicrobial photodynamic 
therapy that can give insight for the development of feasible strategies to 
overcome antibiotic resistance as well as help understand the mechanisms 
underneath bacterial cell death upon singlet oxygen-mediated photokilling. 
• The study and/or development of new probes that elicit better singlet oxygen 
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Steady state measurements 
 
INSTRUMENTS 
Equipment: Absorption spectra were recorded on a double beam Cary 6000i spectrophotometer (Varian, 
Palo Alto, CA), equipped with a 110 mm diameter integrating sphere and high performance 
photomultiplier tube for transmittance measurements. Fluorescence excitation and emission spectra were 
registered in a Spex Fluoromax-4 spectrofluorometer (Horiba Jobin-Yvon, Edison, NJ).  
Light sources: Sorisa Photocare using a 35 mW·cm-2 fluence rate was used in probe conversion 
assays in Chapter IV (1st section). Light wavelength was chosen depending on the type of 
experiment, namely, blue (475 ± 15 nm), green (535 ± 15 nm) or red (635 ± 15 nm). Paterson red 
Lamp BL1000A (630 ± 30 nm) was used for experiments in Chapter IV (2nd section). Fluence rates 
were routinely measured using a power meter. 
METHODS 
Fluorescence quantum yield: The fluorescence quantum yield (ΦF) is defined as the number of photons 
emitted by the sample per absorbed photon. The fluorescence intensity integrated over the entire emission 
spectrum was measured as a function of the sample absorption factor (1-10-Abs) for the sample and a 
suitable reference (ref; i.e. with a similar emission spectrum as the sample), excited at the same 













































          
where F stands for the value of the integrated fluorescence and n  is the refractive index of the 
solvent used in each case.1 Absorbance of the sample and the reference are to be less than 0.05 
arbitrary units (a.u.) in the overlap region between absorption and emission to avoid inner filter 
effects. 








Equipment: Time-resolved fluorescence and phosphorescence measurements were carried out using a 
customised PicoQuant Fluotime 200 fluorescence lifetime system and its FluoFit 4.0 software for the data 
analysis. For fluorescence assays, excitation was achieved by means of picosecond diode lasers or LEDs 
(PicoQuant, 10 MHz repetition rate) and the counting frequency was always below 1 %. For direct 1O2 
phosphorescence detection, a diode-pumped pulsed Nd:YAG laser (FTSS355-Q, Crystal Laser, Berlin, 
Germany) working at 10 kHz repetition rate at 532 nm (12 mW, 1.2 µJ per pulse) or at 355 nm (5 mW, 
0.5 uJ per pulse) was used for excitation. A 1064 n m rugate notch filter (Edmund Optics, U.K.) was 
placed at the exit port of the laser to remove any residual component of its fundamental emission in the 
near-IR region. The luminescence exiting from the side of the sample was filtered by two long-pass filters 
of 355 and 532 nm (Edmund Optics, York, U.K.) and two narrow bandpass filters at 1275 nm (NB-1270-
010, Spectrogon, Sweden; bk-1270-70-B, bk Interferenzoptik, Germany) to remove any scattered laser 
radiation. A near-IR sensitive photomultiplier tube assembly (H9170-45, Hamamatsu Photonics 
Hamamatsu City, Japan) was used as the detector at the exit port of the monochromator. Photon counting 
was achieved with a multichannel scaler (PicoQuant’s Nanoharp 250). 
Transient absorption experiments in the UV-VIS region were carried out using a home-built 
nanosecond laser flash photolysis system. In this instrument, either the 2nd harmonic (532 nm) or the 3rd 
harmonic (355 nm) of a Continuum Surelite I-10 Nd:YAG laser (10 Hz, 5 ns pulse width, 1-10 mJ per 
pulse) was directed to the sample. In other experiments, the 355 nm the the Nd:YAG laser was used to 
pump a Continuum OPO laser to produce laser pulses in the 400-700 nm region. Changes in the sample 
absorbance were detected using a Hamamatsu R928 photomultiplier to monitor the intensity variations of 
an analysing beam produced by a 7 5 W short arc Xe lamp (USHIO) and spectral discrimination was 
obtained using a PTI 101 monochromator. The signal was fed to a Lecroy Wavesurfer 454 oscilloscope 
for digitising and averaging (typically 3-10 shots) and finally transferred by a GPIB interface (National 
Instruments) to a PC computer for data storage and analysis. The TTL sync output of the laser was used 





measured with a pyroelectric energy meter (RJP 735 and RJ 7610) from Laser Precision Corp. The 
system was controlled by the in house-developed LKS sofware (LabView, National Instruments).  
A schematic representation of our setup is depicted in Scheme 1: 
 
Scheme 1 Experimental setup for nanosecond UV-VIS laser flash photolysis. Image adapted from ref. 2 
 
GENERAL TECHNIQUES 
The time-resolved techniques involve the observation, of excited states or other reaction 
intermediates generated upon pulsed-laser irradiation of a sample.  
Time-Correlated Single Photon Counting (TCSPC): It is the most commonly used technique for 
singlet state lifetime determination. It is based on the detection of single photons of a periodical light 
signal, the measurement of the detection times of the individual photons and the reconstruction of the 
waveform from the individual time measurements. TCSPC technique makes use of the fact that for low-
level, high-repetition-rate pulses, the produced light intensity is so low that the probability of detecting 
one photon in one signal period is less than one. Therefore, is not necessary to seek for the possibility of 
detecting several photons in one signal period. It is sufficient to record the photons, measure their time in 
the signal period, and build up a histogram of the photon times.3 
For fluorescence measurements, an instrument’s response function (IRF) is needed because the 
response of the electronics can be convoluted with the chromophore’s decay spectrum. In the absence of 
chromophore, any decay measured will be the solely the result of the electronics. This is not necessary for 
samples with lifetimes approaching 1.0 μs. To achieve the IRF signal a sample able to scatter excitation 
light into the photomultiplier is needed. Diluted solutions of commercially available Ludox is an option, 
but whatever scattering sample may work. 




Time-resolved Near-IR phosphorescence detection (TRPD): This technique is commonly used for 
directly and specifically monitoring 1O2 formation and decay, the measurement of its lifetime (τ∆) and its 
quantum yield of formation (Φ∆). It is based on the detection of the weak 1O2 phosphorescence, centred 
at 1275 nm (Scheme 2) and has its major potential in homogeneous systems.2  
 
Scheme 2. Near-IR phosphorescence spectrum of 1O2 .Image taken from ref. 3 
Direct 1O2 luminescence was detected by means of PicoQuant Fluotime 200 system but with a 
different customisation respect to TCSPC measurements, as described in the previous section. 
 
UV-VIS nanosecond laser flash photolysis: this technique addresses to the measurement of triplet states 
of photochemical and photophysical phenomena. There are many experimental setups for the detection of 
triplet-triplet absorption spectra, but two elements are common. First, an exciting source to produce the 
triplet state species is required. Second, each experiment has a monitoring light source to probe their 
absorbance. Triplet states can be generated in several ways; however, two are the main methods for 
achieving substantial triplet state populations: photolysis with light and radiolysis with ionising radiation.4 









Singlet state decay kinetics (τS): A solution of the sample in the proper solvent was prepared ensuring 
that the absorbance of the sample was less than 0.05 in the overlap region between absorption and 
emission to avoid inner filter effects. The deconvolution of the TCSPC fluorescence signal with the IRF 
signal yields the singlet lifetime (τS). 
Assessing 1O2 formation and decay kinetics: 1O2 lifetimes were obtained and assigned by fitting 
Equation (4) to the time-resolved phosphorescence signals (St) detected at 1275 nm,  
( )Tttt eeaS ττ // −− −×= ∆
 (4)
 
where a is the zero-time amplitude of the signal and τΤ and τ∆ are the actual lifetimes of the PS’ triplet 
state and 1O2, respectively.  
1O2 luminescence quantum yield (Φ∆): Optically matched solutions of sample and reference were 
measured and the time-resolved phosphorescence signals analysed. The amplitude (a) is proportional to 
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Thus, the relationship between amplitudes (from sample and reference, respectively) together with 
Φ∆ (ref) renders the Φ∆ (sample) value, as represented in Equation (6)   





Φ = Φ ×
      (6) 
 
This result is only valid if both –sample and reference- show the same τΤ and τ∆ values. May this 
condition not be fulfilled, one needs to make a correction taking into account the aforementioned changes 
in lifetimes, rendering Equation (7): 
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Assessing reaction rate constants: The rate constant for 1O2 quenching (kq) by a q uencher (Q) was 
determined by measuring the 1O2 lifetime as a function of the quencher concentration. 1O2 was generated 
by an external PS and the concentration of the sample was varied. A plot of the reciprocal lifetime vs the 
concentration of the sample afforded kq as the slope of the linear-fit Equation (8).  
0
1 1 [Q]qkτ τ∆ ∆
= + ,  (8) 









Chemicals. Phosphate buffer saline (PBS) or deuterated PBS (dPBS) solutions were prepared dissolving 
the required amount of a PBS tablet (Sigma) in 100 mL milliQ water o deuterium oxide (Fluka). 
isopropyl β-D-1-thiogalactopyranoside (IPTG), arabinose and disodium carbenicillin were purchased 
from Sigma and used as received. Growth media and agar were purchased from Scharlau. 
Microbial strains: The microbial strains used for the PDI experiments in Chapter 3.1 were: 
Staphylococcus aureus (CECT239) and methicillin-resistant strain of S. aureus (ATCC BAA-44) as 
Gram-positive bacteria; Escherichia coli (CECT101) and Pseudomonas aeruginosa (ATCC 25668) as 
Gram-negative bacteria; Candida albicans (ATCC 10231) and Candida krusei (ATCC 6258) as yeasts. 
For spectroscopic measurements in Chapter 3.2 we used E. coli (CECT101). E. coli strain BL21 (DE3) 
and E. coli DH5α were the strains used in Chapter 3.3. 
Light sources: The light source used in the inactivation experiments was selected in order to provide the 
highest possible overlap between the irradiation range and the absorption spectrum of the PSs. Different 
light sources were used. MRSA and P. aeruginosa inactivation (corresponding to Chapter 3.1) were 
irradiated with red light (600 -750 nm) with the Waldmann PDT 1200 lamp (Waldmann; Medizintechnik) 
with a fluence rate at the level of the samples of 40 mW·cm-2. A CW 532 nm laser beam (Cobolt Samba, 
Sweden) was used at low power density (40 mW·cm-2) for irradiation of TagRFP expressing E. coli in 
Chapter 3.3. Sorisa Photocare using a 35 mW·cm-2 fluence rate was used for the rest of PDI experiments 
(Chapters 3.1 and 3.3). Fluence rates were routinely measured using a power meter. Light wavelength 
was chosen depending on the type of experiment, namely, blue (475 ± 15 nm), green (535 ± 15 nm) or red 
(635 ± 15 nm). 
 
GENERAL METHODS 
Microbial growth and protein induction: Bacterial cells were aerobically grown overnight at 37 ºC in 
brain-heart infusion (BHI), lysogeny broth (LB) broth or tryptic soy broth (TSB) to stationary phase. A 
reinoculum was then grown in fresh LB medium at 37 ºC to an optical density at 600 nm (OD600) of 0.2 




(start of log phase). TagRFPHis expression was induced with 50 µM solution of IPTG and miniSOGHis 
expression with 0.1 % arabinose for 1 hour at 37 °C to an attenuance value of ca. 0.6-0.7 at 600 nm or 
0.35 at 660 nm, corresponding to ca. 108 colony forming unit per milliliter (CFU·mL-1).5 If protein 
expression was not required cells were grown directly to the previous attenuance values. The cell 
suspensions were then centrifuged (5 min, 3000 rpm) and resuspended with sterile PBS or dPBS at pH 
7.4 at the same concentration. 
Candidas spp were grown overnight at 35 ºC in Sabouraud broth, and then subcultivated in new 
Sabouraud medium at 35ºC in an orbital shaking incubator at 130 rpm to an OD600 = 0.7, corresponding 
to ca. 107 CFU/mL. The suspensions were then centrifuged (5 min, 3500 r pm) and resuspended with 
sterile PBS at pH 7.4 at the same concentration for phototoxicity experiments. 
Cultures were maintained by two weeks of subcultures in agar-medium in the presence of the 
appropriate amount of antibiotics in the media when required (100 µg/mL disodium carbenicillin).  
 
Spectroscopic measurements in cell suspensions: Spectroscopic measurements were recorded on the 
systems previously described. Cell suspension samples were prepared as follows: bacterial suspensions 
were incubated in the dark with the desired amount of PS for the required contact time; when required, 
bacterial samples were centrifuged, excess PS removed and samples resuspended in PBS or dPBS to a 
final concentration of ~ 5 x 108 CFU·mL-1. The suspensions were gently stirred during the measurements 
to avoid cell settlement. 
 
Photodynamic inactivation protocol: Cell suspensions in PBS were incubated in the dark at rt for 30 
min with the appropriated amount of PS. Centrifugation (3 min, 12000 rpm) of aliquots was used to 
remove the excess of PS that was not taken up by the bacteria when experiments required it. Then, 
bacterial suspensions aliquots were placed in 96-well plates. The wells were illuminated from the top of 
the plates by light of the selected wavelenght. At the time points when the desired light doses had been 
delivered, aliquots were thoroughly mixed before sampling to avoid the settlement of bacteria. Light-
alone controls (without PS) were also performed for all experimental conditions in order to rule out any 
inactivation effect due to the light and heating effects. For determination of population reduction, aliquots 
were serially diluted, streaked on nutrient agar plates and incubated in the dark for 18 h at 37 ºC (bacterial 
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Chapter III.  
 











“the future of humanity and microbes will likely evolve as episodes […] of our 
wits versus their genes” 
- Joshua Lederberg 








We have previously introduced the emerging threat due to global diffusion of new antimicrobial 
infections as well as the continuously increasing resistance of pathogens against many of the commonly 
used antibiotics. Enhanced efflux pumps, loss of porins, antibiotic inactivation by enzymes and, most 
worrying, gene transfer codifying resistance to antibiotic among species are several of these strategies 
bacteria have developed or refined in the latest years (Scheme 1).1  
 
Scheme 1. Representation of the most common antibiotic resistance mechanisms. 1: Entrance of the antibiotic 
through porins. 2: Binding to the target. A: Loss of porins. B: Antibiotic inactivating enzymes (modification, B1, or 
hydrolysis, B2). C: Enhanced efflux. D: Pre-transcriptional modification of the target. E: P ost-translational 
modification of the target. (i) Bacterial chromosome bearing the gene encoding the target. (ii) Resistance plasmid 
bearing genes encoding for modifying enzymes. Image from reference 1 
In the past time immense efforts led to new natural and semi-synthetic antibiotics. Development of 
novel antimicrobial agents, derivatisation of currently known active molecules to overcome resistance, 
and the development of potentiators of commonly used antimicrobials represent current areas of 
investigation. For instance, the propagation of DNA extracted directly from environmental samples in 
laboratory-grown bacteria provides a means to study natural products encoded in the genomes of 
uncultured bacteria. Tetarimycin A, a tetracyclic MRSA-active antibiotic, was found this way.2  
It is foreseeable that, in spite of the immense expenditure, the therapeutic success will soon be only 
minimal. Past and current policies for dealing with resistance have been only partially effective. Thus, an 
imperious effort to the development of novel approaches to the problem is badly needed.3 Several 




alternatives to antibiotic treatments will be briefly reported in the following paragraphs. Some of them are 
not novel, but their use was eclipsed mainly due to two causes: insufficient understanding among researchers 
at the moment of its discovery and the advent of antibiotics. 
• Use of polymicrobial vaccines: alternative in early stages of development. Koch’s postulates are the 
reference and have proven useful for vaccination against several diseases, but they do not adequately 
consider the pathogenesis of microbes with multiple virulence factors or polymicrobial infections. 
Even if a vaccination attempt successfully blocks virulence factor for one pathogen (i.e. a toxin), 
virulence could potentially be complemented by another factor produced by a neighbouring species 
in the polymicrobial community. Microbes can benefit from virulence factors of other organisms or 
strains during coinfection to enhance their own pathogenesis and colonisation. The eradication of 
one species from the polymicrobial community may be insufficient to reduce overall disease, as 
another organism present may fill the niche left behind.4 A vaccine composed of a multivalent 
cocktail of antigenic proteins from all microbes involved in disease pathology is expected to be 
required, making the approach still far from its use. In line with this idea, more modest attempts rely 
on the idea to use inhibitors of bacterial virulence functions. The rationale for this concept is that 
antivirulence drugs would deprive pathogenic bacteria of their virulence functions, which would 
enable their elimination by the body’s immune system. 
• Synbiotic approach: an overwhelming number of polymicrobial diseases are propagated on abiotic 
surfaces, such as intravenous and urinary catheters, stents, artificial heart valves, parenteral nutrition 
feeding tubes, pacemakers and orthopedic devices (e.g. prostheses). These implants may serve as 
sources of chronic infection and can potentially serve as a source of inoculation into the 
bloodstream, leading to sepsis. In these cases a failure of antimicrobial therapy requires an 
alternative treatment strategy, given the evidence that the administration of antibiotics may actually 
increase overgrowth by potentially pathogenic microorganisms.4 A synbiotic is defined as the 
combination of a probiotic and a prebiotic: an oligosaccharide indigestible by humans but able to be 
fermented by beneficial gut bacteria therefore promoting their growth and displacing the pathogenic 
colonies.4-6 
• Antimicrobial peptides: Antimicrobial peptides (hereafter AMPs) are small biological molecules 





ribosomal-synthesised AMPs, provide effective microbial defence for all organisms from bacteria to 
mammals.7 Bacteriocins are a specific subgroup of AMPs that are produced by bacteria themselves 
and active against other bacteria.8,9 But AMPs can also be originated from fungi, plants and animals. 
Among the main drawbacks –to overcome if desired as a feasible therapy- is that the proteinaceous 
nature of AMPs makes them vulnerable to proteolytic enzymes and also the membrane-target makes 
the possibility of acquiring resistance in the middle/long term. 
• Miscellaneous treatments: here we include a repertoire of minority options that –in specific cases- 
can be useful. Examples include the use of vacuum-assisted closure, hyperbaric oxygen treatment 
and maggot debridement therapies. These techniques –in combination with conventional surgical 
treatments- have been proven to aid in the recovery and clearance of wound infections.4 
 
• Phage therapies: Bacteriophages were first identified in 1915 and were used as antimicrobial agents 
from 1919 onwards. Despite its initial successes and widespread application, their efficacy remained 
controversial. Although they were replaced by antibiotics in the west countries, bacteriophages 
remained a common therapeutic approach in parts of eastern Europe (especially in Georgia) where 
they are still in use. Bacteriophages are bacterial viruses that invade bacterial cells and, in the case 
of lytic ones, disrupt bacterial metabolism and cause the bacterium to lyse. It has been well 
established that phages can kill microorganisms which are resistant to many or all broad spectrum 
modern antibiotics. This effect has been shown 
both in vitro and in vivo and reflects the fact that 
phage mechanisms of bacterial killing differ 
radically from those of antibiotics. Despite its 
many advantages, its world-wide use is still to 
come. Some problems arise from controversial 
proof of efficacy and problems of 
stability/viability of some preparations in the 
beginning. Advanced purification techniques 
together with careful selection for lytic phages 
are key points in their feasibility for their 
potential common use.10    
Figure 1. Electron micrograph of bacteriophages 
attached to bacterial cell. (from Dr. Graham 
Beards ; Wikimedia Commons / Public Domain) 




• Antimicrobial PDT: While the photodynamic effect was initially discovered in paramecia, the use in 
the microbial field was stopped due to the incapacity of typical antitumor PSs (neutral or anionic) to 
perform against Gram-negative bacteria. The better understanding of the system and the new 
developments in the photodynamic field have re-emerged antimicrobial PDT (hereafter aPDT) as a 
very promising strategy, particularly for the treatment of superficial and localised infectious 
diseases. Advantages over traditional antibiotics include a broad-spectrum activity (also against 
antibiotic-resistant spp) and the lack of development of resistance mechanisms due to the multi-
target process; one extra attractive feature peculiar to PDT as an antibacterial treatment is the 
possibility that the generated ROS may chemically destroy many of secreted virulence factors 
(especially those that are proteins).11  
 
Scheme 2. aPDT broad spectra of action.  
 
Moreover, aPDT it has gained use as research tool: to help identify the photochemical and 
photophysical mechanisms involved in inactivation, to develop potent and clinically compatible PS, 
to understand how photoinactivation is affected by key microbial phenotypic elements (multidrug 
resistance and efflux, virulence and pathogenesis determinants, biofilms), to explore novel delivery 
platforms inspired by current trends in pharmacology and nanotechnology and to identify 








In line with the first objective of the thesis we have focused our study in 3 different aPDT-based 
approaches: 
a) 3rd generation cationic PSs. 
While new families of PS have been developed and tailored, still many conventional 2nd generation 
PSs tend to aggregate in aqueous media due to π-stacking and hydrophobic interactions, resulting in self-
quenching of their photoexcited states. Thus, the photodynamic effect becomes significantly weaker. The 
concept of ‘3rd generation PSs’ evolved as a combination of the 2nd generation PSs associated to any drug-
delivery system which allows enhanced transport into the desired target.13 Examples of such delivery 
strategies comprise the use of emulsions or encapsulations with nanoparticles (NPs) and liposomes or 
association with antibodies or other biomolecules. However, they carry the risk of associated loss of 
photodynamic effect as well. When one considers the delivery strategy, the final receiver must be borne 
in mind. Gram-positive and Gran-negative bacteria differ in the composition of their bacterial wall, 
implying different susceptibility to PDT treatments. This fact, however, was only observed and 
understood in the 1990s, leading to a turning point in the use of aPDT.14 As previously described, the 
absence of external membrane in Gram-positive bacteria allows the entrance of conventional PS (neutral 
and anionic) while the highly organised and negatively charged outer membrane of Gram-negative 
bacteria retains them outside the outer membrane in most cases, preventing them from causing inner-cell 
damage upon illumination. The use of cell wall-disrupting agents such as EDTA or cationic polypeptides 
such as polymixin B was the next improvement step in this sense.15,16 However, the crucial discovery was 
the verification that PSs with intrinsically cationic charges at physiological pH were capable of achieving 
photoinactivation in both types of bacteria without the need for any co-administered agent.17,18 
Cationicity, thus, can be presented itself as a potential delivery tool for the objective to targeting Gram-
negative bacteria through a simplistic way minimising, a priori, loss of activity. Their overall positive 
charge ensures accumulation at the poly-anionic microbial cell surfaces in both types of bacteria. 
b) PSs conjugated to antimicrobial peptides 
An alternative approach to improve the susceptibility of Gram-negative bacteria to the photodynamic 
action of neutral PSs involves the covalent attachment of the PS to AMPs. AMPs are components of the 
innate defence system of many organisms and they are being considered a promising source of new 
antibiotics.19 Beyond the presence of several cationic amino acids, a s ubstantial proportion of 
hydrophobic amino acid residues permit most AMP to fold into an amphipathic structure that inserts into 




the phospholipid bilayer of the cell membranes. After insertion, AMPs act by either disrupting the 
physical integrity of the membrane or translocating across the membrane to hit internal bacterial targets.20 
This multi-target mode of action promises both low susceptibility to antibiotic resistance and a broad 
spectrum of activity against a v ariety of microorganisms. Among AMPs, the family of short proline-
arginine rich peptides attracts particular interest because of some unique features, such as a higher activity 
against Gram-negative bacteria, a relative stability against proteolysis, and a very low toxicity against 
mammalian cells. Apidaecin 1b, an insect 18-residue long peptide belonging to this family, is effective 
against a large number of Gram-negative bacteria and a few Gram-positive bacteria,21 where it acts by a 
non-pore-forming mechanism only partially elucidated. Mutagenesis22,23 and structure-activity 
relationship studies24 have identified the C-terminal half of apidaecin as essential for its antimicrobial 
activity and several studies have shown that the peptide is able to translocate a f luorescent tag into a 
bacterial cell.  
c) Fluorescent proteins as genetically encoded PSs. 
Because the PS is delivered from the cell exterior it has not been possible so far to separately study 
the contributions of external and internal damage, nor has it been possible to control the location of the PS 
and thus the primary site of photodamage.25 The small size of bacteria (Figure 2) precludes the use of 
fluorescence microscopy techniques due to the limited spatial resolution of this technique.  
 
Figure 2. Fluorescence image of TagRFP-expressing bacteria upon laser illumination at 532 nm (scale bar 5 µm) 
Electron microscopy (EM) has the necessary resolution and has recently revealed progression of 
envelope damage inflicted during irradiation.26 On the other hand, time-resolved studies of the formation 
and decay of 1O2 have been instrumental in establishing the coexistence of externally-bound and 
internalised PS molecules in E. coli.27 Still, a sound understanding of the role of drug location in the 





Since the discovery of the fluorescent proteins (FPs), novel variants have been engineered to tailor its 
properties. The development of mutants able to generate reactive oxygen species is pursued as a tool in 
microscopy, chromophore-assisted light inactivation (CALI) or PDT. Genetically encoded 1O2 PS that are 
able to express inside the cell can be a solution both to the issue of PS location in aPDT mechanistic 
studies and as mere photosensitising agents.  
KillerRed was the first genetically encoded ROS fluorescent protein and it has led to a plethora of 
successful studies especially in the CALI  field,28,29 but its sex-appeal was partially lost when it was 
discovered it was not a purely 1O2 PS.30,31 Previous studies in the group have shown that some green and 
red FPs are able to photosensitise 1O2 (Scheme 3).32-34  
 
Scheme 3. Towards efficient genetically-encoded 1O2 production by FPs. Graphical representation of the studies 
performed in the group over the years. 
Firstly we have approached TagRFP, a monomeric orange FP generated from the wild-type red 
fluorescent protein (RFP) from sea anemone Entacmaea quadricolor.35 It possesses bright fluorescence 
with excitation/emission maxima at 555 and 584 nm, respectively and it was recently reported to be a 
purely 1O2 generator that is able to sensitise 1O2 with a Φ∆ value of 0.004.36 Flavin-binding FPs have 
recently gained attention due to its smaller size and the maturation of the chromophore without the 
presence of oxygen.37 We have also focused our attention to miniSOG (for mini Singlet Oxygen 
Generator), a recently-reported flavin-binding FP claimed to produce 1O2 with high yield.38-40 
 





3rd generation cationic PSs 
AIM OF THE STUDY 
In the present study we analyse the photophysical properties as well as their behaviour against 
typical Gram-positive and Gram-negative bacteria of selected members of two families of cationic PSs as 
potential 3rd generation PSs. 
 
Graphical Abstract 1. Representation of the different behaviour of the tricationic porphycenes (a,b) or dendrimeric 
phthalocyanines (c,d) either in aggregated (a,c) or disaggregated (b,d) form. 
Porphycenes have long been shown as an interesting family of PS due to the appealing optical and 
photochemical properties conferred by their lower molecular symmetry as compared to porphyrins. A 
new tricationic porphycene, namely,  2,7,12-tris(trimethyl-p-tolyl)–17-(p-(methoxymethyl)phenyl) 
porphycene (NMe3MeO-TBPo) is compared against its predecessor, 2,7,12-tris(α-pyridinio-p-tolyl)–17-
(p-(methoxymethyl)phenyl) porphycene (Py3MeO-TBPo), in order to unravel the effect of different 
substituents on PDI activity (Scheme 4).  





Scheme 4. Representation of tricationic porphycenes of study 
On the other hand, we have also explored phthalocyanines bearing dendrimeric substituents (zero 
and first generation). Dendrimer-encapsulated chromophores are attractive for PDT because the inner 
chromophores are partially shielded from media while maintaining their photoactive form. Four highly 
charged dendrimeric phthalocyanines varying in degree of ionicity (4 or 8 positive charges) and 
coordinating metal (zinc or ruthenium) are presented as potential photosensitising agents in terms of 
antimicrobial activity (Scheme 5). 
 
Scheme 5. Representation of zero (n = 0) and first (n = 1) generation of dendrimeric cationic ruthenium (upper 
scheme) or zinc (lower scheme) phthalocyanines of study.  
 





Photophysical characterisation of porphycene derivatives.  
The main photophysical properties of NMe3MeO-TBPo are summarised in Table 1 and compared 
to those already reported for Py3MeO-TBPo and the parent 2,7,12,17-tetraphenylporphycene (TPPo).41,42 
Figure 3 shows a compilation of spectral differences between both compounds. In panels a,c comparison 
of the absorption spectra of NMe3MeO-TBPo and Py3MeO-TBPo in methanol (MeOH) and water can 
be seen, respectively. The profile remains similar for both compounds and in line with that of other 
porphycene derivatives. Only a small red shift can be observed for NMe3MeO-TBPo. Namely, a main 
band in the Soret region plus a small shoulder and three bands in the Q-region can be distinguished in 
MeOH while a remarkable loss of structure occurs (especially in the Q-region) in aqueous media due to 
aggregation effects. However, the absorption coefficient values are smaller in both media for NMe3MeO-
TBPo. 
 
Figure 3. Absorption (a,c) and fluorescence spectra of Py3MeO-TBPo (red) and NMe3MeO-TBPo (blue) in MeOH 
(a,b) and water (c,d) (solid and dotted line, respectively). Insets: Excitation spectra of the fluorescence at 700 nm (c). 
Time-resolved fluorescence decays (b,d). Signal, signal fit and instrument response function at 700 nm upon 
excitation at 375 nm. 
Regarding fluorescence measurements (panels b,d), ΦF values are smaller for NMe3MeO-TBPo both  
in MeOH and water (1.4 and 2.5-fold, respectively; Table 1). Cresyl violet in MeOH (ΦF = 0.54)43 was the 
chosen reference (see methodology in chapter II). Again, no significative spectral changes can be 




observed between both compounds. While minor spectral shifts occur due to solvatochromic effect, both 
compounds in both media exhibit the same fluorescence emission spectra profile, again characteristic of 
porphycenes (a main band and a weaker vibrational overtone at lower energy that are the mirror image of 
the S1  S0 absorption transition).44 This result let us hypothesise that the aggregates are not emissive. 
The fluorescence excitation spectra in water (inset panel c) match that of the compounds in MeOH, 
clearly confirming that only the monomers are fluorescent. 
As for the singlet state kinetics, fluorescence decays are monoexponential, consistent with the 
previous observation that only the monomeric species are fluorescent.42 The lifetime values are equal in 
MeOH for both compounds, only a tiny difference being found in aqueous media where the lifetime is 
slightly longer for NMe3MeO-TBPo (Table 1). 
1O2 signals were detected through direct observation of the 1O2 luminescence at 1275 nm –
maximum of 1O2 phosphorescence- for samples excited at 532 nm (Figure 4). Analysis of the signals for 
NMe3MeO-TBPo resulted in decay lifetimes that matched the literature 1O2 lifetime values in neat water 
and MeOH, respectively. No rising signal could be observed, thus triplet lifetime could not be assessed 
through direct luminescence neither in water or MeOH. 
 
Figure 4. 1O2 luminescence signals observed at 1275 nm for optically matched solutions at 532 nm of NMe3MeO-
TBPo (solid lines) and reference PSs (dashed lines) in water (a) or in MeOH (b). Inset: magnification of NMe3MeO-
TBPo signal in water. 5,10,15,20-tetrakis(m-hydroxyphenyl)-21H,23H-porphine (m-THPP) in water (a) and 
5,10,15,20-tetrakis(N-methyl-4-pyridyl)-21H,23H-porphine (TMPyP) in MeOH (b) are the chosen PSs. 
Comparison of the intensity of the 1O2 signals shown by NMe3MeO-TBPo to that of optically-
matched solutions of reference PSs (TMPyP; Φ∆ = 0.74 in water; m-THPP; Φ∆ = 0,69 in MeOH)45,46 are 
depicted in Figure 4 and yielded the Φ∆ values reported in Table 1. Once again, the comparison rendered 
slightly smaller values for NMe3MeO-TBPo respect to Py3MeO-TBPo. 




Table 1. Summary of photochemical properties of the porphycenes of study. 
Compound Solvent λAbs / nma λFluo / nmb ΦFc τS / ns ΦΔd τ∆ / µs 
TPPoe Toluene 659 (5.0·104) 667 0.150 4.8 0.230 - 
Py3MeO-TBPo 
MeOH 655 (5.1·104) 664 0.075 2.6 0.193 10.0 
Water 644 (2.6·104) 657 0.005 1.8 0.004 3.7 
NMe3MeO-TBPo 
MeOH 657 (4.7·104) 669 0.054 2.4 0.180 9.6 
Water 641 (2.0·104) 660 0.002 2.0 0.003 4.1 
a maximum of the lowest-energy absorption band with ε values (M-1·cm-1) in brackets. b maximum of the fluorescence band. 
c,d values at 532 nm. e Data from reference 41 
 
Photoinactivation studies of porphycene derivatives 
As a first approach, porphycene NMe3MeO-TBPo was tested against representative members of the 
Gram-positive and Gram-negative families (namely E. coli and S. aureus) as well as against two Candida 
spp (albicans and krusei). Population reductions up to 6-log10 in colony forming units per millilitre 
(CFU/mL) could be achieved in a light-dose and PS-concentration dependent fashion (Figure 5). Results 
were comparable to those previously reported for Py3MeO-TBPo while slightly less harmful. Dark 
controls revealed less than 1-log10 reduction in CFU/mL at the assayed concentrations (data not shown). 
 
Figure 5. Bacterial (a,b) and yeast (c,d) survival curves with Py3MeO-TBPo (red solid line) and NMe3MeO-TBPo (blue dashed 
line) upon red LED light (635 ± 15 nm) irradiation. (a) Light doses: 30 J·cm-2 (Py3MeO-TBPo) and 20 J·cm-2 (NMe3MeO-TBPo) 
against S. aureus (filled inverted triangles); 60 J·cm-2 against E. coli (open squares). (b) Bulk concentrations: 2 µM against S. 
aureus; 5 µM against E. coli. (c) Light doses: 15 J·cm-2 (Py3MeO-TBPo) and 22.5 J·cm-2 (NMe3MeO-TBPo) against C. krusei 
(filled triangles); 30 J·cm-2 (Py3MeO-TBPo) and 22.5 J·cm-2 (NMe3MeO-TBPo) against C. albicans (open circles). (d) Bulk 
concentrations: 10 µM against C. krusei; 20 µM (Py3MeO-TBPo) and 35 µM (NMe3MeO-TBPo) against C. albicans. 




The ability of NMe3MeO-TBPo as photosensitising agent was also assessed against more resistant 
strains, namely MRSA and P. aeruginosa. Over 6-log10 reduction in CFU/mL was achieved against 
MRSA for both porphycenes at concentrations below 0.75 µM keeping a light dose constant (Figure 6 a). 
Keeping the concentration constant at 0.5 µM, a population reduction up to 6-log10 CFU/mL could be 
achieved increasing the light dose to ca. 20 J·cm-2. A difference ca. 1-log10 CFU/mL was encountered 
when samples were centrifugated, the excess of PS removed, and bacteria resuspended in neat PBS prior 
to irradiation. This trend could be observed for both PSs under almost all conditions assayed. 
 
Figure 6. Bacterial photoinactivation and uptake studies. Py3MeO-TBPo (a,b; solid line) and NMe3MeO-TBPo 
(c,d; dashed line) survival curves against MRSA before (filled symbol) and after (open symbol) removing the excess 
of PS from the solution before irradiation. Light-dose was maintained at 7.5 J·cm-2 (a,c) and bulk concentration of 0.5 




µM was assayed (b,d). FACS population distribution of cells incubated with 0.5 μM Py3MeO-TBPo (e,g) or 
NMe3MeO-TBPo (f,h) for 30 min before (e,f) and after (g,h) removing the excess of PS. 
Fluorescence-activated cell sorting (FACS) flow cytometry experiments were carried out in order to 
correlate the binding of the PS with the photokilling efficiency. Samples incubated with 0.5 µM 
porphycene for 30 min were analysed removing or not the PS excess. Panels e-h in Figure 6 show the 
overall profile of the FACS distributions. The clear shift of the maximum to lower populations and the 
overall lower fluorescence intensity are indicative of partial removal of the PS (see data in Table 2). 
Figure 7 shows the results correponding to analogue experimentes assayed against Gram-negative P. 
aeruginosa. We were gladly surprised to also achieve ca. 6-log10 reduction for both PSs in the two series 
of experiments, altough higher doses either of light or concentration were required. 
 
Figure 7. Bacterial photoinactivation and uptake studies. Py3MeO-TBPo (a,b; solid line) and NMe3MeO-TBPo 
(c,d; dashed line) survival curves against P. aeruginosa removing (empty symbol) or not (filled symbol) the PS 




excess from the solution before irradiation. Light-dose was maintained at 100 J·cm-2 (a,c) and bulk concentration of 
20 µM was assayed (b,d). FACS population distribution of cells incubated with 0.5 μM Py3MeO-TBPo (e,f) or 
NMe3MeO-TBPo (g,h) for 30 min before (e,g) and after (f,h) removing the excess of PS. 
 
In this case, differences removing or not the excess of PS were less evident and differences only in 
the experimental errors were in the data set. FACS analysis was carried out for the optimum conditions, 
namely incubation with 20 µM PS for 30 min in the absence of light. Fluorescence measurements of the 
cell populations analysed rendered the results included in Table 2. As can be seen, and consistent with the 
survival curves, no significative difference in cell binding could be obtained removing or not the PS 
excess. Interestingly, the population profiles were not as narrow as for MRSA. This was especially 
noticeable for the case of NMe3MeO-TBPo where 2 different populations could be observed.  
 
Table 2. FACS fluorescence distribution upon uptake experiments. 
 Fluorescence Intensity / Counts 
Compound PS removal MRSA P. aeruginosa 
Py3MeO-TBPo 
NO 2600 ± 900 4200 ± 1000 
YES 2100 ± 400 4300 ± 2000 
NMe3MeO-TBPo 
NO 2600 ± 700 2600 ± 900 
YES 2000 ± 900 2600 ± 700 
    
 
Photophysical characterisation of dendrimeric charged phthalocyanines.  
A compilation of the photophysics of the 4 dendrimeric charged phthalocyanines is summarised in 
Table 3. As we will see in the following paragraphs, the different behaviour between organic and aqueous 
solvents has very much to do with aggregation issues. 
Figure 8 shows the normalised absorption spectra of all four phthalocyanines in tetrahydrofuran 
(THF), water and dimethylsulfoxide (DMSO). As previously anticipated, marked changes appear due to 
the degree of aggregation that they exhibit in each solvent. Aside from minor peak shifts derived from 
solvatochromic effects, the important changes rely in the relative intensities of the bands in each region. 
The spectrum in DMSO is taken as representative for the monomeric form, characterised by a narrow and 
intense red Q band.47 The general trend for three out of the four compounds is that they tend to 
disaggregate in aqueous media. This is not completely clear for compound ZnCat4+ (Panel a) whose Soret 




band, but not the Q region, resembles that in DMSO. Both ruthenium compounds pretty much completely 
disaggregate in water. In spite of having the same charges as their zinc analogues, the presence of the 
apical pyridil groups seems to prevent aggregation. 
 
Figure 8. Normalised absorption spectra of dendrimeric cationic phthalocyanines in DMSO (green dashed line), THF 
(red dotted line) and water (blue solid line). ZnCat4+ (a), ZnCat8+ (b), RuCat4+ (c) and RuCat8+ (d). 
 
Fluorescence of the compounds was also studied in the same series of solvents. As observed in 
Figure 9 and Table 3, there is a huge difference in behaviour depending on the nature of the central metal 
ion, only zinc phthalocyanines being fluorescent. Moreover, a great difference in ΦF values can be 
encountered for a given compound depending on the medium, once again due to aggregation.  
 
Figure 9. Normalised fluorescence spectra of dendrimeric cationic phthalocyanines in DMSO (green dashed line), 
THF (red dotted line) and water (blue solid line). ZnCat4+ (a), ZnCat8+ (b) 
 




Especially significant is the case of ZnCat8+ that shows ΦF values two orders of magnitude different 
in THF and water (Table 3). Similarly, the fluorescence of both ZnCat4+ and ZnCat8+ was completely 
lost in PBS. Fluorescence decay kinetics were also studied. 
Finally, the ability of the phthalocyanines to sensitise the production of 1O2 was studied both in THF 
and in aqueous media. Φ∆ measurements were performed by direct observation of 1O2 luminescence at 
1275 nm (as described above for porphycene derivatives), exciting either at 532 nm (for RuCats) or at 
355 nm (for ZnCats). In line with the fluorescence results, the photosensitising properties of the 
phthalocyanines hinged on the degree of aggregation, being more efficient when less aggregated. This 
effect was –once again- especially exagerated for compound ZnCat8+ whose Φ∆ value in water was two 
orders of magnitude higher than in THF (Table 3). The τ∆ values indicate that RuCats are better 1O2 
quenchers than ZnCats, as their τ∆ values are shorter than reported in the literature for the solvents used 
(21 µs in THF and 64 µs in D2O).48 This effect has previously been reported for other ruthenium 
dendrimeric derivatives, although to a lesser extent.49  
Table 3. Summary of photochemical properties of the dendrimeric phthalocyanines of study. 
Compound Solvent λAbs / nm λFluo / nm ΦF  a ΦΔb τ∆ / µs 
ZnCat4+ 
THF 679 688    < 1·10-4 0.002 20.8 
D2O 634 692 0.035 0.022 62.8 
ZnCat8+ 
THF 684 667 0.002 0.004 21.0 
D2O 690 698 0.538 0.119 64.0 
RuCat4+ 
THF 628 - < 1·10-4 0.011 19.7 
D2O 633 694 < 1·10-3 0.015 45.3 
RuCat8+ 
THF 631 - < 1·10-4 0.001 19.4 
D2O 636 694 < 1·10-3 0.017 38.7 
a Rhodamine 6G as reference (ΦF (ethanol) = 0.94). 50 b 5,10,15,20-Tetraphenyl-21H,23H-porphine (TPP ; Φ∆ (THF) = 
0.62) and meso-tetrakis(4-sulfonatophenyl)-porphyrin (TPPS ; Φ∆ (D2O) = 0.64) as references.46 
 
Photoinactivation studies of dendrimeric charged phthalocyanines 
All 4 dendrimers were assayed against E. coli to assess their potential use as photosensitising agents 
(Figure 10). Dark toxicity was below 1-log10 CFU/mL for the ZnCat compounds and RuCat8+, but ca. 2-
log10 CFU/mL for RuCat4+ at concentrations above 5 µM. A remarkable difference in PDI efficiency was 
also displayed depending on the coordinated metal. Undoubtedly, ZnCats performed far better than their 




ruthenium analogues. Ca. 6-log10 CFU/mL reductions were achieved at concentrations as low as 2.5 µM 
for ZnCat4+ and 5 µM for ZnCat8+ at 30 J·cm2 light dose. In contrast, a m ore modest reduction was 
obtained when using RuCat4+ in even more demanding conditions (ca. 5-log10 reduction at best with 5 
µM and 60 J ·cm2, but with dark toxicity over 1-log10 reduction). Compound RuCat8+ caused only a 
modest 2-log10 CFU/mL reduction even at 50 µM and 100 J·cm2; data not shown). 
An interesting effect could be observed for all families of compounds at high concentration: instead 
of achieving higher killing efficiency the efficiency worsened. Aggregation above a concentration 
threshold could be a plausible explanation to this behaviour. 
 
Figure 10. E. coli photoinactivation studies with ZnCat4+ (a), ZnCat8+ (b), RuCat4+ (c) and RuCat8+ (d) upon red 
LED light (635 ± 15 nm) irradiation. Different concentrations were used at different light doses: 10 J·cm-2 (triangles), 
30 J·cm-2 (filled squares), and 60 J·cm-2 (inverted triangles). Dark toxicity is represented with empty squares. 





Porphycene is a s tructural isomer of porphyrin and constitutes an interesting new class of 2nd 
generation PS. Porphycene derivatives show higher absorption values than porphyrins in the red spectral 
region (λ > 600 nm, ε ~ 50000 M-1·cm-1) owing to the lower molecular symmetry.44 Photophysical and 
photobiological properties of porphycene derivatives make them excellent candidates as PSs and have 
proven interesting in several recent studies addressing not only antimicrobial but also tumor targets.42,51-53 
Based on the encouraging results obtained with the first cationic aryl porphycene Py3MeO-TBPo 
against a wide variety of pathogenic spp both in vivo and in animal model42 a second member of the 
family of the tricationic porphycenes was synthesised in order to further investigate in the properties of 
the family. Decades of research on porphycenes has built the knowledge that most dramatic photophysical 
changes arise either by increasing the conjugation (electronic circulation of the core) or with the 
introduction of heteroatoms to the porphycene core.44 Thus, one would not expect remarkable changes 
due to the presence of trimethylammonium groups instead of pyridynium groups. Spectral changes were 
not huge; however, a general decrease in the photophysical parameters of study for NMe3MeO-TBPo 
was found. Moreover, a remarkable decrease in the ΦF value was observed not fully in line with the 
decrease in the τs. A notorious decrease in the ε value was also observed. Still, both Py3MeO-TBPo and 
NMe3MeO-TBPo photophysics lie far from those of parent TPPo. For instance, the τs values are almost 
half faster as compared to TPPo in toluene (4.8 ns), that can be attributed both to new deactivation 
pathways due to intermolecular interactions consequence of aggregation but also to the higher degrees of 
freedom conferred by the periferical residues. 
The PDI experiments resulted in a similar antimicrobial efficiency for both tricationic porphycenes 
with slight differences depending on the microbial type. In the case of Candida spp, Py3MeO-TBPo 
clearly outperformed NMe3MeO-TBPo. The reverse situation was found for MRSA and P. aeruginosa 
even though the difference between both compounds was below 1-log10. One remarkable difference was 
the significative dark toxicity of Py3MeO-TBPo at the highest concentration needed to photoinactivate P. 
aeruginosa. More significative is the fact that Py3MeO-TBPo had previously been unable to inactivate P. 
aeruginosa at 100 μM porphycene concentration and light dose up to 100 J·cm-2.42 However, both light 
source and, especially, cell strain (ATCC 19660 vs ATCC 25668) were markedly different. In fact, it is 
described that ATCC 19660 strain is especially virulent when inoculated in an area of burned skin, 




producing septicemia in mice while strain ATCC 25668 is sensitive to common antibiotics such as 
carbenicillin or gentamicin.54 
The second result to debate is the outcome regarding removal of the unbound PS prior to irradiation. 
In the case of MRSA the difference was ca. 1-log10 in performance for both PSs; however, little loss of 
efficiency occurred when same experiments were tested for P. aeruginosa. Overall, no clear effects can 
be attributed to the difference in charge density among Gram-positive and Gram-negative bacteria. In 
fact, previous studies for Py3MeO-TBPo also showed no significative differences between inactivation 
curves recorded either in the presence of excess of PS or after three washings.42 
 As far as the bacterial wall in Gram-negative is much more densely packed and negatively charged 
it is expected that the cationic PS will be better attached and less PS will be lost after centrifugation step 
as compared to the same experiment in Gram-positive bacteria. This hypothesis seems to correlate with 
the data obtained in our flow cytometry studies (bearing in mind the high error associated with the mean 
fluorescence intensity; Table 2). Thus, the positive charges on the PS appear to promote a tight 
electrostatic interaction with negatively charged sites at the outer surface of the Gram-negative bacteria. 
The fact that the efficiency of the photoinactivation processes is not highly altered seems to indicate that 
only the PS bound to the cells is involved in the photodynamic effect.  
Dendrimer-encapsulated chromophores are attractive for PDT because the bulky substituents 
prevent aggregation of the macrocycle. Their large dimensions should allow prolonged circulation in the 
blood and higher accumulation of dendronised PSs in the tumor tissues via the so-called enhanced 
permeation retention effect.55 We have assessed the potential of four different cationic dendrimeric 
phthalocyanines as potential antibacterial PSs. The study of the photophysics revealed substantial 
differences among them, the ZnCats dendrimers showing superior properties than the RuCats. This 
behaviour perfectly correlates with the results obtained in the PDI treatments against E. coli. While 
ZnCat4+ and ZnCat8+ achieved bacterial reduction over 6-log10 CFU/mL at low concentration/light doses 
this is not the case for RuCats, especially for the octacationic compound. 
The incorporation of positive charges in PSs has been a benchmark in the reemerging of aPDT as a 
potential platform to fight antibiotic-resistant microbials. Still, cationicity is not a straightforward 
property and caution is to be borne in mind since most PSs are comprised of a highly hydrophobic core. 
In spite of the solubility in aqueous media that cationicity confers, one must not forget the fact that 




aggregation is likely to be present. And most of the times aggregation means loss of photodynamic 
potential. The photophysical studies summarised in Tables 1 a nd 3 clearly exemplify that some 
photophysical properties can decrease up to two orders of magnitude (i.e. ΦF or Φ∆ values). It is 
interesting to note that the disaggregated form –and thus the one that exhibits best photophysical 
properties- corresponds to opposite media depending on the family of the studied compounds. Thus, for 
porphycenes the best performance in cuvette is found in organic-like media, while for the dendrimeric 
compounds the most powerful skills arise in aqueous media.  
Results show that both cationic porphycenes as well as ZnCats perform nicely against E. coli, 
reaching 6-log10 reduction in CFU/mL at concentrations 5 µM or lower. We infer three different issues in 
the explanation: A) there must be different localisation of the active compounds so that in all cases they 
are disaggregated (no matter where or how). B) In line with the previous statement, the 
hydrophobicity/hydrophilicity balance must be an important factor. C) Finally, but not least important, the 
number and distribution of charges in the compounds is also a key parameter. Some studies have 
attempted to establish relationships between PDI efficiency and the overall charge of the PSs. The study 
of Caminos et. al showed that the photosensitising efficiency of a series of meso-substituted cationic 
porphyrins against E.coli , followed the trend (PS)3+ > (PS)4+ >> (PS)2+ > (PS)+.56 In our case, a shallow 
comparison would point out that ZnCat4+ outperforms them all while tricationic Py3MeO-TBPo and 
NMe3MeO-TBPo, and ZnCat8+ work more or less with the same efficiency. However, it is very risky to 
extrapolate the results as different families with markedly different behaviour are being compared. Thus, 
no extra conclusions should be taken without further investigation under same conditions.  
Photokilling efficiency among dendrimers seems to go in line with the photophysics of the 
compounds. In general, ZnCats showed better properties, namely higher ΦF and Φ∆ values. However, 
behaviour in the presence of cells should be further studied. In order to correlate the promising results in 
killing efficiency one could hypothesise that in the presence of bacteria ZnCats will be able to 
disaggregate in order to exhibit their best photophysical behaviour. On the contrary, RuCats will probably 
have worse affinity towards E. coli. Especially, this is expected for RuCat8+ whose killing efficiency 
rendered extremely poor. 
 
 





Six different cationic PSs have been assayed against bacterial cultures in order to correlate its 
photochemical behaviour in cuvette with their photokilling efficiency. The differences arising from their 
macrocyclic inner structure renders different behaviour in solution towards aggregation. While 
porphycene family seems to disaggregate more in organic solvents dendrimeric phthalocyanines present 
better skills in aqueous media. Still, best candidates in both families achieve a similar photoinactivation 
efficiency towards E. coli, indicating disaggregation when uptaken and consequent different localisation. 
The more complete study of tricationic porphycenes renders a higher affinity towards Gram-negative 
organisms as deduced from the photoinactivation and flow cytometry results comparing experiments 
removing or not the excess of PS. Finally, the different amount of charges seem to have an important 
effect, while further conclusions cannot be obtained since different conditions have been used. 
 




SPECIFIC EXPERIMENTAL SECTION 
Chemical synthesis. 2,7,12-Tris(r-pyridinio-p-tolyl)-17-(p-(methoxymethyl)phenyl) porphycene 
(Py3MeO-TBPo) was synthesised as previously described42 and its analogue 2,7,12-
tris(trimethylamonioum -p-tolyl)-17-(p-(methoxymethyl)phenyl) porphycene (NMe3MeO-TBPo) with 
small variation in the last step. Purity of NMe3MeO-TBPo was confirmed by thin layer chromatography 
using a pre-coated TLC plate (Silica gel C18 0.25 mm; Macherey-Nagel) in a t rifluoroacetic 
acid/acetonitrile mixture (20:80), providing a unique spot at Rf = 0.26. 1H-NMR (δ / ppm, d6-MeOD): 
10.02 (brs, 4H), 9.98 (brs, 4H) 8.58 (d, 6H), 8.38 (d, 2H), 7.84 (d, 2H), 8.06 (d, 6H); 4.86 (s, 6H), 4.58 (s, 
2H); 3.72 (s, 2H), 3.59 (s, 2H), 3.30 (s, 27H).  
UV/Vis (MeOH): 657 (46483), 626 (41129), 584 (32590), 393(80599), 377 (102543) 
 
HRMS (ESI-TOF) m/z C58H64N7O13+ [M-3Br] found, 290.5054.  
Flow Cytometry. The interaction of PSs with bacteria was evaluated by flow cytometry. For these 
experiments, the bacteria were subjected to the same treatments used for PDI experiments, but instead of 
being illuminated after incubation and washing they were analysed with a FACSCantoTm II flow 
cytometer. Samples were excited with the 488 nm laser, and fluorescence emission signals were recorded 
at wavelengths higher than 670 nm. The bacteria population was isolated from instrument noise by setting 
electronic gates on the dual-parameters dot plots of forward scatter against side scatter. For each sample, 
20000 events were acquired and analysed with the FACSDiva software (BD). Samples not incubated with 














AIM OF THE STUDY 
Binding to a cationic antimicrobial peptide offers the attractive prospect of improving both the water 
solubility and the localisation of the photoactive drug in bacteria. In this work we have compared a 
number of free and apidaecin-conjugated PSs differing in structure and charge. 
We report the photophysical characterisation and relation to the phototoxicity studies against E. coli 
and MRSA of new conjugates in which apidaecin and its C-terminal octapeptide were modified at the N-
terminus with neutral or charged porphyrin and porphycene PSs. 
Our results indicate that the conjugation of per se ineffective highly hydrophobic PSs to a cationic 
peptide produces a photosensitising agent effective against Gram-negative bacteria. Apidaecin cannot 
improve the phototoxic activity of cationic PSs, which mainly depends on a very high yield of singlet 
oxygen production in the surroundings of the bacterial outer membrane. Apidaecin−PS conjugates appear 
most promising for treatment protocols requiring repeated washing after sensitiser delivery. 
 
 
Graphical Abstract 2. Representation of the combination of different PSs and Apidaecin 1b seeking synergistic 
effects for enhanced aPDT treatments.  
 
                                                 
i This section has been adapted from the work published in J.Med.Chem. 2013. Vol.56. pp 1052-1063  





Conjugates description.  
 4 conjugates comprised by Apidaecin 1b and 4 different PSs (two neutral porphyrins, a tricationic 
porphyrin and a neutral porphycene) were the basis of the study (Scheme 6). Further details on the 
synthesis, purification and characterisation of the compounds can be found in reference 57.  
 
Scheme 6. Structure of the PSs of study and the conjugated peptides 
 
Absorption and fluorescence of the conjugates.  
 The spectroscopic and photophysical properties of the PSs and their conjugates were measured in 
aqueous and organic media and in cell suspensions in order to assess structural and environmental effects 
as well as their correlation with antibacterial activity. 
MeOH. Figures 11 and 12 show the absorption and fluorescence spectra of the free PSs and of their 






Figure 11. Absorption spectra in MeOH (A−D), PBS (E−H), and E. coli suspensions (I−L), normalised to facilitate 
their comparison. The concentration is 5 μM for all compounds. MeOH: (A) 4e (red) and 4b (blue); (B) 2c (red) and 
2a (blue; dichloromethane (DCM) as solvent); (C) 1d (red) and 1b (blue); (D) 1c (red) and 1b (blue). PBS: (E) 4e 
(red) and 4b (blue); (F) 2c (red) and 2a (blue); (G) 1d ( red) and 1b (blue); (H) 1c (red) and 1b (blue). E. coli 
suspensions (green): (I) 4e; (J) 2c; (K) 1d; (L) 1c. Spectra in MeOH (red) and PBS (blue) are given for comparison. 





Figure 12. Emission spectra in MeOH (A−D), PBS (E−H), and E. coli suspensions (I−L), normalised to facilitate 
their comparison. The concentration is 5 μM for all compounds. MeOH: (A) 4e (red) and 4b (blue); (B) 2c (red) and 
2a (blue; DCM as solvent); (C) 1d (red) and 1b (blue); (D) 1c (red) and 1b (blue). PBS: (E) 4e (red) and 4b (blue); (F) 
2c (red) and 2a (blue); (G) 1d (red) and 1b (blue); (H) 1c (red) and 1b (blue). E. coli suspensions (green): (I) 4e; (J) 





While the spectra of porphyrins are essentially insensitive to conjugation (panels A, C, D), clear 
changes can be observed for the porphycene (panel B). In turn, the ΦF value does not change appreciably 
for the porphyrins while it drops by ca. 50% for the porphycene (Table 4). Finally, all porphyrins show 
monoexponential fluorescence decay kinetics and conjugation does not change the lifetime values either 
(Table 4). Again, the situation is different for the porphycenes in that the conjugate 2c shows 
biexponential kinetics unlike the free porphycene 2a (Table 4) and on average the singlet state decays 
faster (Table 4). 
Table 4. Fluorescence properties of the peptide conjugates and model compounds in MeOH, PBS and in E. coli 
suspensions. (Fractional amplitudes in parentheses) 
 λF, max / nm   ΦF  τS / ns 
Compound MeOH PBS E. coli  MeOHa PBSb  MeOH PBS E. coli 
           
1b 647 nsc -  0.040 ns  10.1 ns - 




















2a 715 ns -  0.030d -  1.46d - - 
2c 697 - - 
 
0.016 <1·10-3 





4b 656 675 -  0.022 0.008  7.9 4.2 - 









a Cresyl violet as standard (ΦF (MeOH) = 0.54.43 b TMPyP as standard (ΦF (PBS) = 0.017).58 c Not soluble. d In toluene. 
 
Aqueous solutions (PBS). Porphyrin 4b is water soluble as a co nsequence of its positively- and 
negatively-charged groups. It remains water soluble after conjugation (4e) with small but clear shifts in 
the position of the Soret and Q absorption bands and changes in their relative intensities (Figure 11E). 
The fluorescence spectrum of 4b shows a single, structureless broadband (Figure 11E), a behaviour 
strikingly different from that in MeOH but in line with that of the related tetracationic TMPyP.59 
Conjugation to the peptide (4e) leads to partial recovery of the two well-resolved fluorescence bands 
observed in MeOH. The fluorescence decay kinetics of 4b is monoexponential, albeit with lifetime much 




shorter than in MeOH. For the conjugate 4e two decay components can be observed, whose lifetimes are 
close to those of 4b in MeOH and in PBS, respectively (Table 4). The kinetics are independent of 
concentration over 3 orders of magnitude (Figure 13).  
Figure 13. Time-resolved fluorescence at 660 nm in MeOH and IRF (grey) upon excitation at 405 nm, normalised to 
facilitate their comparison. A) 4e at 5 μM (red), 0.5 μM (blue) and 0.05 μM (green). B) 1d at 5 μM (red), 0.5 μM 
(blue) and 0.05 μM (green). C) 1c at 5 μM (red), 0.5 μM (blue) and 0.05 μM (green). 
On the other hand, porphyrin 1b and porphycene 2a are insoluble in water and therefore no 
fluorescence can be recorded in this solvent. Conjugation to the peptides (1c, 1d and 2c, respectively) 
renders them water-soluble but the spectroscopic and photophysical properties change substantially 
relative to MeOH: the absorption spectra show broadening of the Soret band and loss of structure in the Q 
region (Figure 11F-H) and the fluorescence is dramatically quenched. In addition, the fluorescence 
spectra of 1c-1d are slightly red shifted (Figure 12G,H), and the decays are biexponential (Table 4) and 
show a clear concentration trend (Figure 13B,C). 
E. coli suspensions. The conjugate 4e shows in cell suspensions the same absorption and fluorescence 
properties as in PBS (Figures 11I-12I and Table 4). On the other hand, there are evident changes for 
conjugates 1c and 1d relative to PBS, particularly in the absorption spectrum and in the fluorescence 
kinetics, which show a third decay component not present in PBS or in MeOH (Table 4). Finally, 
porphycene conjugate 2c shows a very similar absorption spectrum in PBS and in E. coli suspensions 
(Figure 11J). However, while we could record no fluorescence in PBS, we were nevertheless able to 
observe extremely weak biexponential fluorescence decay in cell suspensions (Figures 12, and Table 4). 
Singlet oxygen production and decay. All free and conjugated PSs were able to photosensitise the 
formation of 1O2 in MeOH as evidenced by its phosphorescence at 1275 nm. The quantum Φ∆ values 
were in the 0.6-0.7 range for the porphyrins and 0.1-0.3 for the porphycenes (Table 5). The kinetics of 





shown). Likewise, an excellent match was found between the observed lifetime of 1O2 and literature 
values. In PBS, only porphyrins 4b and 4e retained their high ability to produce 1O2. All other 
compounds experienced a decrease of the Φ∆ value by 20-30-fold (porphyrins 1c and 1d) or even 100-
fold (porphycene 2c; Table 5). Inspection of the kinetics of 1O2 reveals that production of 1O2 by 
conjugate 4e is as fast as by the free porphyrin 4b (Table 5), yet for the conjugates 1c, 1d and 2c it is one 
order of magnitude slower. On the other hand, the lifetime of 1O2 for all conjugates in dPBS is shorter 
than the value expected in this solvent (65 μs),60 which is actually observed only for the free porphyrin 
4b. When E. coli suspensions were studied, the 1O2 signals showed essentially the same pattern as in PBS 
solutions (Table 5).  
Table 5. Kinetics of singlet oxygen production (ΦΔ) and decay (τ∆) of the peptide conjugates and model compounds 






 / µs 
MeOH a PBS b MeOH PBSc E. colid 
1b  0.63 Ns
e
  9.8 f ns - 
1c 
 




1d  0.66 0.036  9.5 45g - 
2a  0.26h ns  - ns - 
2c  0.14 0.001  9.8 42g - 
4b 
 










a TMPyP as reference (Φ∆  (MeOH) = 0.74).46 b TPPS as reference (Φ∆  (water) = 0.69).46 c Literature value 












In a p revious communication it has already been shown that the conjugate 1c is endowed with 
antibacterial activity upon light activation.57 In this work we have extended the investigations towards 
other porphyrin-apidaecin conjugates, containing either neutral or cationic groups in order to assess the 
effects of structural modifications. Porphycene, a structural isomer of porphyrin, was also included in the 
study for its larger absorption coefficients in the red part of the spectrum, where light can deeply 
penetrate in tissues (Scheme 6). Because positively-charged PSs are effective in PDT against Gram-
negative bacteria without the addition of outer membrane-disrupting agents,62 we hypothesised that a 
conjugate between apidaecin and a ca tionic porphyrin could further promote the uptake of the PS in 
Gram-negative bacteria, thereby reducing the minimum effective dose. Moreover, in order to establish 
whether the antimicrobial peptide is able to direct the PS against specific bacterial targets, we synthesised 
also a conjugate between porphyrin 1b and a short cationic nonapeptide (GPRPPHPRL) corresponding to 
the C-terminal segment of apidaecin.  
Although the mode of action of apidaecin has not been determined in detail, several evidences 
suggest that this peptide enters E. coli cells by a non-pore forming mechanism and, once inside the cell, it 
interacts with components of the protein synthesis machinery, impairing protein synthesis and folding. 
The full-length apidaecin sequence is very important and the C-terminal nonapeptide does not possess 
any antibacterial activity63 nor is able to translocate a fluorescent cargo into bacterial cells.64 Thus, most 
probably, the conjugate with this cationic peptide (1d) can effectively bind to the bacterial cell wall 
without being able to reach the cytosol.  
Efficient PSs for PDT must have appropriate photophysical properties, such as an intense red-light 
absorption band and a high quantum yield of generation of both the long-lived excited triplet state and 
cytotoxic ROS, in particular 1O2. To establish whether the peptide moiety negatively affects the PS 
photosensitising efficiency, the porphyrin-peptide conjugates were submitted to a detailed photophysical 
characterisation.ii  
                                                 
ii For the sake of a more complete discussion, correlation with phototoxicity results as well as with FACS and circular dichroism 
(CD) spectroscopy has been included even though they were conducted by our collaborators in the Biology and Chemistry 






The fluorescence properties and the 1O2 production ability of the peptide conjugates 1c-d and 4e in 
MeOH (Tables 4 and 5) are essentially identical to those of free PSs, demonstrating that the peptide 
moiety exerts no influence on the PS photosensitising efficiency in this solvent. Only in the case of 
porphycene 2a changes can be observed in the absorption spectrum and a reduction by about 50% of the 
ΦF value of the PS and in 1O2 production after conjugation to the peptide, which may be ascribed to 
interactions between the peptide and the macrocyclic core.  
The situation is different in aqueous environment where the photophysical data change considerably 
relative to MeOH for all conjugates and particularly for those containing a neutral PS. The decrease in ΦF 
value, the concentration dependence of the fluorescence kinetics, and the slow kinetics of 1O2 production 
in 1c-d and 2c reveal the presence of intermolecular interactions as observed also by CD spectroscopy 
(data not shown). Such interactions account also for the 20-fold lower production of 1O2 in PBS relative 
to MeOH (Table 5). Nevertheless, following illumination (with blue light for 1c-d and red light for 2c) 
the conjugates resulted phototoxic against E. coli cells, inducing a decrease of survival of 3-4 log10 at 15 
µM concentration (data not shown). On the other hand, the unconjugated PS 2a was completely 
ineffective towards E. coli (data not shown), consistently with data previously reported for 1b57 and other 
neutral porphyrins, which are unable to diffuse through the highly organised outer membrane of Gram-
negative bacteria.65  
Peptide conjugates 1c-d and 2c associate efficiently to E. coli cells, as suggested by the observation 
that repetitive washing of bacteria treated with conjugates, before illumination, caused only a moderate 
reduction of phototoxicity (data not shown). In the case of 1c-d this is also supported by the flow 
cytometry results (data not shown). Porphycene was not fluorescent enough for FACS studies but the 
detection of fluorescence by time-resolved techniques in the E.coli suspensions, but not in PBS (Table 4), 
is taken as proof for binding.  
A deeper understanding of the type of binding/association of 1c-d to E. coli cells was obtained by 
analysing the fluorescence decay kinetics: unlike PBS or MeOH, three decay components were observed 
in cell suspensions, which suggest multiple binding sites (Table 4). The match between two of the three 
observed lifetimes with those detected in PBS indicates that one binding site is located in an aqueous-like 
environment. Thus, the third decay component suggests that an additional binding site exists where the 
conjugates experience a less hydrophilic environment. However, the phototoxicity, the photophysical and 




flow cytometry results for the apidaecin conjugate 1c and its truncated analogue 1d are so similar that it is 
difficult to propose a different localisation of these conjugates in E. coli cells. Most probably both 
conjugates can diffuse through the OM and localize in different environments, but since the C-terminal 
apidaecin fragment is unable to translocate a PS across the cytoplasmic membrane, we are led to conclude 
that the apidaecin conjugate is also not able to reach the bacterial targets of apidaecin in cytosol. 
The conjugate between the cationic porphyrin 4e and apidaecin possess a +6 net positive charge, 
well distributed along the whole molecule that is expected to discourage the aggregation phenomena 
observed in conjugates 1c and 2c. In confirmation of this, the far-UV CD spectrum of 4e in water is very 
similar to that of the free peptide and no dichroic signal, indicative of porphyrin-porphyrin interactions, 
was detected in the Soret band region (Figure 11 A and B). Aggregation can also be ruled out by the lack 
of concentration effects on the decay kinetics (Figure 13). It can therefore be safely concluded that the 
major differences observed between 4b and 4e (Table 4) are due to interactions between apidaecin and 
the porphyrin within the conjugate.  
Comparison of the fluorescence spectrum, quantum yield and kinetics for 4b and 4e, reveals that 
two populations of conjugates coexist, in which the porphyrin is either exposed to water or shielded from 
it by the peptide. This conclusion is consistent with the well-known solvent-polarity effects on the 
fluorescence of tetra-pyridinium porphyrins.59 Nevertheless the production of 1O2 was very high in PBS, 
comparable or even higher than that in MeOH (Table 5). In fact, the conjugate 4e caused total 
photokilling of E. coli cells at a co ncentration (10 µM) at which 1c induced a strong (4-log10) but 
incomplete reduction of cell survival. The cationic porphyrin 4b proved to be even more potent than its 
apidaecin conjugate 4e.  
The 1O2 lifetime data in Table 2, particularly in dPBS, indicate that apidaecin is able to quench 1O2. 
Thus, because 1O2 molecules are generated in the vicinity of apidaecin, some of them will be quenched 
by the peptide during their lifetime rather than by cell components. The washing of the cells before 
illumination, to remove the unbound or weakly associated PS, caused a tremendous reduction of 
photokilling of E. coli cells and under these conditions 4b became the least efficient PS (data not shown). 
Flow cytometry measurements showed that only unwashed cells exhibited red fluorescence slightly above 





Thus, the results indicate that 4b and 4e associate very weakly to E. coli cells and the killing of 
unwashed cells is caused mainly by 1O2 generated by the PS molecules not associated or loosely 
associated to bacteria. Several reports of PDT on Gram-negative bacteria have pointed out that if 1O2 can 
be generated in sufficient quantities near to the bacterial OM, it will be able to diffuse into the cell to 
inflict damage to vital structure. Our photophysical data thus support this hypothesis. 
 





Binding to an AMP offers the attractive prospect of enhancing both the water solubility of the PS 
and the efficiency of the PDT treatments through a synergistic effect. In this work we have compared a 
number of free and apidaecin-conjugated PSs differing in structure and charge. Our results confirm 
previous findings that the conjugation of per se ineffective highly hydrophobic PSs to a cationic peptide 
produces a photosensitising agent effective against Gram-negative bacteria. The apidaecin ability to 
penetrate Gram-negative bacteria is lost after conjugation to a bulky PS, but the amphiphilic character 
conferred by the peptide enforces the binding of the PS to the bacterial OM. 
Apidaecin-PS conjugates appear most promising for treatment protocols requiring repetitive 
washing after sensitiser delivery, where the most active cationic PSs, such as 4b and its apidaecin 
conjugate 4e, are rapidly washed out. On the other hand apidaecin cannot improve the phototoxic activity 
of the cationic porphyrin, which is mainly determined by a very high yield of singlet oxygen production 















AIM OF THE STUDY 
In the present study we explore the use of TagRFP and miniSOG as genetically encoded PSs in 
aPDT not only as antimicrobial agents but also as “Trojan horses” that shed light on cell death 
mechanisms underlying bacterial photoinactivation treatments. Moreover, for miniSOG the 1O2 
generation mechanism has been analysed in further detail and the Φ∆ value has been reassessed (Φ∆ = 
0.03 ± 0.01) using two alternative and independent methods. We provide further insight into the 
photochemistry of miniSOG and we ascertain the reasons for the discrepancy in Φ∆ values (reported 
value of Φ∆ = 0.47 ± 0.01).  In addition, we find that cumulative irradiation of miniSOG increases its Φ∆ 
value ca. 10-fold due to a photoinduced transformation of the protein 
 
 
Graphical Abstract 3. TagRFP and miniSOG, fluorescent proteins capable of photosensitising the production of 
singlet oxygen have been expressed in E. Coli. Photophysics and mechanistic aspects of photoinduced cell death have 
been thoroughly studied and discussed.  
   
                                                 
iii This section has been adapted from the work published in Photochem.Photobiol.Psi. 2012. Vol.11 pp 1411-1413; Proc. of SPIE 
2013. Vol. 8596 doi: 10.1117/12.2000695 and JACS 2013. (under revision) 





Photodynamic inactivation studies.  
When E. coli BL21 (DE3) cells expressing TagRFP in the cytosol were irradiated (535 ± 15 
nm) no significant damage was observed for light doses below 750 J·cm-2. However, a population 
reduction of ca. 4-log10 in CFU/mL was achieved after a l ight dose of 3200 J·cm-2 in dPBS 
suspensions (ca. 2.5-log10 CFU/mL reduction in normal PBS; Figure 14A). E. coli cells transformed 
with pET20b control plasmid, devoid of the TagRFP sequence, were tested under the same 
experimental conditions. As shown in Figure 1A, a reduction less than 0.5-log10 CFU/mL was 
observed in all cases. In addition, non-irradiated bacteria expressing TagRFP did not significantly 
lose viability (data not shown). These negative controls confirm that damage is inflicted by 
photodynamic effect, i.e., by the combination of light, oxygen and TagRFP acting as PS. 
A similar experiment was performed with E. coli DH5α cells expressing miniSOG in the cytosol. A 
population reduction of over 1-log10 units was achieved after light doses as mild as 2.5 J·cm-2 and up 
to 3.5-log10 units was observed after 12 J·cm-2 treatment (Figure 14B). As above, an enhancement of 
photoinduced cell death was observed when the experiment was performed in dPBS. No damage was 
observed at maximum light dose without miniSOG. Moreover, no damage could be effected to 
bacteria expressing miniSOG in the absence of light (data not 
shown).
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Figure 14. A) Photoinactivation of E. coli BL21 (DE3) expressing TagRFP in the cytosol upon irradiation with 532-
nm laser light. Light-dose dependence on cell death transformed with pET20TagRFPhis in PBS (red circles) or dPBS 
(blue triangles). Control with pET20b in PBS (black diamonds) or dPBS (grey squares). B) Light-dose dependence 
(475± 15 nm LED irradiation) on bacterial cell death in E. coli DH5α expressing miniSOG in PBS (red circles) and 
dPBS (blue triangles). 





In order to obtain further insight into the mechanism of cell death photosensitised by both FPs, 
several additional assays were performed. First, we focused on the cytoplasmic cell membrane. Damage 
to the bacterial IM can be tracked spectroscopically through absorbance measurements at 260 nm.66,67 The 
results of this assay are shown in Figure 15 (red circles), where the 260 nm absorbance of the 
supernatants of irradiated bacteria suspensions is plotted as a function of the light dose. Data have been 
normalised against the values for non-irradiated samples. In both cases (TagRFP- and miniSOG-
expressing bacteria) a clear growth in the 260 nm absorbance can be observed almost from the outset. 
In a s econd series of assays, the integrity of the OM was assessed after PDI treatments. The 
fluorescent probe 1-N-phenylnaphthylamine (NPN) increases its fluorescence upon binding to cells with a 
damaged OM.67,68 As shown in Figure 15 (blue circles), there is a markedly different behaviour between 
TagRFP- and miniSOG-expressing bacteria. For TagRFP, no increase in NPN fluorescence was observed 
relative to dark control suspensions. However, over two-fold increase in NPN fluorescence was observed 
in miniSOG-tagged bacteria. NPN fluorescence measurements in water and in lysed cells served as 
further controls (data not shown). 













































Figure 15. Bacterial cell envelope integrity assays after different aPDT light-dose treatments. Red circles: absorbance 
of supernatants at 260 nm. Blue triangles: fluorescence of NPN. Data are normalised to values measured for non-
irradiated samples. A)TagRFP in E. coli BL21 (DE3), laser irradiation at 532 nm; B) miniSOG in E. coli DH5α. LED 
irradiation at 475 nm.  
 Finally, damage to genomic DNA from genomic E. coli cells was studied. DNA from irradiated 
cells was extracted by standard procedures and electrophoresis of the extracts was run in a 0.6 % agarose 
gel. As shown in Figure 16, no differences could be observed between samples irradiated at the maximum 
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The triplet state of miniSOG was investigated using nanosecond laser flash photolysis (for 
experimental details consult Chapter II). Upon excitation of oxygen-free solutions at 355 nm, a transient 
signal with lifetime of 35 µs was observed at 300 and at 700 nm (Figure 18a-b), with a decay rate that 
was accelerated by oxygen (3 µs in aerated solutions; Figure 18c). This transient signal is therefore 
ascribed to the triplet state of miniSOG. For comparison, the triplet lifetime of FMN was 42 µs and the 
transient absorbance was two-fold larger for an optically-matched solution (Figure 18a-b). 
 
Figure 18. Transient absorption decays of FMN (blue line) and miniSOG (red line) observed at 300 nm (a) and 700 
nm (b) for argon-saturated optically-matched solutions excited at 355 nm. Transient absorbance decays for argon-
saturated solutions (green line) or aerated solutions (pink) of miniSOG observed at 300 nm and excited at 475 nm (c). 
As the previously reported Φ∆ value of miniSOG (Φ∆ = 0.47 ± 0.05 40) was determined by an 
indirect method based on the fluorescence photooxidation of 9,10-anthracene dipropionic acid (ADPA), 
we have now measured it by directly monitoring the phosphorescence of 1O2 at 1275 nm  in a time-
resolved manner.71 For these studies, miniSOG was dissolved at a concentration of 2.5 µM either in PBS 
or in a mixture of dPBS and PBS (9:1) since deuteration increases the 1O2 lifetime and thus facilitates its 
detection.72 Upon pulsed excitation at 355 nm, clear 1O2 phosphorescence signals could be detected in 
both media (Figure 19). Comparison of the intensity of the miniSOG 1O2 signal to that of optically-
matched reference solutions of FMN and phenalenone-2-sulfonate (PNS; Φ∆ = 1),73 at the excitation 
wavelength of 355 nm and in the same solvent,74 yielded Φ∆ = 0.03 ± 0.01 irrespective of solvent 
deuteration. 






Figure 9. MiniSOG-photosensitised 1O2 formation. 1O2 phosphorescence signals for optically-matched solutions of 
the reference photosensitiser PNS (top, green line), FMN (middle, blue line) and miniSOG (bottom, red line) excited 
at 355 nm in PBS; the intensities are proportional to the Φ∆ values. 
To resolve the discrepancy between the reported and the measured values we used an alternative 1O2 
chemical trap. Uric acid (UA) was chosen as it reacts with 1O2 through a different mechanism than 
ADPA.75,76 Using UA we obtained Φ∆ = 0.03 ± 0.01 both in PBS and in dPBS upon excitation at 450 nm 
(Figure 20), fully in line with the value measured by time-resolved 1O2 phosphorescence (Table 6).  
 
Figure 20. Singlet oxygen quantum yield determination using UA as probe. Spectral variations of optically-matched 
solutions of FMN (a) and miniSOG (b) in the presence of UA 50 µM upon excitation at 450 nm. Insets: time-
dependent absorbance variations at 292 and 315 nm. (c) Comparison of UA bleaching rate at 292 nm in the presence 
of miniSOG (red) or FMN (blue). 
Table 6. MiniSOG Φ∆ values obtained by different techniques 
Φ∆ 
Method PBS dPBS 
Luminescence 0.03±0.01 0.03±0.01 
Uric Acid 0.03±0.01 0.03±0.01 
ADPA 0.42±0.02 0.18±0.02 
 




Next series of experiments were carried out to ascertain the ADPA mismatching results. When 
oxygen-depleted solutions of miniSOG or FMN were blue-irradiated in the presence of increasing 
amounts of ADPA formation of new long-lived transient species could be readily observed, whose 
absorbance increased in an ADPA-concentration dependent manner (Figure 21a-b). In addition, we 
observed that, in the presence of ADPA, the fluorescence of miniSOG was partially quenched and the 
spectrum lost its vibronic structure (Figure 21c). 
 
Figure 210. Transient absorption of (a) FMN and (b) miniSOG in deaerated PBS solutions in the presence of 
increasing amounts of ADPA (0 µM, blue line; 12 µM, green line; 60 µM, black line). λexc = 475 nm; λobs = 300 nm. 
(c) MiniSOG fluorescence time-dependent changes upon addition of 20 µM ADPA. λexc = 450 nm. 
Finally, we have further assessed the involvement of electron-transfer processes in ADPA 
degradation by studying the photooxidation of ADPA by 4-diphenyl-6-(4´-methoxyphenyl)pyrylium 
tetrafluoroborate, which acts as an electron acceptor and does not generate 1O2.77  Figure 22 
unequivocally shows that ADPA fluorescence gradually disappears upon irradiation of this type I PS.  
 
Figure 22. (a) Absorption spectra of ADPA (blue) and 2,4-diphenyl-6-(4´-methoxyphenyl)pyrylium tetrafluoroborate 
(Pyrilium; orange). (b) ADPA fluorescence photobleaching upon blue light irradiation in the presence of Pyrilium. 
λexc = 355 nm. 
The results above led us to the necessity of performing a series of experiments focused on studying 
the effect of the protein environment on miniSOG’s 1O2 photosensitisation efficiency. First, miniSOG 
was denatured in a 6 M  solution of guanidinium hydrochloride (Gdn HCl)78 (Figure 23a-b). The 1O2 




photosensitisation efficiency increased over 10-fold upon protein denaturation (Figure 23c), coming close 
to the value for free FMN.  
 
Figure 11. Absorption (a) and fluorescence (b) spectral changes of 2.5 µM miniSOG in Gdn HCl 6 M PBS over time. 
λexc = 355 nm. The initial resolved vibronic structure of miniSOG is progressively lost as the protein denatures and 
FMN is released. Note that, unlike other flavoproteins, denaturation results in loss of fluorescence as free FMN has a 
lower fluorescence quantum yield than miniSOG. (c) Time-resolved near IR phosphorescence of 1O2 photosensitised 
by folded (red line) or denatured (green line) miniSOG in PBS. 
As far as miniSOG contains a l arge number of aminoacids that are effective 1O2 quenchers, 
measurements of 1O2 upon cumulative irradiation of miniSOG were carried out. We were rewarded to 
observe that the amplitude of the 1O2 signal, and therefore the Φ∆ value, increased ca. 10-fold after 
irradiation (taking into account the small absorbance decrease upon irradiation) in a light-dose dependent 
manner (Figure 24c). Absorption and fluorescence measurements rule out any contribution of protein 
denaturation to this effect (Figure 24a-b).  
 
Figure 12. Absorption (a) and fluorescence (b) changes of 2.5 µM tag-less miniSOG in dPBS upon cumulative 
irradiation at λexc = 355 nm . Fluorescence was probed at λexc = 400 nm . c) Effect of cumulative irradiation of 








In contrast, photolysis of free FMN leads to a decrease in the 1O2 phosphorescence signal (Figure 
25). As a final remark, removal of the His-tag did not change the Φ∆ value (data not shown). 
 
Figure 13. Absorption (a) and fluorescence (b) changes of FMN in dPBS upon cumulative irradiation at λexc = 355 
nm. Fluorescence was acquired at λexc = 355 nm . (c) Relative enhancement of Φ∆ values taking into account 
absorbance decrease. 
 





Photoinactivation studies.  
We report an approach to the issue of PS location in aPDT mechanistic studies by using two 
genetically-encoded 1O2 PSs that have been expressed in the cytoplasm of two E. coli strains. It is known 
that some green and red FP variants are able to photosensitise 1O2.32,34,36 In our first approach, we have 
chosen TagRFP as a PS because, unlike other FPs such as KillerRed,28,30,31 it is able to photosensitise the 
production of 1O2 but not of other ROS,36 and is therefore uniquely suited to ascertain the role of 1O2 in 
bacterial cell death. Our observation of ca.1-log10 population reduction difference between PBS- and 
dPBS-suspended cells is consistent with a 1O2 lifetime of 3.5 µs in H2O and 65 µs in D2O.72 Such 
enhancement of oxidative damage upon deuteration has long been used as a mechanistic test for the 
involvement of 1O2. This also agrees with our previous report that TagRFP is a p ure 1O2 PS36 and 
constitutes the first report showing that cytoplasmic location of a 1O2 PS is sufficient to induce bacterial 
cell death following light irradiation. Regarding the light dose used, it is orders of magnitude higher than 
that used in typical aPDT treatments25 but comparable to that in CALI assays79 and –again- in line with 
the low quantum yield of 1O2 generation by TagRFP (Φ∆ = 0.004 ± 0.001).36  
As for miniSOG, similar correlation was observed since deuterotopic effects could be observed in 
the PDI treatments. However, the light dose required was orders of magnitude lower than that used in 
previous PDI treatments with TagRFP, but comparable to the those of KillerRed.80  
 
Mechanistic studies 
When bacterial IM is compromised, leaching-out of low molecular-weight species and DNA 
and RNA fragments occurs, which are also able to permeate the external membrane. Release of such 
intracellular components can be, thus, conveniently monitored by spectroscopic means, and the onset 
of UV absorption at 260 nm in the supernatant is taken as a strong indication of membrane damage. 
According to the results, photodynamic damage to the inner cell membrane occurs in both cell types. 
It is well known that Gram-negative bacteria are markedly more resistant to PDI treatments than 
Gram-positive spp due to the highly organised structure of its cell envelope.81 Specifically, many studies 
have shown that the presence of an additional OM prevents many PSs from reaching and/or binding to the 
IM, resulting in lowered photosensitisation efficiency.81 The OM is, thus, a typical target in Gram-




negative bacteria.82 According to the data presented in Figure 2B, it looks clear that the more efficient 
photosensitising properties of miniSOG result in a significant amount of 1O2 being able to reach the OM 
and inflict damage, which is not the case for TagRFP-tagged bacterial experiments. 
Finally experiments regarding DNA damage indicate that FP-induced photodamage to genomic 
DNA does not occur to any measurable extent. Our results are in line with those of previous studies where 
it was concluded that DNA damage is not the primary cause of bacterial cell photoinactivation.25,83 
However, we cannot exclude that a lethal effect may be produced by localised DNA damage that could 
not be detected in our assay.84  
Overall, TagRFP photodamage seems to occur mainly in the cytoplasm and IM. No damage of the 
OM or of genomic DNA could be observed. These observations are markedly different to those reported 
for an external PS.67 As for miniSOG, its enhanced ability to sensitise 1O2 makes it inflict more severe 
damage that also affects the OM viability. Thus, not only the amount but also the site where 1O2 is 
primarily generated proves crucial for inflicting different types of cell damage. It is relevant to recall that 
the latest estimates of the radial diffusion distance of 1O2, which represents its sphere of activity, are 
about 155 nm and 550 nm in H2O and D2O, respectively.72 These distances are below the typical size of a 
bacterial cell.  
 
Unravelling 1O2 generation by miniSOG 
Basic photophysical properties of miniSOG are markedly different to those of FMN. The 
characteristic vibronic absorption and fluorescence spectra of miniSOG indicate tight binding of the 
chromophore to the protein. This is consistent both with the reported small dissociation constant of 170 ± 
8 pM40 and with the environmental restrictions to the chromophore motion resulting from its confinement 
and interactions within the active pocket of the protein.69  
The most novel aspect of miniSOG is its stronger photosensitisation ability compared to FPs from 
the green fluorescen protein (GFP) family.40 We have herein confirmed this superior ability by comparing 
the photoinduced cell death of E. coli bacteria expressing either miniSOG or TagRFP. Consistent with our 
expectations, miniSOG clearly outperformed TagRFP (vide supra). The higher photosensitisation ability 
of miniSOG was initially explained by its apparently higher Φ∆  value (0.47 ± 0.0540) very close to that of 
free FMN in solution (Φ∆ = 0.51).85 However, when we performed direct measurements of 1O2 
phosphorescence or indirect Φ∆ quantification with UA we got a value ~ 15-fold smaller (Φ∆ = 0.03 ± 




0.01) -irrespective of solvent deuteration- that, per se, was unable to explain the behaviour overall and, 
thus, further investigations were required. 
The reported Φ∆ value for miniSOG was arrived at using ADPA as 1O2 probe.40  Specifically, Φ∆ 
was determined by comparing the rates of ADPA photooxidation sensitised by miniSOG and by the 
reference FMN, the loss of ADPA being monitored by fluorescence. It was found that the rates of ADPA 
photooxidation were very similar, a result that we have reproduced in our laboratory. Surprisingly, when 
we repeated the experiment in dPBS the ratio of photooxidation rates decreased to ca. 1/3, corresponding 
to an apparent Φ∆ value of ~ 0.18. This lower value is totally unexpected if ADPA photooxidation occurs 
exclusively through a 1O2 reaction (as the longer 1O2 lifetime in dPBS would increase the rate of ADPA 
photooxidation)86 and suggests that a more complex mechanism is involved. In view of the results above, 
we were led to conclude that processes other than reaction with 1O2 contributed significantly to ADPA 
photooxidation by miniSOG. Photooxidation reactions may occur through two mechanisms: type-I, where 
the PS reacts directly with the substrate, or type-II, where 1O2 is formed instead.87 Indeed, it has been 
reported that, in addition to their reaction with 1O2, anthracene derivatives can be oxidised by electron-
transfer processes.88  
Support of the previous statements was achieved thanks to the series of experiments performed. 
First, flash photolysis experiments revealed the formation of new species that we assigned to 
semioxidised forms of ADPA, in line with previous reports for other anthracene derivatives.89 Next, 
miniSOG alteration in the presence of ADPA (without irradiation) strongly suggests that ADPA binds to 
miniSOG as observed for other anthracene derivatives that bind to proteins through electrostatic and 
hydrophobic interactions thereby interfering in some cases with protein function.90,91 Finally,  we could 
support that direct photoinduced electron transfer reactions can contribute to ADPA photooxidation with 
the degradation of ADPA in the presence of a p urely electron-transfer PS such as 4-diphenyl-6-(4´-
methoxyphenyl)pyrylium tetrafluoroborate. It is well documented that flavins are able to undergo electron 
transfer reactions with suitable electron donors.92,93 The observations above indicate that photooxidation 
of ADPA results from both 1O2 and electron-transfer processes, the latter facilitated by the binding of 
ADPA to the protein. Thus, in addition to generating 1O2, miniSOG is capable of photooxidising 
substrates by type-I mechanisms as well, which should be taken into account by researchers using 
miniSOG as a genetically-encodable 1O2 source.  




Our observations upon miniSOG denaturation point to a strong effect of the protein environment on 
1O2 photosensitisation efficiency. The high increase of the Φ∆ value upon denaturation highlights the 
effect of protein residues, which could either modulate the excited states of FMN in the folded protein 
and therefore affect the quantum yield of 1O2 production, or quench a fraction of 1O2 molecules before 
they can diffuse into the bulk medium.  
As to the first possibility, it is well established that the photosensitised production of 1O2 occurs in 
three steps, each with its own efficiency: first the PS’s triplet state must be populated by ISC from the 
originally photoexcited singlet excited state; second, the triplet-state molecules must be trapped by 
oxygen before they decay; finally, ET from the triplet sensitiser to oxygen must take place.74 Regarding 
the first process, it has been reported that the protein environment can modulate ISC in flavoproteins by 
electrostatic effects.69 Consistent with this, we do observe smaller triplet transient absorbance signals for 
miniSOG than for free FMN (data not shown) and a higher fluorescence quantum yield. ISC in miniSOG 
would therefore be less efficient than in free FMN, although this effect alone fails to account for the 15-
fold decrease in Φ∆. The triplet lifetime data likewise indicate that oxygen trapping of miniSOG’s triplet 
state is almost as efficient as for FMN in water, which also rules out the second process as an important 
factor. Finally it must be recalled that oxygen quenching of triplet excited states can occur by either ET, 
producing 1O2, or electron transfer, yielding the superoxide radical anion. The lack of any evidence for 
radical formation in transient absorption experiments suggests that the electron transfer pathway is of 
minor importance.  
Our data, thus, suggest that 1O2 production by the flavin inside the protein is probably not much 
different from that in the bulk aqueous solution. Even though FMN is located at about 10-15 Å of the 
protein surface, the triplet lifetime of miniSOG, similar to that of FMN, indicates that the chromophore is 
accessible to oxygen. Therefore, the most relevant cause for the difference in measured Φ∆ may be 
attributed to a substantial fraction of the nascent 1O2 molecules being quenched on their way off the 
protein.94,95 This notion is supported by the fact that miniSOG contains a large number of aminoacids that 
are effective 1O2 quenchers (Figure 25): tryptophan (Trp; x1), histidine (His; x1), tyrosine (Tyr; x3), 
methionine (Met; x2) (Figure 3a), plus the His-tag (x6) used for purification.  





Figure 14. MiniSOG’s molecular model based on the structure of iLOV protein (PBD ID: 4eet), built using the 
Swiss-model server (http://swissmodel.expasy.org/). The backbone of miniSOG is shown as a green ribbon, FMN as 
orange sticks, and the aminoacids that may quench 1O2 as magenta sticks. 
 
As for the increase of the Φ∆ value upon cumulative irradiation, experiments both for miniSOG and 
free FMN seem to indicate progressive photoinactivation of the aminoacids responsible for 1O2 
quenching,  discarding the build-up of FMN photoproducts of higher Φ∆ value. Respect to the fact that 
the miniSOG mutant lacking the His-tag showed the same Φ∆ than miniSOG itself was not totally 
unexpected since this tag is far away from the site of 1O2 production. This is relevant for drawing 
comparisons between miniSOG’s photochemistry as a purified protein in solution with that as a fusion 
partner in a cell. It is worth to note that redox-active aminoacids (Trp, Tyr) that are involved in electron 
transfer reactions in some flavoproteins are also present in miniSOG’s sequence.96 However, these 
residues are not in the chromophore vicinity (Figure 14), and are not likely to participate in direct electron 
transfer reactions with FMN (see ref 97 and references therein). For example, replacement of Trp81 by 
phenylalanine (Phe) does not improve 1O2 photosensitisation (Φ∆ = 0.01), which seems to rule out the 
direct participation of this residue in electron transfer reactions. 
 





Purely endogenous 1O2 produced by genetically-encoded photosensitising proteins expressed in the 
bacterial cytosol is able to induce bacterial cell death. Photodamage seems to occur mainly in the bacterial 
membrane, the extent of which correlates with the photosensitising efficiency of the protein. Both 
TagRFP and miniSOG can induce damage in the IM, but only miniSOG in the OM. No damage of 
genomic DNA could be observed. Our observations are markedly different to those reported for an 
external photosensitiser.67 Thus, the site where 1O2 is primarily generated proves crucial for inflicting 
different types of cell damage.  
Moreover, we have unravelled the photochemical 1O2 generation of the fluorescent protein 
miniSOG. Our most important result is the revision of the Φ∆ value, which we have determined to be 
0.03 ± 0.01, ca. 15-fold lower than reported previously.40 We have accounted for potential reasons for the 
discrepancy, namely the contribution of electron transfer processes to ADPA oxidation, and the increase 
of Φ∆ upon cumulative irradiation. Regarding the first point, a contribution of electron-transfer processes 
to the photodynamic activity of miniSOG in biological media should not be excluded a priori. As to the 
second one, increase of Φ∆ upon irradiation may prove advantageous for EM imaging and other potential 
uses of miniSOG. A recent communication in which miniSOG is shown to outperform commercial 
fluorescent tag ReAsH (for resorufin arsenical hairpin) in EM experiments suggests that this may indeed 
be the case.38  As a final remark, it is worth pointing out that the screening method used to evolve 
miniSOG was based on evaluating the photobleaching of a fused fluorescent protein. Photobleaching can 
be due not only to 1O2, but also to other ROS and radical reactions. Thus, there is still scope to improve 
the value of Φ∆ by screening with another, more specific method that selects for singlet oxygen-
generating mutants. Detection of 1O2 phosphorescence at 1275 nm as described within this work is thus 
highly suited to develop new and better miniSOG variants. 
This work supports the potential of genetically-encoded strategies in mechanistic studies of aPDT, 
and using appropriate gene transfer methods could be extended to therapeutic strategies. 
 




SPECIFIC EXPERIMENTAL SECTION 
Chemical Compounds: UA, PN, Gdn·HCl and NPN were purchased from Sigma; FMN was purchased 
from Chemochroma and ADPA from Chemodex. All these reagents were used as received. PNS was 
resynthesised according to the published method in reference.73 
Cell membrane integrity assessment protocol: After photodynamic treatments, samples were 
centrifuged (13000 rpm, 10 min) and the supernatant was monitored by UV-vis spectroscopy in order to 
measure the absorbance values at 260 nm, which indicates leakage of small cellular components due to 
inner membrane damage.16 Supernatant of non-irradiated cells was also measured as control and 
normalisation factor. To test the integrity of the outer membrane, the pellet was resuspended and NPN 
was added to a final concentration of 15 µM.14, 17 Fluorescence spectra were readily measured after NPN 
addition upon excitation at 350 nm. Cell lysate (3 x 1 minute sonication) was used as a positive control 
(data not shown). 
DNA purification and electrophoresis: Genomic DNA was extracted immediately after photodynamic 
treatments by means of a Wizard Genomic DNA Purification Kit (Promega). DNA samples were gently 
mixed with 3 µL of Loading Buffer 6x and analysed by agarose gel electrophoresis (0.6 % agarose in 
TBE buffer). The nucleic acid stain Sybr Green (1 mg/mL; Invitrogen) was incorporated during 
preparation of agarose gel. The Lamda DNA/EcoRI + Hind III Marker (BioRad) was used as molecular 
weight marker (0.5 mg/mL) with DNA fragments between 564 and 21,226 bp. 
Protein protocols: miniSOG expression and purification were performed by our collaborators Sara H. 
Mejías and Aitziber L. Cortajarena following reference 98 with minor modifications. For denaturation, 
miniSOG was adjusted to a concentration of 2.5 µM in a 6 M solution of Gdn HCl (PBS or dPBS) 
according to a well-established protocol.78 The solution was stirred over time and, periodically, 
absorption and fluorescence spectra were acquired in order to assess the degree of denaturation. 
Φ∆ using UA as a 1O2 probe: In the presence of 1O2, UA forms an intermediate that undergoes an 
additional degradation step to allantoin.99 As a result, absorbance at 292 nm decays with biexponential 
kinetics. The degradation of the intermediate is known to be oxygen-independent, so only the first decay 
(k1) reflects the reaction with singlet oxygen. The reaction can also be monitored at 315 nm, with the 
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Chapter IV.  
 








The real voyage of discovery consists not in seeking new landscapes but in 
having new eyes” 













With all this previous considerations, it lo oks clear that 1O2 measurement is a goal of general 
interest for the scientific community. In fact, over the years a great effort has been made in developing 
techniques and/or methods able not only to detect but also to quantify the generation of 1O2. As a general 
idea, high sensitivity and selectivity towards 1O2, high signal-to-noise ratio, and ease of measurement are 
a must for any candidate probing system. So far, 1O2 detection methods can be sorted into two groups: 1) 
physical detection, given by direct measurement of near-infrared 1O2 phosphorescence at 1275 nm and 2) 
chemical probes that, in the presence of 1O2, undergo a reaction with a subsequent great magnification of 
a measurable physical property, such as absorption, fluorescence or chemiluminescence. 
1O2 can be detected through its intrinsic phosphorescence with maximum centered at 1275 nm.1 This 
is a robust, specific, noninvasive and direct method; but it suffers from weak signal due to the lower 
efficiency particularly in biological media, where the lifetime of 1O2 is very short (3.1 µs)2 and the 
phosphorescence quantum yield is very small, ca. 10-7.3 
Among the chemical traps, UA is a good alternative that has recently gained atention.4,5 In the 
presence of 1O2, UA forms an intermediate that undergoes an additional degradation step to allantoin.6 As 
a result, absorbance at 292 nm decays with biexponential kinetics. As a drawback, it is not convenient for 
in vivo measurements due to the difficulty of measuring absorption in the UV region without interferences 
of biological components. Plus tracking the bleaching of a physical property is less desirable than 
tracking its enhancement. 
Another approach has been the development of chemiluminescent probes, believed to be one of the 
most sensitive methods in 1O2 detection. Compared with fluorescence, chemiluminescence does not 
require excitation light, so background fluorescence and scattered light interference are eliminated. The 
set of widely-used chemiluminescence probes includes 2-methyl-6-phenyl-3,7-dihydroimidazo [1,2-a] 
pyrazin-3-one, and its derivatives.7,8 More recently developed chemiluminescence probes, include 
tetrathiafulvalene9 and probes based on s table dioxetane precursors10. Tetrathiafulvalene is a strong 
electron donor that enhances its reaction with 1O2 and it offers improved sensitivity and good ratiometric 
correlation between 1O2 and chemiluminescence. Dioxetane-based traps comprehend the reaction of 1O2 
with a p recursor (sporoadamantyl-substituted vinyl ether) that can form a d ioxetane, 1O2 chemical trap 




that can be used for quantification purposes by chemiluminescence after addition of a chemical trigger. 
Again, the lack of water solubility and the short emission wavelength are the main drawbacks when 
assessed in detection of 1O2 in biosamples. 
Another commonly used 1O2 trap system consists of molecules able to react with 1O2 through 
photochemical endoperoxidation reactions. In the presence of 1O2, anthracene (or acene-like) or furan 
derivatives specifically react with 1O2 to form an endoperoxide.11 This reaction is accompanied by a 
decrease in absorbance which can be used as a signal of 1O2 production. Again, such detection is not very 
sensitive since it is based on an absorbance measurement. However, lately, the fluorescence bleaching of 
anthracene has also been used as 1O2 reporter with good results.12,13 Unfortunately, anthracene 
fluorescence is observed in the blue, which is difficult to monitor in living systems due to overlap with 
cell autofluorescence.14 
Fluorescent probing of 1O2 is probably the most studied and developed technique. Fluorometric 
assays were firstly based on the use of the chemically reduced, non-fluorescent forms of highly 
fluorescent dyes such as fluorescein and rhodamine that when properly oxidised to the parent dye 
molecule, resulted in a notorious increase in fluorescence intensity.15 However, these dihydro-compounds 
are highly photosensitive compounds (they tend to be autoxidised producing a large background 
fluorescence even in the absence of ROS) and lack selectivity for 1O2.  
In later studies, it was concluded that the fluorescence properties of fluorescein derivatives were 
controlled by a p hotoinduced electron transfer process from the benzoic acid moiety to the xanthene 
ring.16-18. Thus, it paved the way to devise a new general approach: a two-component system comprised 
of a 1O2 trapping moiety coupled to a light-emitting chromophore. Several probes have been developed 
following this principle: DPAX and DMAX,16,19 MTTA-Eu3+ 20 and  more recently SOSG (for Singlet 
Oxygen Sensor Green),21 use an anthracene moiety to trap 1O2. In their native state, the luminescence of 
the emitting moiety is quenched by the anthracene by an electron-transfer process. Oxidation of the 
anthracene by 1O2 eliminates this quenching channel and the probe becomes luminescent. The same 
concept has been recently used to develop a n ear-infrared probe, His-Cy, where anthracene has been 
replaced by a histidine and a cyanine is chosen as fluorophore.22 A common drawback for all the above 
probes is that the fluorescence increases only moderately after reaction with 1O2, e.g., from less than two-





dependent on solvent polarity, false positive signals arise that merely reflect location of the probe in a 
less-polar microenvironment rather than reaction with 1O2, e.g., when the probe is in hydrophobic pockets 
of proteins.23 In addition, the presence of an anthracene moiety in the structure is potentially misleading 
since anthracene is itself a 1O2 PS that may auto-oxidize the probe, which further complicates its use.24  
Most 1O2 probes have in common that they have been envisaged to measure 1O2 in solution or in 
extracellular systems. As a consequence, when interest was drawn to measuring 1O2 intracellularly and 
the available probes were tested in this context they failed, needed harsh/not physiological conditions, or 
were not successful enough.14,20,23 Recently, a s ynthetic 1O2 sensitive construct has been reported to 
successfully perform in intracellular systems. However, the synthetic complexity of the system –
comprised by a photocleavable moiety, two fluorophores and a cholesterol unit to achieve cell 
internalisation (Scheme 1)- makes it far from being the ideal and accessible 1O2 probe.25 
 
Scheme 1. Representation of the system described in ref 25. An anthracene moiety is coupled to two fluorophores 
(whose fluorescence is initially quenched) and a cholesterol unit to enhance cell penetration. In the presence of 1O2 
an unstable endoperoxide breaks liberating the fluorophores that recover their inner fluorescence. 
For the sake of measuring 1O2 intracellularly, extra features are requested from the probing 
candidates that need to be borne in mind during their design, i.e. stability, ease of uptake, and lack of 
toxicity. Inside the cell, the 1O2 produced will encounter mainly an aqueous-like environment, what 
means that the probe must be water soluble and non-toxic in working concentrations for good and viable 
cell internalisation. Most 1O2 probes are highly hydrophobic and, thus, lack water solubility and ease of 




cell uptake. Although new water-soluble chemical probes have been developed,13,19,21,26,27 problems 
associated with dye toxicity or cell uptake are also being encountered. On the other hand, the 1O2 lifetime 
in water and inside cells is very short.28 This results in the immediate quenching of a l arge fraction of 
the 1O2 produced, hence reducing the emission signal to the threshold of detection by physical methods. 
In addition, it i s extremely difficult for the physical method to monitor the accumulation of 1O2 
production during, for instance, a PDT process. Another important feature of 1O2 measurement is its 
spatial localisation. Even considering that the 1O2 probe could be successfully internalised, still its 
targeting to the subcellular region where 1O2 will be located is a great handicap (or goal). Microscopy has 
been used to achieve resolution in a spatio-temporal manner, but the resolution limit is very close to the 
diffraction limit. Still, interesting approaches have been achieved in this respect.29-31  
There is an emerging trend to the use of polyacrylamide NPs in cellular and in vivo drug delivery,32-
34 sensing35,36 and imaging37 and successful examples of the system have recently been published in 
several fields.38-40 Their first and well-known advantage is the biocompatibility and ease of delivery into 
cellular systems. While dyes usually rely on passive uptake by cells, NPs design elicits a more targeted 
delivery of the probe, especially as they can easily be chemically tailored for enhanced targeting to cells 
and subcellular compartments. Another property of NPs is their ability to be encapsulated/conjugated 
with a vast variety of molecules. The loaded NPs can be used in aqueous solution regardless of the 
hydrophobicity of the drug/probe. NPs thus become potential carriers and physical protectors of the 
cargo. The dye molecule will be shielded from the chemical and biological environment in the 
physiological system while, simultaneously, the physiological system will also be protected from the 
potential toxicity of the dye molecules.  
Some previous approaches have been tried to combine 1O2 chemical probing with the advantages of 
using biocompatible carriers. Steinbeck et al.,41 used micron-sized glass beads coated with 9,10-
diphenylanthracene, a well-known 1O2 chemical trap. Although they demonstrated that 1O2 was produced 
from the cells, its huge size (1.6 µm) is likely to perturb the cells, thus, limiting its use in vivo. More 
recently, Cao et al.42 reported the results of a system composed by another common 1O2 chemical probe, 
9,10-dimethyl anthracene, entrapped in a p ermeable silica matrix (ORMOSIL) leading to NPs able to 
detect 1O2 while maintaining the advantages of being a biocompatible carrier. Further studies of its 
performance in intracellular systems have not been published to date. With all this shown, it is clear that 







Naphthoxazole-based 1O2 fluorescent probesi 
 
AIM OF THE STUDY 
In this study we report the synthesis and photochemical behaviour of a new family of photoactive 
compounds in order to assess its potential as singlet oxygen probes. The candidate dyads are composed by 
a singlet oxygen trap plus a naphthoxazole moiety linked through an unsaturated bond. In the native state, 
the inherent great fluorescence of the naphthoxazole moiety is quenched; but in the presence of 1O2, 
generated by the addition and appropriate irradiation of an external PS, a photooxidation reaction occurs 
leading to the formation of a new chemical entity whose fluorescence is two orders of magnitude higher 
than that of the initial compound, at the optimal selected wavelength. The presented dyads outperform the 
commonly used indirect fluorescent singlet oxygen probes in terms of fluorescence enhancement 
maintaining the required specificity for singlet oxygen detection in solution. 
  
 
Graphical Abstract 1. Conjugation of a fluorescent and a 1O2-trapping moieties leads to a dyad with a low fluorescence in its 
native state. In the presence of 1O2 a new photooxidised chemical entity is born, leading to a fluorescence enhancement over two 
orders of magnitude at the optimal selected wavelength. 
                                                 
i This section has been adapted from the work accepted in Photochem.Photobiol. 2013 (DOI: 10.1111/php.12106). 





Naphthoxazole dyads description.  
2-(2-(Furan-2-yl)ethyl)naphtho[1,2-d]oxazole, FN-I1, contains a naphthoxazole linked to a furan 
through a saturated ethyl bridge. In 2-(furan-2-yl)naphtho[1,2-d]oxazole, FN-I2, the furan moiety is 
bonded directly to the position 2 of the oxazole ring, whereas in (E)-2-(2-(furan-2-yl)vinyl)naphtho[1,2-
d]oxazole, FN-4, the naphthoxazole and the furan are conjugated through an unsaturated ethylidene link. 
In the control molecule, (E)-2-(4-methylstyryl)naphtho[1,2-d]oxazole, FN-7, the furan ring of FN-4 has 
been replaced by a non-reactive tolyl group. Two candidates could be used as singlet oxygen sensors, 
namely FN-I2 and FN-4, since their fluorescence is boosted by a factor of ca. 135 and 300, respectively, 
upon reaction with 1O2. Four described compounds are depicted in Scheme 2. 
 
























FN-4 is a dyad composed by a furan ring linked to a naphthoxazole moiety through an ethylidene group. 
The absorption spectrum is dominated by a main band with maximum at 367 nm and a second weaker 
band at 314 nm (Figure 1a) that compares reasonably well with the values of 387 and 314 nm obtained 
from TD-DFT calculations using G09W. The position of the bands follows no obvious trend with the 
solvent polarity (data not shown). The high values of molar absorptivity, ca. 3·104·M-1cm-1 in all solvents 
except in water, and the molecular orbital analysis of the minimum energy structure obtained from DFT 
calculations, indicate a π,π* transition. A similar behaviour of the absorption properties was observed for 
FN-I2 (data not shown), in which the furan ring is linked directly to the naphthoxazole moiety, and for 
FN-7, in which a non-reactive tolyl substituent replaces the furan moiety. When the linker is saturated 
(FN-I1) spectral bands shift substantially to the blue (λmax = 322 nm) and become more structured. These 
results correlate with the distinct degree of electronic coupling between the aromatic moiety and the 
naphthoxazole fluorophore. Similar trends are observed in the maximum of the fluorescence spectra 
(Figure 2b), consistent with the reports for related benzoxazole derivatives.43  
Figure 1. Normalised absorption (a) and fluorescence (b) spectra of FN-4 (thick solid), FN-I1 (dashed), FN-I2 
(dotted) and FN-7 (thin solid) in MeOH. 
Aryl oxazoles typically exhibit a very high ΦF value, in the 0.7-1.0 range 44,45. Among all studied 
compounds, this is observed only for FN-I1 ((ΦF = 0.93 in MeOH). In contrast, FN-4 and FN-7 show 
high ΦF values in low-polarity solvents only, the quantum yield decreasing by 1-2 orders of magnitude as 
the solvent polarity increases (Figure 2). However, for (E)-4-(2-(naphtho[1,2-d]oxazol-2-
yl)vinyl)benzonitrile (FN-7CN), an FN-7 analogue in which the methyl group is replaced by the strong 




electron-attractor cyano group, the fluorescence quantum yields are close to 1 in all solvents, irrespective 
of their polarity (A. L. Zanocco, unpublished data). Finally, FN-I2 is scantly fluorescent even in non-
polar solvents (Figure 2). These results indicate that electron-rich aromatic moieties can act as effective 
quenchers of naphthoxazole fluorescence in conjugated dyads and, particularly, in polar protic 
environments, likely due to a charge-transfer interaction. Thus, furyl-oxazole dyads fulfill the first 
condition requested for a potential 1O2 probe, namely that the fluorescence is severely quenched in their 
native form, thus deserving further scrutiny. 
 
Figure 2. Correlation of ΦF values with the solvent polarity (represented by the ET(30) values) for the dyads FN-4 
(red circles), FN-I2 (green squares), FN-7 (light blue triangles), FN-7CN (black inverted triangles) and FN-I1 (dark 
blue diamond) 
  
Reactivity towards singlet oxygen  
The ability of the dyads to react with 1O2 has been studied by monitoring changes in their absorption 
and fluorescence properties. No changes could be recorded for FN-I1 and FN7, as expected. In the case 
of FN-4, reaction with 1O2 in MeOH caused bleaching of the main band at 367 nm and the growth of a 
new band in the 325-350 nm region (Figure 3a). The clear isosbestic point at 348 nm suggests a clean 
transformation to a single photoproduct (hereafter FN-4OX). This was confirmed by HPLC experiments 
that, after 95% FN-4 (tr = 14.3 min) consumption, show the formation of a main product at tr = 8.3 min 
and several minor secondary products (data not shown). Experiments to identify reaction products are in 
progress; however, furan is well known to selectively react with 1O2 through an endoperoxidation 
reaction, followed by methanolysis of the endoperoxide.46-48  





Figure 3. Absorption (a,b) and fluorescence (c,d) spectra of FN-4 (a, c) and FN-I2 (b, d) before (solid line) and after 
(dashed lines) reaction with 1O2. The PS was NMB 1 µM, the irradiation wavelength was 635 ±  15 nm, and the 
experiments were carried out in aerated MeOH. Insets show normalised excitation (a, b) and fluorescence (c, d) 
spectra to facilitate their comparison. 
Involvement of 1O2 in the process was unequivocally demonstrated by the inhibitory effect of 
selective 1O2 quenchers (data not shown). Most effective were α-terpinene and sodium azide that 
inhibited the FN-4 photo-oxidation by ca. 90%. DABCO was able to diminish the FN-4 consumption to a 
lesser extent.  A strong fluorescence increase and a concomitant shift of the fluorescence peak to the blue 
could also be observed (Figure 3c), the excitation spectra of the original and final fluorescence bands 
being markedly different, implying that they correspond to different chemical entities (Figure 3a, inset). 
The spectral overlap is minimised at 330 nm, which suggests that this excitation wavelength should be 
chosen to maximise the fluorescence of FN-4OX. As shown in Figure 4 the fluorescence intensity at 378 
nm is enhanced by more than 300-fold. Compared to SOSG, the fluorescence enhancement of FN-4 is 30-
fold larger.  
In a similar fashion to that observed for FN-4, emission of FN-I2 also increases considerably upon 
reaction with 1O2 in MeOH (Figure 3d), concomitant with the bleaching of the low-energy absorption 
band at 367 nm (Figure 3b). Both the absorption and fluorescence spectra reveal the appearance of new 
bands shifted to the blue. The absorption spectra show a clear isosbestic point at 352 nm, suggesting the 




formation of a single photoproduct as for FN-4. Excitation at 333 nm maximises the system emission, 
which increases by a factor ca. 135 at 363 nm (Figure 4).  
 
Figure 4. Fluorescence enhancement of FN-4 (solid red triangles; λexc = 330 nm; λobs = 378 nm) and FN-I2 (solid 
blue circles; λexc = 333 nm; λobs = 363 nm.) upon external generation of 1O2 in MeOH. Open red triangles stand for 
FN-4 fluorescence intensity changes upon cumulative irradiation at 355 nm. F stands for the fluorescence intensity at 
each point of study while F0 refers to the background fluorescence.  
The rate constant for 1O2 quenching by the dyads (kq) was determined by time-resolved detection 
of 1O2 phosphorescence at 1275 nm.1,49 Increasing concentrations of the dyads enhanced the decay rate 
of 1O2 in a linear fashion. The slope of the plots afforded the kq values, which are collected in Table 1.  
 
Table 1. Summary of photophysics, 1O2 production and reactivity data for the compounds of study in MeOH. 


















9.1 x 105 
1.9 x 107 






a PN in MeOH (Φ∆ = 1.0) was used as standard; λexc = 355 nm.50 b naphthalene in ethanol (ΦF = 0.21) was 
used as reference 51 Excitation wavelength was λexc = 280 nm for FN-I1. c acetonitrile as solvent 
 
Interestingly, the value for FN-4 (vinyl bridge) is 20-fold smaller than that for FN-I1 (ethyl bridge) 
and for FN-I2 (direct link), and about 40-fold smaller than for isolated 2-methylfuran (kq = 9.9x107 M-1s-1 
in MeOH 52), which confirms the strong electronic delocalisation of the furan ring across the vinyl bridge 




in FN-4. Notice that the fluorescence enhancements do not correlate with kq. Finally, the low kq value for 
FN-7 confirms that naphthoxazole derivatives lacking the furyl substituent are essentially unreactive 
towards 1O2.  
 
Self-sensitisation of 1O2 by the dyads and reactivity towards other ROS 
A drawback of SOSG is the growth of fluorescence due to self-sensitisation of 1O2 (19). Other dyads 
lack selectivity towards 1O2 and react also with different ROS. We investigated whether the 
naphthoxazole dyads suffered from the same problems. All dyads sensitised the production of 1O2, 
although with very small quantum yields (Φ∆, Table 1 and Figure 5). Nevertheless, Figure 4 show that the 
fluorescence of FN-4 does not increase upon cumulative irradiation in MeOH and that of FN-I2 actually 
decreases (data not shown).  
Figure 5. 1O2 phosphorescence signals upon excitation at 355 nm and observation at 1275 nm. Amplitudes of the 
dyads’ decays were compared to that of PN used as standard. 
 
Reactivity towards other ROS was also tested for FN-I2 and FN-4 with negative results for both 
superoxide (KO2) and H2O2 (Figure 6). 
 
   
 





Figure 6. Fluorescence changes of methanolic solutions of FN-4 upon addition of H2O2 (a) or KO2 (b). Analogous 









The results above demonstrate that the new family of naphthoxazole dyads represented by 
compounds FN-4 and FN-I2 outperform any other fluorescent probe currently available for 
monitoring 1O2. The key novelty of the system relies on the fact that the fluorophore in the 
photooxidation adduct is different from that in the initial species. Thus, spectral changes arise that elicit 
the selection of optimal excitation wavelengths to enhance the fluorescence of the photoproducts. 
Enhancement factors up to 310-fold have been observed, that compare favorably with the 2-fold observed 
recently for His-Cy or with the 10-fold for SOSG. While both dyads are able to self-sensitise 1O2, their 
fluorescence does not increase in the absence of external 1O2 PSs. Finally, a high degree of specificity 









FN-4 and FN-I2 are two examples of successful naphthoxazole-based dyads capable of 
monitoring 1O2 in solution with unprecedented sensitivity. Photooxidation of the trapping moiety leads to 
the formation of a new chemical entity whose fluorescence is spectrally different from that of the non-
irradiated conjugate. Fluorescence enhancement factors up to 310-fold have been observed taking 
advantage of the change in spectral properties upon photooxidation. Its added selectivity towards 1O2 and 
the negligible effects of self-sensitisation, make naphthoxazole dyads worth of further development 
as 1O2 fluorescent probes. 
 





Polyacrylamide nanoparticles as scaffold for 1O2 
detection in intracellular systems 
 
AIM OF THE STUDY 
We have envisaged a polyacrylamide nanoparticle scaffold that might be able to circumvent many of 
the general drawbacks of 1O2 intracellular detection while meeting the requirements for a good in 
vivo 1O2 reporter readily compatible with biological systems. Two commercial 1O2 probes, namely 9,10-
anthracenedipropionic acid (ADPA) and singlet oxygen sensor green (SOSG) with different working 
mechanisms have been covalently bound through different size linkers to the nanoparticle core and their 
detecting performance and biocompatibility have been tested in solution as well as in cells. 1O2 
generation has been achieved either by an exogenous PS coadministered with the nanoparticles or by 
including the PS in the polyacrylamide matrix. The preliminary results show biocompatibility and uptake 
feasibility with concomitant localisation inside cells. While the system is not yet fully optimised it s till 
serves as proof of concept for the scaffold. 
 
Graphical Abstract 2. Rational of the designed system intended for detecting 1O2 in intracellular systems. Key structures of a 
versatile system endowed with a polyacrylamide nanoparticle scaffold where different units can be probe is clicked to a generic 
fluorogenic 1O2 probe through different linkers. Other units such as charged moiety or porphyrin are also shown.  





As a primary approach, we developed the simplest scenario where the 1O2 probe is readily attached 
to the NP scaffold, following the Scheme 3. Amino-derivatised NPs were covalently bound either to 
ADPA or SOSG.  
 
Scheme 3. Rational design of ADPA (blue dots) or SOSG (green dots) probes readily linked to amino-NPs through 
amide bonds, together with the chemical structures of ADPA and SOSG 
Solutions containing 2 mg/mL NPs and 1 µM NMB were irradiated by means of a red light source 
and fluorescence changes were observed over time. The behaviour of the nano-probes in solution was 
poor as compared to the free probes, especially for SOSG-NPs, where the fluorescence enhancement was 
very mild (Figure 7).  




Figure 7. Fluorescence bleaching (a,b) or enhancement (c,d) upon irradiation in the presence of 1 µM of NMB for 
aqueous solutions of (a) ADPA, (b) ADPA-NPs, (c) SOSG and (d) SOSG-NPs. Solid red line represents basal 
fluorescence and green dotted line first irradiation time. Extra light doses were given to NP-probe systems to assess 
their evolution. 
The excessive vicinity of the probe to the polyacrylamide matrix could be responsible for the 
aforementioned low probing efficiency by non-specific interactions of the probe to the NPs. Thus, we 
decided to include a spacer between the polyacrylamide scaffold and the probe, as can be seen in Scheme 
4. In order to be able to include the linker, the polyacrylamide matrix was synthesised exposing alkyl 
groups in the outer surface so that linkers could be coupled via click chemistry. Moreover, all the linkers 
exposed a terminal amino group allowing them to be bound either to ADPA or SOSG through amide 
bond. 
 





Scheme 4. Rational design of nano-probes including different size linkers between the NP and the probe. Blue dots 
represent ADPA dye and green dots SOSG. 
New scaffolds including linkers of three different lengths were synthesised, characterised and tested 
in solution, as summarised in Figure 8. For both types of probe, absorption and emission spectra match 
those of the free probe. In the case of the absorption, a tail in the base line can be seen due to NP 
scattering. The results in terms of 1O2 sensing are modest and still the free probe outperforms them all. 
However, for both types of probe, the linker with an intermediate size (“M”) seems to provide an 
acceptable behaviour, at least to serve as a p roof of concept of the system. After 10 min irradiation, 
ADPA-M-NPs were photobleached up to a 90%; and over 95% photobleaching was achieved after 20 min 
irradiation. For SOSG-M-NPs, a 3.5-fold fluorescence enhancement could be achieved in dPBS and 3-
fold when in PBS.  
 
Figure 8. Behaviour in solution of probe-link-NPs. Absorption (solid line) and emission (dashed line) spectra of 
representative ADPA-M-NP (a) or SOSG-M-NP (c). Probing efficiency in solution of probe-link-NPs was assessed 
by addition of 1 µM NMB to 1 mg/mL nano-probe solutions and irradiation. ADPA bleaching in % (b) or SOSG 
fluorescence enhancement (d) was plotted, respectively. 
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In order to discard a problem of inner filter effect due to scattering, solutions of SOSG containing 
increasing concentrations of plain bare NPs were tested in the presence of 1 µM NMB and irradiated 
(Figure 9). Our experiment shows that for concentrations below 5 mg/mL SOSG solutions are able to 
behave almost equally with or without free NPs.  
 
Figure 9. Scattering effect on SOSG conversion. 
Once proved the viability of the system, further development was carried out to our best scaffold 
system: particles with the probe and a medium-size linker (probe-M-NPs). Our next goal was to confer 
charge to the system so as to be apt to be uptaken by the cells. Two different charged groups were 
developed: trimethylamoniumbysacrylamide (-NMe3+) and trimethylphosphoniumbysacrylamide (-
PMe3+) and integrated in the system as depicted in Scheme 5. Chemically speaking, the main difference 
with the previously developed particles is that now the NPs, apart from exhibiting alkyl groups, do also 
carry the charged functionalised groups. The new particles were characterised and its 1O2 sensing ability 
resulted comparable to its non-charged analogues. 
 
Scheme 5. Rational design of charged nano-probes including the probe and a medium-size linker. Blue dots represent 
ADPA dye and green dots SOSG. 
One of the main problems found in the performance of available probes in living systems is their 
difficulty to be uptaken by the cells due to interactions with serum proteins.23 Thus, next stage was to test 
their behaviour in the presence of bovine serum albumin (BSA). Fluorescence measurements were 




registered upon addition of increasing amounts of BSA. In previous reports it has been described that 
shifts can be observed for SOSG in both absorption and emission spectra in the presence of BSA even at 
very low concentrations.23 In contrast, in our system, while partial fluorescence quenching occurs, no 
fluorescence shifts can be observed as presented in Figure 10. This result seems to point out that 
interactions of the protein with the nano-probe are minimised, especially for SOSG were even the 
fluorescence quenching effects are low. Likewise, the efficiency of the probe in the presence of BSA 
and 1O2 is decreased (data not shown), consistent with the fact that BSA is known to be a good 1O2 
quencher. 
 
Figure 10. Interaction of probe-link-NPs in the presence of BSA. Figures a and b show fluorescence changes upon 
addition of BSA up to150 µM to ADPA-M-NPs (a) or SOSG-M-NPs (b).  
Another drawback encountered for the 1O2 probes used intracellularly up till now is the difficulty of 
delivering the probe and the PS to the same subcellular localisation.14 Taking advantage of the versatility 
of our system, a new class of nano-probes was designed and synthesised including both the 1O2 probe and 
the PS, as schematised in Scheme 6. 
 
Scheme 6. Rational design of porphyrin-containing NPs including the probe and a medium size linker. 
A zinc porphyrin polymerised within the polyacrylamide matrix was chosen as model PS. In Figure 
11 it can be observed the absorption and emission resulting from the new constructs. 
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Figure 11. Behaviour in solution of porphyrin loaded probe-link-NPs. Absorption (a,c) and fluorescence (b,d) spectra 
for the ADPA systems (a,b) or SOSG systems (c,d). Dotted lines correspond to probe fluorescence and dashed lines 
to porphyrin fluorescence. 
Apart from the majority porphyrin absorption bands, shoulders corresponding either to ADPA or 
SOSG can also be observed, respectively. More interestingly, in both cases the fluorescence from both the 
porphyrin and the probe is sufficiently well separated. That will confer an extra aid in terms of 
fluorescence detection intracellularly as fluorescence colocalisation will be possible. Regarding its 
sensing behaviour, it is even more modest than for the previous system. Comparison between the 
behaviour of the NPs with and without porphyrin is depicted in Figure 12. 
 
Figure 12. Probing behaviour in solution of porphyrin loaded probe-link-NPs upon irradiation. 





 In order to assess the potential of the polyacrylamide as a scaffold for the development of 1O2 
probes for its use in intracellular systems, several items have been studied and are worth of further 
comments.  
 One of the requirements to meet for a potential scaffold is versatility. As our final goal was to obtain 
a general platform able to perform inside a cell independently of the probing molecule, we chose two 
commercial 1O2 probes, fairly different in mode of action. ADPA is a water-soluble anthracene derivative 
that in the presence of 1O2 undergoes an endoperoxidation that results in a decrease of both its absorbance 
and fluorescence.11,53 On the other hand, SOSG is a dyad composed by a fluorescein moiety whose 
fluorescence is quenched by photoinduced intramolecular electron transfer due to the presence of a near 
covalently bound anthracene moiety. In the presence of 1O2, the anthracene suffers an endoperoxidation 
and, as a result, the electron transfer is blocked leading to great fluorescence enhancement.23 Chemically 
speaking, both probes are acidic salts that under proper activation can readily react with amino groups. 
This is the reason why all the NPs developed presented amino groups either directly on the surface or 
throughout the linker. Coupling through an amide bond is a fairly straightforward reaction and high yields 
of reaction were obtained. Moreover, amino derivatisation was easily achieved. When required on the 
surface, commercial amino-bisacrylamide was used; when needed detached from the surface, linkers were 
directly connected via click chemistry. 
 The second requirement is, of course, that the system should work. This was first tested in solution. 
In the first approach, with the probes readily attached to the NP surface, results were unfruitful and very 
modest conversion rates were obtained as compared to the virgin probe. Incorporation of spacers of 
different length improved substantially the result. However, no clear correlation between linker length 
and probing efficiency was found. For both compounds the medium-size linker NPs performed more 
efficiently. NPs composed of mixed linkers of different lengths were also synthesised and tested, but 
without improving the general outcome.  
 Biocompatibility with living systems is another must. As previously mentioned, one of the main 
problems dealing with regular 1O2 probes is that they have not been envisaged to act in intracellular 
systems and many fail due to toxicity, biocompatibility or difficulties in uptake. For instance, SOSG has 
been proved hard to be internalised in HeLa cells cultures when administered in whole media (including 
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serum proteins). One of the advantages of our system is that NPs presented minimised interaction in the 
presence of BSA. While still partial fluorescence quenching occurs, no spectral changes arise. Thus, 
administration and uptake in whole medium has been proven feasible (preliminary results, Figure 13). 
Cationicity has been shown necessary for polyacrylamide systems to be internalised. Thus, two different 
cationic groups have been designed and added to the system from the NP synthesis. Thankfully, the 
incorporation of these groups on the surface of the NP did not affect the global performance of the NPs. 
Once again, this result elicits more versatility on the system since different subcellular localisations can 
be targeted. 
 One of the most interesting approaches developed on the system is the incorporation of both the 
probe and a reference PS. One of the main problems in detecting 1O2 is the difficulty to achieve that the 
probe is present just in the loci where 1O2 is being produced. By incorporating a porphyrin in the matrix 
of the NP this problem is overcome. Moreover, dual fluorescent localisation is displayed since porphyrin 
and probe fluorescent spectra are fairly well separated. It is true that performance in cuvette has proven 
less efficient that their analogues without porphyrin. However, the PS’ concentration loaded in the 
construct is minor to that of the experiments performed in cuvette. Still we could observe enhancement 
and the system is closer to reality when administered in cells. Further data has not been provided, but 
preliminary experiments (Figure 13) show that NPs loaded both with probe and PS are uptaken and 
colocalisation occurs. Next stage will be to assess the performance upon generation of 1O2. 
 
Figure 13. Confocal merged image of HT-29 cells incubated for 18 h with NP-M-SOSG-Porph (2 mg/mL in whole 
medium). Plasma membranes were stained with Cell Mask Deep Red (5 min; 5 mg/mL; green). Little red dots 
inside the green circles indicate that smaller NPs have been taken in. Some NPS are aggregated at the surface of the 
membrane (big red blobs). Big yellowish bright blobs correspond to artifact from the laser light going through both 
membrane and aggregate. FITC set up (488 nm Ar laser) and Alexa Fluor set up (633 nm HeNe laser). 






In summary, we have designed, synthesised and preliminary proven a multifunctional biodegradable 
polyacrylamide NP scaffold for 1O2 detection inside cellular systems. By a combination of two different 
commercial 1O2 chemical probes linked to the polyacrylamide nanocore we obtain an interesting 
approach to achieving intracellular 1O2 ratiometric measurements. Modification of the polyacrylamide 
matrix with linkers of different length between the core and the probe enabled changes in sensing 
response towards 1O2. Moreover, the NP scaffold hampered the interactions between the hydrophobic 
probes and BSA thus proving minimised efficiency losses when in a cell-like environment. Best candidate 
positively charged NPs incorporating either SOSG or ADPA were successfully uptaken by cells without 
appreciable dark toxicity and localisation assessed by the probe basal fluorescence. NPs incorporating a 
porphyrin PS in the polyacrylamide matrix were also tested and demonstrated both a better colocalisation 
and the possibility to generate 1O2 in situ. Even though the best candidates are far from ideal, we believe 
the described platform is endowed with potential features to soon become the reference system for 
intracellular 1O2 measurement. 
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SPECIFIC EXPERIMENTAL SECTION 
Materials.  
Chemicals: Acrylamide (99% minimum), ammonium persulsufate, dioctyl sulfosuccinate sodium salt and 
N,N,N,N-tetramethylethylenediamine were purchased from Sigma-Aldrich. 
N,N’methylenebis(acrylamide) and Brij 30® were obtained from Fluka Analytical. 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were 
purchased from Alfa Aesar. Hexane HPLC grade and ethanol analytical grade were obtained from Fisher 
Scientific. SOSG was purchased from Invitrogen. ADPA was supplied by Chemodex. 
Methods.  
Synthesis of polyacrylamide NPs: Amino functionalised NPs were synthesised by adopting the free 
radical microemulsion polymerisation procedure optimised by Chauhan et al.38 Briefly, a final volume of 
1.9 mL containing acrylamide (540 mg, 7.60 mmol), N,N-methylenebisacrylamide (150 mg, 1.04 mmol) 
and N-(3-aminopropyl)methacrylamide hydrochloride (10 mg; mmol; 1% equivalence to acrylamide) in 
water (1.7 mL) was added to a deoxygenated hexane (42 mL) solution containing Brij 30 (3.08 g, 8.49 
mmol) and completely dissolved dioctyl sulfosuccinate sodium salt (1.59 g, 3.58 mmol). To this solution 
30 μL of ammonium persulfate (0.4 μmol) in water and 15 μL N,N,N,N-tetramethylethylenediamine (0.1 
μmol) were added and the mixture stirred for 2 h under a positive argon pressure at rt. Excess hexane was 
removed in vacuo. The resulting viscous yellow colored solid was washed with ethanol, centrifuged (8 x 
50 mL, 10 min, 4500 r pm) and recovered by microfiltration (Whatman Anodisc 25, 0.02 μm, 25 mm 
filters) to yield the desired NPs. Yield: 86% (602 mg). 
To synthesise alkyl functionalised NPs, the above synthesis procedure was followed with the exception of 
addition of N-(pent-4-yn-1-yl)methacrylamide instead of N-(3-aminopropyl)methacrylamide. To 
synthesise charged alkyl functionalised NPs, the above synthesis procedure was followed with the 
exception of extra addition of trimethylamoniumbysacrylamide or trimethylphosphoniumbysacrylamide 
together with the rest of the acrylamide monomers.  
Linker synthesis: (2-azidoethoxy)methanamine hydrochloride (medium linker; “M”) and 2-(2-(2-
azidoethoxy)ethoxy)ethanamine hydrochloride (large linker; “XL”) were synthesised following protocols 
described in references 54,55. Short description for “XL” is explained as example. To a stirred solution of 
tert-butyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate (10 mmol) in MeOH (50 mL) was added copper 
(II) sulphate (1 mg), and anhydrous potassium carbonate (2.5 g; 12 mmol) was added, and the mixture 




stirred at rt for 24 h . The solvent was removed under reduced pressure and the product purified via 
column chromatography (1% MeOH: DCM) to yield tert-butyl (2-(2-(2-
azidoethoxy)ethoxy)ethyl)carbamate as a colourless oil (2.37 g, 87 %). The obtained product was 
dissolved in 20 mL ethyl acetate and 10 mL HCl in dioxane were added and the reaction mixture stirred at 
rt for another 24 h. The solvent was removed under reduced pressure, and the residue washed with diethyl 
ether yielding “XL”. 3-azidopropan-1-amine (Small linker; “S”) was synthesised according to 
reference 56. Commercially available Boc-propanolamine was converted to the mesylate, which then 
smoothly underwent direct substitution with sodium azide to give the Boc-protected azide. Removal of 
the amine protecting group under standard anhydrous conditions gave the azidoethylamine as the 
hydrochloride salt. 
Coupling and purification: coupling between carboxylic dyes and amino groups were performed by 
standard protocols. Namely, dye-carboxylate was activated for 30 min upon addition of 1 EDC and NHS 
per mg dye followed by addition of the amino-NPs (20 mg in 2 mL NaHCO3). Stirring of the mixture 
was allowed overnight and dye-NPs were collected after running of the sample through a 8 .3 mL 
Shepadex PD-10 desalting columns (GE Healthcare) and precipitation in cold ethanol. Coupling of the 
linker to the NP was achieved using standard click chemistry protocol.57 Namely, a mixture of the alkyne-
NPs, the azide linker (2 equiv.), sodium ascorbate (0.2 equiv.) and copper sulphate (0.2 equiv.) was 
stirred for 8 hours and subsequently recovered after Shepadex column purification. 
Porphyrin: 5-{4-[3-(2-methylpropenamido)propylamino]thiocarbonylamino]phenyl}-10,15,20-tris-[4-
(methylpyridinium)-yl]-porphyrinato zinc (II) trichloride was kindly provided by Francesca Giuntini. 
NPs characterisation: particle size and size distribution properties of the NPs were measured by PCS, 
Zetaplus particle size analyzer (Malvern 3000) at 25 ºC and at a scattering angle of 90º. A dilute sample 
of 1 mg/mL NPs was prepared in Milli-Q water, sonicated for 30 s and filtered (Millex GP, 0.22 μm filter 
unit) before analysis. The value was recorded as the average of 30 data measurements. Porphyrin and dye 
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“There must be no barriers to freedom of inquiry. 
There is no place for dogma in science. 
The scientist is free, and must be free to ask any question, 
to doubt any assertion, to seek for any evidence, to correct any errors.” 
- Robert Oppenheimer 





GENERAL DISCUSSION & OUTLOOK 
Getting involved in a PhD has made me grow as a scientist and as a person. And not only scientific 
knowledge has been gained. I find it important to share a couple of thoughts I have obtained throughout 
my PhD thesis.  
Firstly, the realisation of how small we are as compared to science and the scientific world. One has 
only two hands and a finite time to dig in the infinite vineyard that is science. Reading every Monday 
over the discoveries in the field –and science in general- has helped me to start every week both 
enthusiastic about thrilling science and also with the feeling that I am late and at times obsolete in my 
research. And that tells you the more you think you know, the more humble you must be.  
I would like to add a second reflection concerning science in general. After my first research stay in 
Edinburgh I learnt that science is a lonely world. But it is not only loneliness; it also has to do with 
frustration and getting stuck many times. Feeling stupid, even. Fortunately to me, a summer later in Hull, 
I got to read the amazing reading “The importance of stupidity in scientific research”.1 I found it utterly 
revealing and encouraging. At times we forget we have to muddle through a field where we do not have 
insight. But nobody has insight and that’s why it is science research!! 
“I remember the day when Henry Taube (who won the Nobel Prize two 
years later) told me he didn’t know how to solve the problem I was having 
in his area. I was a third-year graduate student and I figured that Taube 
knew about 1000 times more than I did (conservative estimate). If he 
didn’t have the answer, nobody did. That’s when it hit me: nobody did. 
That’s why it was a research problem. And being my research problem, it 
was up to me to solve.” 
 Focusing, now it’s time to shift discussion towards scientific matters. After three lovely years 
devoted to singlet oxygen, its detection and its application in antimicrobial photodynamic therapy, what 
have I learn out of it? My first reflection goes towards “classical aPDT”, may I call it that way. With this 
term, I recall the cyclic concept of 1) designing and synthesising the “miracle” PS that will likely solve 
the problem of antibiotic resistance and outperform all previous last-resort drugs or PSs. 2) Measuring its 




photophysics in cuvette and its photokilling efficiency in bacterial cultures. 3) Realising it is another PS 
as good as the others but nothing especially new. Evolution towards 3rd generation PSs, as for me, 
represents an opportunity to better understand the processes of antimicrobial killing trough the 
photodynamic effect and unraveling key factors that would allow aPDT as a regular tool in our medical 
repertoire. But I believe we should be careful in thinking we are getting closer to the “Holy Grail PS”. 
This idea became clear to me in the last congress of the ESP I attended in Geneve (September 2011). 
Most studies regarding photodynamic inactivation were pretty similar to mine, even though different 
families of classy PSs with several degrees of complexity were used. Our cationic porphycenes were as 
good as the rest. However, what I could appreciate is that there was an upcoming shift in direction. 
Instead of looking for a new drug candidate, “old-fashioned” 2nd generation PSs were being used (or 
“recycled” somehow) as disinfectant agents in waters in conjunction with white light, to treat malaria, 
fungi or other parasites where little had been previously done (and thus becoming cool for publication) or 
to ascertain the relationships of photodynamic effect and immune system. The results obtained in the 
Chapter III section “cationic PSs as 3rd generation PSs” points out the previous statement. Out of the 6 
tested compounds, nice results have been achieved with at least 4 of them, even though they varied in the 
family of PS, the number of charges and probably in the subcellular localisation. However, little has been 
improved since first approaches with cationic phenothiazine or porphyrins PSs in terms of photodynamic 
efficiency.2,3 Rather, further and more thorough rationalisation regarding charge effects should be 
undergone, since little focus have been gained in recent years and shallow studies have been performed.4,5 
Out of our 4 good candidates two were tricationic, one tetracationic and one octacationic. Still, big 
differences among them make it hard to canalize the feasibility of the comparison. Especially regarding 
mechanistic issues as important limitations are found as far as the PS is delivered externally.  
Despite the previous reflections, I believe “classical aPDT” is far from death, but it needs a shift in 
direction. And one gap looks clear to me: biofilms. If one consults the number of scientific publications 
resulting from the search “antimicrobial photodynamic therapy” in PUBMED 
(http://www.ncbi.nlm.nih.gov/pubmed) and compares it with the same search for “microbial biofilms” the 
result goes as follows: 





Figure 1. Evolution on scientific publications on “microbial biofilms” (red; left ordinate axis) and “antimicrobial 
photodynamic therapy” (blue; rightt ordinate axis) and combined topics (green) over the last 40 years. Publications 
for 2013 have been extrapolated from results up to date and trend. 
 While both topics seem to be hot spots, if one goes for a combined search of both topics, the result 
obtained is as surprising as 57 results altogether!! Biofilms have gained a lot of attention since our 
understanding and the techniques have let us gain a lot of insight in the complex architecture that bacteria 
build-up in different niches.6,7 It was previously believed that a single virulence factor sufficiently 
mediated disease caused by a single organism. While true in some cases, many diseases can no longer be 
defined as an infection by a s ingle species. And here we include diseases of the oral cavity, otitis media, 
diabetic foot wound infections, and chronic infection in the cystic fibrosis lung. In these cases, the composition 
of microbial populations predicts both disease severity and outcome.8 Thus, if aPDT is meant to go for gold, 
further aPDT-mediated studies should be addressed. Almost twenty years ago Roberto Kolter (one of the 
popes on biofilms) saw clear it was about time to move from bacterial cultures to biofilms;9 now it is time 
for aPDT to move onwards.  
“However, things changed for me in 1994 when, noticing my depressed 
state, members of my laboratory gave me a fish tank in an effort to draw 
me out of the blues. As I sat locked-up in the office staring at the tank, I 
realized that by studying shaken cultures of E. coli I had been barking up 
the wrong tree. The water in the fish tank remained crystal clear, it was 
on the surfaces where most microbial activity was occurring.” 




Introduction of Chapter III intended to offer the reader some background on the approach of AMPs 
and bacteriocins as possible helpers in the fight against bad bugs. From the outside and within, we are 
constantly bombarded with a myriad of diverse microbial species. Fortunately, our bodies are equipped 
with an evolutionarily conserved innate immune defence system that allows us to thwart potential 
pathogens. AMPs are a unique and assorted group of molecules produced by living organisms of all 
types, considered to be part of the host innate immunity. These peptides demonstrate potent antimicrobial 
activity and are rapidly mobilised to neutralize a broad range of microbes, including viruses, bacteria, 
protozoa, and fungi.10 Thus, the idea of combining the use of PSs with AMPs in order to seek for a 
synergistic effect looks promising. In spite of the encouraging results obtained, further studies are 
necessary: new conjugates assaying other AMPs (magainin, bufforin, etc.), going to animal models (for 
instance to check if AMPs are degraded before getting to the target) and, importantly, controls in 
mammalian cells. Recent reports have shown that small modification of AMPs can result in targeting to 
mammalian cells,11 fact that could lead to undesired properties for our candidates. Another issue to bear 
in mind is that conjugation of the PS with other entities sometimes results in loss of efficiency.  
Definitely, to me, the approach that employs FPs as genetically-encoded PSs results the most 
promising and the most elegant of all. What better than a PS that can be built by the bacteria itself with its 
own machinery. Whenever I come to think of it, it reminds me the idea of a Trojan Horse. Giving bacteria 
plasmids encoding for tasty FP, letting them grow, making them glow to observe where they are and 
finally sheding light to kill them or exert localised damage at will! 
The beauty of using FPs that are able to generate sufficient amounts of 1O2 is multiple. First, 
localisation issues: by properly tailoring a plasmid we are able –on paper- to target any protein (and thus 
any part) of the cell by fusing our FP-gene to that of the protein of interest. Second, tracking issues: FPs 
are –as their name indicates- fluorescent. And we can take advantage of the property to check the 
feasibility of the construct and even the life of the protein. Finally, being able to generate 1O2 opens the 
door to a plethora of unprecedented opportunities. We can finely tune the amount of 1O2 we need to 
provoke cell death (addressing dosimetry issues, key in clinical success), we can damage selectively a 
fused protein, we can compare the damage at different loci (thus going to selectivity issues) or we can 
improve the development of probes that can perform in intracellular systems (as far as FPs are not 
restricted to bacteria). 





Figure 2. Drawing representing Trojan Horse. (Image from www.keiththompsonart.com; retrieved April 2013) 
 The potential of its use as a t herapy could be explored combined with the use of a p roper carrier 
systems (siRNA, phages, etc.). But before anything, new flavin-binding proteins with enhanced capacity 
to produce 1O2 have to be developed. And also further insight needs to be given. Questions such as why 
miniSOG ability to sensitise 1O2 is increased upon cumulative irradiation are not fully understood yet. 
 
 Shifting to the issue of 1O2 detection I would like to comment first on the fact that it is a recurrent 
issue and that has had broad interest. Some of the already mentioned reviews regarding the topic clearly 
show that it has attracted a never-ending interest and pretty beautiful and smart approaches have been 
published.12,13 Having had the necessity of quantifying 1O2 myself in different scenarios I have had the 
chance to experience with many of them what has given me a better idea on what advantages and 
drawbacks each technique exhibits. 
 As for me, the number one option has always been direct 1O2 measurement through 
phosphorescence at 1275 nm. You just need to adjust solutions of the sample and a reference to the same 
absorbance at the excitation wavelength and let it shine for a certain period of time, depending on the 
efficiency of the sample as 1O2 generator. If the unknown sample is a chemical substance soluble in 
organic solvents not many inconvenients will appear. May the sample be water soluble, a bit more patient 
one will have to be as far as the 1O2 phosphorescence efficiency in aqueous media is low.14 But with 
enough sample and using deuterated solvents usually it is enough to solve the measurement. Direct 1O2 




phosphorescence detection looked perfect to me until two especial water-like scenarios came to my 
hands. First, I had the necessity of measuring 1O2 generated by PSs uptaken by living cells. The huge 
scattering and the amazingly low signals made me realise the limitations of the system. Later on, we 
found the problem of obtaining a Φ∆ value much lower for miniSOG than that published. In the latest 
case, even though we were sure our measurements were correct, we needed at least a second method that 
would proof us right. These two examples told me it was time for me to get to use indirect 1O2 detection 
methods. My first approach was the use of the commercially available SOSG. This fluorescent probe has 
long been used in the topic of assessing 1O2 values in many different systems with pretty nice results.15 
Just to refresh what I previously said, this probe, however, has two important disadvantages. Firstly, it is 
unable to perform in intracellular systems mainly due to unspecific interactions with other substrates 
(such as BSA).16 Secondly, fluorescence enhancement upon reaction with 1O2 in “only” ca. 10 times at 
best. I also had the chance to use another fluorescent probe called ADPA (anthracene dipropionic acid, 
just to remind you). As commented back in chapter III, it has long been used and its use is fairly standard 
in the assessment of 1O2 in PSs. One of the most unexpected results was to find that this probe failed to 
measure 1O2 in proteins due to unspecific interactions with the protein itself. Interaction of anthracene-
like molecules with proteins had been previously reported, but not until the necessity of using both 
systems together did people realise of its inadequacy. Other interesting probe I had the pleasure to play 
with UA: Another indirect probe, this time not fluorescent. In this case, the 1O2 reactivity is tracked by 
absorbance due to bleaching of the probe. While useful in cuvette, this system is endowed with several 
drawbacks. Firstly, it works in the blue part of the spectrum, where many cell components absorb or emit 
(e.g. mitochondria autofluorescence); second, it is not such a straightforward measuring method, as far as 
a second order reaction takes place and one must be careful with the kinetics of the bleaching. Finally, the 
decrease in absorption can be really hard to measure -once again- in living systems. 
 With the previous background on the topic I was happy to have the opportunity to work with two 
new 1O2 detection scaffolds, corresponding to the two sections in Chapter IV. 
 The approach of the naphthoxazole dyads offered a pretty nice surprise. While the first 
measurements were conducted early on my thesis, not until the last months did we realise the power of 
the scaffold we had in our hands. At the beginning, we thought the system was “just” another fluorescent 
dyad in which fluorescent was prevented by photoinduced electron transfer until reaction with 1O2 




hindered the electron transfer and the fluorescence was thus recovered. The key point was to realize the 
novelty and usefulness of our system: the presence of two real different chemical entities before and after 
reaction of the dyad with 1O2. In common fluorescent 1O2 traps such as SOSG, the fluorophore is 
fluorescein. And it always is. However, in our system the conjugation of the two partners of the dyads 
makes that, in fact, the native and oxidised photoproducts are not the same. Such fact results in a 
fluorescent photoproduct that presents also spectral shift respect to the initial compound, thus enabling to 
choose a wavelength were initial and final products present maximum spectral differences. This double 
phenomenon explains why we achieve the amazing 310-fold fluorescent enhancement values. And it 
confers the system with very promising attributes. However, it is no gold all that glitters. First, we have 
not yet been able to fully ascertain the reasons for the initial quenching of the dyad in its native state. 
Second, the system presents huge dependence on the solvent polarity (in apolar solvents the probe is 
fluorescent before irradiation and photoconversion is slowed down and minimised). Finally, its solubility 
in aqueous media is very poor what hampers its use as a probe in intracellular systems. 
 In line with the end of the previous sentence, solubility in aqueous media and cell uptake are two of 
the milestones that a probe has to overcome so as to present itself as a potential 1O2 candidate to perform 
in intracellular systems. Of course, cell uptake talks about biocompatibility (low toxicity, for instance) 
and minimised (ideally lack of) interaction with other biological entities such as serum proteins. With 
these requirements in mind we decided to develop a system whose core would have polyacrylamide NPs 
that would confer both solubility in aqueous media and biocompatibility (at least by itself). Another 
attractive point is that it presents affordable chemical synthesis and versatility. Polyacrylamide NPs have 
long been used in several fields, also as probes for other analytes, so much of the chemistry needed was 
unravelled.17,18 The first approaches with direct ADPA and SOSG attachment to the NP didn’t render the 
desired performance. And thus we went for the incorporation of the linkers using the well-established 
click-chemistry. Despite we have seen the systems are not perfect in terms of fluorescent changes upon 
conversion, still we decided it was worth giving them a try in cellular systems. The first reason, because 
we needed to check they really were cell-compatible and that the scaffold was tolerated and uptaken. It 
was this way we realised we needed to incorporate charges in the system when the cationic porphyrin was 
not incorporated in the NP matrix. One of the greatness of the system we developed is the versatility as 
mentioned before. In a first approach, it allows the incorporation of several entities. For instance, we have 
incorporated the probe and the porphyrin. This idea provides two important factors: it improves the 




localisation of the NP (by colocalising both fluorophores) and it puts together the probe and the 
generation of 1O2, something not achieved up till now. Besides, it opens the door to much more 
elaborated systems still without introducing too much complexity into the system. For instance, we could 
include both probes to check both the bleaching of the anthracene moiety and the enhancement of the 
SOSG fluorescence; we could also try new probes (naphthoxazole-based dyads!!) or even load it with 
other PSs. However, better performance in cuvette is needed before moving much forward. As mentioned 
in the corresponding chapter, we are not the first group trying to measure 1O2 in intracellular systems; but 
none of us has fully succeeded up till now. After all, the main conclusion on this topic can be that none of 
the kind-of-successful systems published are ideal. Every system is inherently different (and difficult 
enough) and thus room for new improved 1O2 will always be welcome. 
 
 To finish this chapter I would love to give further emphasis on the reality of the bacteria resistant to 
antibiotics. Sadly, I’m afraid little will be done until cases of the “big monsters” land at home (just to 
recall, most of the cases of the pan-resistant bacteria are present in India or Pakistan, still far from western 
Europe). I also believe that people are not fully aware of the risks of misuse and abuse of antibiotics (not 
only in humans but also in cattle industry). And sadly is such a common use. Together with the 
improvement in the development of new therapies and drugs, much more should be done regarding 
raising awareness of the problem on society. And we should take notes on what our neighbours in the 
USA do in this respect with institutions such as ISDA (Infectious Diseases Society of America). Finally, I 
would also like to send a message of hope. And it comes from one of the aforementioned therapies: phage 
therapies. I was astonished by reading that this therapy is being used in Georgia (and other URSS-derived 
countries) routinely since 1920s!! And you can purchase phage-cocktails as easy as you can get an 
aspirin. Again, we have much to learn (and reading interesting reviews helps!).19 Hopefully some research 
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As a result of the present work, the following conclusions have been arrived at: 
• Tricationic porphycene NMe3MeO-TBPo has slightly improved photoinactivation 
ability against MRSA and P. aeruginosa as compared to its analogue Py3MeO-
TBPo, but it is less efficient against Candida spp. Dendrimeric phthalocyanines 
bearing zinc group clearly outperform their ruthenium analogues. Still, all 
dendrimers except RuCat8+ are capable of effectively photoinactivating E. coli. 
Aggregation effects have been observed for all compounds, while differences in 
behaviour occur depending on the family of PS. 
• Photophysical studies on A pidaecin 1b c onjugated to four different PSs indicate 
binding to the bacterial OM but not improved photophysical properties respect to 
the parent PS, except for the water solubility conferred by the intrinsic charge of 
Apidaecin 1b. The reported results are consistent with photoinactivation 
experiments, FACS analysis, and circular dichroism studies. 
• 1O2 production by TagRFP has proven sufficient to exert bacterial cell death in a 
light dose dependent manner, being the first report on bacterial photokilling via 
purely 1O2 endogenous production. MiniSOG has been shown to outperform any 
other reported fluorescent protein in terms of bacterial photoinactivation. 
Additionally, insight has been gained unravelling mechanistic aspects on bacterial 
cell death. 
 




• MiniSOG capability of sensitising 1O2 has been revisited and an apparent Φ∆ value 
of 0.03 ± 0.01 has been established through direct 1O2 luminescence and indirectly 
by using uric acid as probe. An increase in the Φ∆ value of almost an order of 
magnitude upon cumulative irradiation of miniSOG indicates that its sensitisation 
ability is hindered by scavengers inside the protein. 
• Conjugated naphthoxazole-based dyads have shown an unprecedented fluorescence 
increase up to 310-fold in the presence of 1O2. This effect can be explained since 
native and photooxidize species are indeed different chemical entities allowing 
optimised wavelength selection.  
• Polyacrylamide-based NPs linked to 1O2 chemical traps have been successfully 
developed and tested in solution. Chemical versatility of the system has allowed the 
inclusion of two different trapping moieties (ADPA or SOG), linkers varying in 
size, charged groups and even a model porphyrin. Moreover, minimised 
interactions of the system towards BSA have been observed. Finally, preliminary 
results in intracellular systems point out on biocompatibility, ease of localisation 






































This first appendix includes two paragraphs corresponding to a published interview to Professor 
John Conly by World Health Organization at the end of 2010 related to the World Health Day 2011 
dedicated to antimicrobial resistance. 
 
 
Q: What’s special about this new type of resistance labelled as NDM1? 
A: NDM1 is an enzyme that confers resistance to one of the most potent classes of antibiotics, 
known as carbapenems, but what has been observed is different in many ways to what we have 
seen to date. This new resistance pattern has been reported in many different types of bacteria 
compared to previously and at least one in 10 of these NDM1-containing strains appears to be 
pan-resistant, which means that there is no known antibiotic that can treat it. A second concern 
is that there is no significant new drug development for antimicrobials. Third, this particular 
resistance pattern is governed by a set of genes that can move easily from one bacterium to 
another. Fourth, NDM1 has been found in the most commonly encountered bacterium in the 
human population, E. coli, which is the most common cause of bladder and kidney infections. A 
further concern is that of the two drugs potentially capable of treating an infection due to one of 
these new multiresistant strains, one of them, colistin, causes toxic effects to the kidney in about 
a third of people. 
 
Q: Is this the doomsday scenario of a world without antibiotics? 
A: Unfortunately yes, with these new multiresistant NDM1-containing strains and their 
potential for worldwide spread. Doctors will face a terrible dilemma when a pregnant woman 
develops a kidney infection that spills over into the bloodstream with a pan-resistant strain 








Not until one gets to know real stories one is not fully aware of the significance of the problem. 
With this purpose in mind, two representative and shocking real and recent cases have been selected and 
attached below as part of this second appendix. More information can be found from the main web page 
of the Infectious Diseases Society of America (IDSA; 
http://www.idsociety.org/Topic_Antimicrobial_Resistance/)  




A 19-year-old from the Seattle area battles several NDM-1 positive antibiotic-resistant infections as he recovers from 
a train accident that cost him his right leg. 
“In just one moment my life changed forever. In June 2011 I  was 19 years old and working as a 
volunteer with HIV/AIDS orphans in Calcutta, India, through the social justice organization YWAM, far 
from my home in the Seattle area.  One morning while I was walking to the orphanage, I took a shortcut 
across some train tracks to avoid the trash-filled roadside. All of the sudden I was hit and dragged by a 
train, resulting in the brutal amputation of my right leg above the knee. 
You never know when it's the biggest day of your life until it's happening. It was as if I was in the 
middle of a nightmare turned reality; I didn’t receive pain relievers until a week after the accident. When I 
received clearance to be airlifted back home to Seattle after a hazy three weeks of agony, I thought the 
worst of my journey would be over: Maybe I would need some antibiotics and other treatment, but I could 





When I arrived back in the U.S., I soon learned that my wounds were infected with multiple drug-
resistant bacteria (including Pseudomonas aeruginosa, Klebsiella pneumoniae, Morganella morganii, 
and Enterococcus), several of which tested positive for New Delhi metallo-beta-lactamase-1 (NDM-1), a 
dangerous and recently discovered enzyme that makes bacteria resistant to a whole class of very 
important  antibiotics. I had never heard of any of those bacteria, nor NDM-1, let alone thought that one 
day I would become infected with them. I remember when the lab results came back, the hospital staff 
was so concerned by the NDM-1 that everyone went into crisis mode, and I was immediately isolated in 
my room. After another surgery to remove infected tissue from my residual limb, I was put on broad-
spectrum antibiotics as a precaution. They thought the infection was 
gone, so I was released and returned home to my family. 
After four weeks at home the pain still hadn’t subsided, and my 
doctor knew something was wrong. Another surgery was required, and 
the surgeon found the tissue was still infected with  the highly drug-
resistant bacteria. I began a course of strong antibiotics, including an 
antibiotic of last-resort called colistin, which is rarely used because it’s so toxic. I felt my body shutting 
down from the toxicity of the treatment. My immune system, kidneys, and liver were failing, and I could 
feel my body giving up. Top doctors were giving me potent cocktails of the most powerful antibiotics 
available, and we were not sure if the drugs were even working. To know that the drugs that were strong 
enough to damage my internal organs might not be powerful enough to fight the bacteria they were 
intended to treat, made me feel incredibly powerless.   
I stopped the antibiotics at the end of September when the infection was thought to be gone. By 
December, it was back again in the form of a golf ball-sized abscess in my thigh. A biopsy revealed that 
the resistant bacteria were back full-force, and I underwent another emergency surgery to have more 
infected tissue removed. The antibiotics I took during this time were even stronger than the first course, 
and the side effects completely exhausted my body. The treatment was very similar to chemotherapy, 
making me vomit daily. It felt as though each of my organs were slowly deteriorating. I felt my body 





Now, eight months after my accident, my wounds are closed, but my worries are not over. My life 
consists of watchful waiting and praying that the infection, like some awful type of cancer, does not 
return. I have weekly doctor visits and monthly hospital visits so that we can keep a close watch on my 
progress. The learning process for my new prosthetic leg has been slow going because I had to restart my 
physical therapy treatments after every emergency surgery, which removed more of my leg tissue. Plus, 
losing more and more of my leg to these antibiotic-resistant infections has made it harder to use a 
prosthetic, since I have less muscle to work with. 
My battle is not over, but I'm thankful to be alive. I survived an impossible accident and continue to 
fight the deadliest of infections.  My family, friends, and faith keep me going, and it is for them that I stay 
optimistic. While things may never be the same as they were before that June morning, I am grateful for 
life. Recovering from a traumatic accident isn't easy, saying it is exhausting is an understatement. The 
infections leave my body weak and broken, but I continue to fight every day. I cheated death because I 
found life too beautiful to resist.” 
April 2012 
 
Addie Rerecich’s story 
 
 
A healthy 11-year-old girl from Tucson, Ariz., who spent months in the hospital fighting several antibiotic-resistant 
infections and needed a lung transplant to save her life. 
 
“Addie will never be the same again, and there’s nothing I can do about it. I thought this as I sat in 
the hospital watching my 11-year-old daughter’s health rapidly fade. She had tubes running all over her 
body, a special machine had been brought in to help her breathe, and doctors were preparing me for the 





nurse, I remember learning about drug-resistant organisms, such as methicillin-resistant Staphylococcus 
aureus (MRSA) and Escherichia coli (E. coli), in school. I preached to my patients and colleagues the 
importance of using antibiotics properly to avoid promoting the development of life-threatening 
pathogens. However, as I sat there watching my little girl fight for her life I realized, dear God, this is 
happening to us!  
It all started on Mother’s Day 2011. I remember Addie being more tired than usual. I didn’t think 
too much of it since she was always such an active kid who loved to swim, run track, and play softball. 
Those things catch up with you, and I figured on this day she was just worn out. About a week later, 
Addie mentioned to me that she had been having a lot of pain in her hip. I suspected a pulled muscle but 
made an appointment with our doctor for the next day just in case. We never made it to that appointment. 
Instead, her pain continued to increase, and she developed a fever of 103, prompting us to make a trip to 
the emergency room. 
Doctors there saw nothing wrong with her white blood cell counts or other lab results that might 
indicate she had a bacterial infection, so they sent us home with ibuprofen and a reminder to see our 
doctor within three days. But Addie didn’t get better. I called paramedics and took her to the emergency 
room one more time before seeking a second opinion at another hospital. Addie walked into the hospital 
with me on May 19, 2011, and would not pass again through those doors until October, five months later. 
Those months were a whirlwind, and it started immediately. Doctors ordered a culture of her blood, and 
found her body was overcome with a Staphylococcus infection, a condition called sepsis. The infection 
had begun growing as an abscess in her hip muscle, and spread into her blood, eventually causing a 
devastating bacterial pneumonia in her lungs. The abscess in her hip had gone untreated for so long that 
she had developed a blood clot deep in a vein near the abscess. Unfortunately, part of the clot broke away 
and caused a pulmonary embolism to her right lung – further complicating matters. 
Within 24 hours, my little girl went from happy and healthy to being intubated and hooked to a 
breathing machine. Her small body was riddled with tubes and wires.  She had surgery to remove the 
abscess from her hip.  She was not getting better. Eventually her lungs began to fail entirely, and she had 
to be placed on a machine called ECMO (extracorporeal membrane oxygenation), which circulated her 




would allow them to heal. The machine is usually only needed for five to seven days; Addie was 
connected to it for three full months. 
During this time, Addie’s doctors realized her lungs were not getting better– she would need a lung 
transplant to survive. However, they were unsure they could perform a transplant, because there were so 
much bacteria running amok in her body.  She had developed infections caused by several drug-resistant 
bacteria – including extended-spectrum beta-lactamase (ESBL)-producing E. coli, Stenotrophomonas 
maltophilia, and a resistant form of pneumonia caused by Enterobacter aerogenes. Addie’s doctors had 
run out of the most common antibiotics used to treat these serious bacteria so, in desperation, they turned 
to an antibiotic known as colistin. Colistin is very powerful, but it is also so highly toxic to the kidneys 
and other organs that doctors rarely use it.  We started saying extra prayers.  
Our prayers were answered as she responded to this antibiotic therapy and was cleared for a double 
lung transplant. The transplant went off successfully, but, in the end, our lives will never be the same. 
When we left the hospital, Addie was in a wheelchair. She had lost the use of her left arm, had almost no 
vision in her left eye, and had restricted vision in her right eye. She had limited use of her left leg. She 
had suffered a stroke. She had lost 30 pounds, almost one third of her body weight. She was so weak and 
debilitated that she couldn't even turn herself side to side in bed. With intensive therapy Addie is 
improving, but progress is slow, and no one is sure how much function she can regain. She has horrible 
scars all over her body from the various procedures, tubes, and tests that ultimately saved her life. My 
once normal, strong, athletic Addie will need medical attention and therapy for the rest of her life. I’m so 
grateful that she’s still with us and that we made it through, but my heart aches when she looks up at me 
and asks, “Why me?”, because I don’t have an answer. 
Nothing can describe my feelings as a mother sitting helpless as I watched my little girl go from 
smiling and healthy to near death in less than a day. Antibiotic-resistant infections have devastated my 
daughter’s life and our family’s health, wellbeing, and finances. The health care costs from Addie's five-
month hospital stay alone came to $6 million. We need to take steps now to ensure we are able to more 
effectively battle these infections in the future and that we have the antibiotics we need to do so. My 










List of articles derived from the thesis 
 
1. R. Ruiz-González, J.H. White, M. Agut, S. Nonell and C. Flors. A genetically-encoded 
photosensitiser demonstrates killing of bacteria by purely endogenous singlet oxygen. Photochemical 
& Photobiological Sciences. 2012. Vol. 9. pp 1403-1486 
2. R. Dosselli, R. Ruiz-González, M. Gobbo, S. Nonell and E. Reddi. Synthesis, characterization and 
photoinduced cytotoxicity of porphyrin type photosensitizers conjugated to the antimicrobial peptide 
Apidaecin. Journal of Medicinal Chemistry. 2012; Vol. 56, pp 1052-1063 
3. R. Ruiz-González; J. H. White; A.L. Cortajarena, L.; M. Agut; S. Nonell; C. Flors. Fluorescent 
proteins as singlet oxygen photosensitizers: mechanistic studies in photodynamic inactivation of 
bacteria. Proc. SPIE, 2013, 859609 
4. R. Ruiz-González, R. Zanocco, Y. Gidi, A. L. Zanocco, E. Lemp and S. Nonell. Naphthoxazole-
based singlet oxygen fluorescent probes. Photochemistry and Photobiology. 2013 (DOI: 
10.1111/php.12106)  
5. R. Ruiz-González, A. L. Cortajarena, S. H. Mejias, M. Agut, S. Nonell and C. Flors. Singlet oxygen 
generation by the genetically-encoded tag miniSOG. Journal of the American Chemical Society. 








During the development of the thesis, some contributions to other articles that do not belong to the 
present work have been performed: 
6. X. Ragàs, D. Sánchez-García, R. Ruiz-González, T. Dai, M. Agut, M.R. Hamblin and S. Nonell 
Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. Journal 
of Medicinal Chemistry. 2010. Vol 53. pp 7796-7803 
7. R. Ruiz-González, P. Acedo, D. Sánchez-García, S. Nonell, M. Cañete J.C. Stockert and A. 
Villanueva. Efficient induction of apoptosis in HeLa cells by a nov el cationic porphycene 
photosensitizer. European Journal of Medicinal Chemistry. 2013. Vol 63. pp 401-414 
8. E. Rosas, S.Nonell, R. Ruiz-González, M.C. Llinàs, D. Sánchez-García, E.R. Edelman and M. 
Balcells. Selective targeting of microvascular endothelial cells using a n ovel immunoconjugated 





















Cite this: Photochem. Photobiol. Sci., 2012, 11, 1411
www.rsc.org/pps COMMUNICATION
A genetically-encoded photosensitiser demonstrates killing of bacteria by
purely endogenous singlet oxygen†‡
Rubén Ruiz-González,a John H. White,b Montserrat Agut,a Santi Nonell*a and Cristina Flors*b,c
Received 29th April 2012, Accepted 30th May 2012
DOI: 10.1039/c2pp25126d
TagRFP, a fluorescent protein capable of photosensitizing the
production of singlet oxygen, was expressed in E. coli. Sub-
sequent exposure to green light induced bacterial cell death
in a light-dose dependent manner. It is demonstrated for the
first time that intracellular singlet oxygen is sufficient to kill
bacteria.
Antimicrobial therapies are being actively sought with the goal
to address the increasing resistance of pathogens to
antibiotics.1–4 Antimicrobial photodynamic therapy (aPDT) is
regarded as very promising in this respect mainly because its
mechanism of action involves non-specific photo-oxidation of
cellular components, which strongly reduces the likelihood to
develop resistance.5 In fact, no reports exist describing the selec-
tion of aPDT-induced resistant pathogens in vitro6,7 or in vivo.8
After light absorption by a molecular entity acting as photosensi-
tizer (PS), the primary molecular event in the photodynamic
action is the generation of reactive oxygen species (ROS) such
as singlet oxygen (1O2), superoxide radical anion, hydrogen per-
oxide, or hydroxyl radicals. Almost every cell component is a
potential target for these ROS, as they react readily with proteins,
carbohydrates, cell-membrane components, and nucleic acids.9
Despite decades of research, the actual mechanism of cell
death triggered by these early photochemical steps is poorly
understood and it is not clear whether bacterial death requires
damage to the external wall and/or the inner cell components.10
Crucially, it has been difficult to establish the role of the PS
location, and thus the primary site of photodamage, since the
small size of bacteria precludes the use of fluorescence
microscopy techniques due to the limited spatial resolution of
this technique. Electron microscopy has the necessary resolution
and has recently revealed progression of envelope damage
inflicted during irradiation.11 On the other hand, time-resolved
studies of the formation and decay of 1O2 have been instrumental
in establishing the coexistence of externally-bound and interna-
lized PS molecules in E. coli.12 Because the PS is delivered from
the cell exterior it has not been possible so far to separately
study the contributions of external and internal damage, nor has
it been possible to control the location of the PS. As a result, a
sound understanding of the role of drug location in the mechan-
ism of cell death has been elusive to date.
In this communication, we report a solution to the issue of PS
location in aPDT mechanistic studies by using a genetically-
encoded 1O2 PS that we are able to express inside the cell. We
have previously shown that some green and red fluorescent
protein variants are able to photosensitize 1O2.
13–15 Here, we
have chosen TagRFP as a PS, which, unlike other fluorescent
proteins such as KillerRed,16–19 is able to photosensitize the pro-
duction of 1O2 but not of other ROS,
15 and is therefore uniquely
suited to ascertain the role of 1O2 in bacterial cell death.
E. coli BL21 (DE3) cells readily expressed TagRFP, as judged
from the development of red color and its distinctive red fluor-
escence (Fig. S1, ESI‡). TagRFP seems to be evenly distributed
in the bacterial cytosol, and no clear accumulation in specific
locations, e.g. near the internal membrane, can be clearly
appreciated within the diffraction-limited spatial resolution of the
fluorescence images. Photodynamic inactivation experiments of
E. coli expressing TagRFP were subsequently carried out. Cell
cultures in exponential growing phase were induced with 50 μM
isopropyl β-D-1-thiogalactopyranoside (IPTG) for 1 h. After
replacing the growth medium with PBS or deuterated PBS
(D-PBS), depending on the experiment, the cells were trans-
ferred to an optical non-treated sterile glass chamber and ir-
radiated through the bottom of the chamber by means of a
532 nm CW laser (40 mW cm−2).
No remarkable damage was observed for light doses below
750 J cm−2. However, a population reduction of ca. 4-log10 in
colony-forming units (CFU) per milliliter was achieved after a
light dose of 3200 J cm−2 in D-PBS suspensions (ca. 2.5-log10
CFU mL−1 reduction in normal PBS; Fig. 1). It is well known
that solvent deuteration extends the 1O2 lifetime
20,21 such that
the enhancement of oxidative damage upon deuteration has long
been used as a mechanistic test for the involvement of 1O2.
22
The light dose used is several orders of magnitude higher than
that used in typical aPDT treatments10 but comparable to that in
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chromophore-assisted light inactivation (CALI) assays,23 and is
consistent with the low quantum yield of 1O2 generation by
TagRFP (0.004 ± 0.0001).15
E. coli cells transformed with the control pET20b plasmid,
devoid of the TagRFP sequence, were tested under the same
experimental conditions. As depicted in Fig. 1, a CFU mL−1
reduction of less than 0.5-log10 units was observed in all cases.
Moreover, bacteria expressing TagRFP which were not irradiated
did not significantly lose viability (data not shown). These nega-
tive controls confirm that damage is inflicted by a photodynamic
reaction, i.e., by the combination of light, oxygen and TagRFP
acting as photosensitizer.
Our observation of ca. 1-log10 population reduction difference
between PBS- and D-PBS-suspended cells is consistent with a
1O2 lifetime of 3.5 μs in H2O and 65 μs in D2O.
24 This is also in
agreement with our previous report that TagRFP is a pure 1O2
PS15 and constitutes the first report showing that cytoplasmic
location of a 1O2 PS is sufficient to induce bacterial cell death
following light irradiation.
In order to obtain further insight regarding the mechanism of
cell death photosensitized by TagRFP, several additional assays
were performed. First, we focused on the cytoplasmic cell mem-
brane. Damage to the inner bacterial membrane is accompanied
by leaching-out of low molecular-weight species in addition to
DNA and RNA fragments, which are also able to permeate the
external membrane. The release of such intracellular components
can be conveniently monitored by spectroscopic means and the
onset of UV absorption at 260 nm in the supernatant is taken as
a strong indication of membrane damage.25,26 The results of
such assays in our TagRFP-tagged bacteria are shown in Fig. 2
(red circles), where the 260 nm absorbance of the supernatants
of irradiated bacteria suspensions is plotted as a function of the
light dose. The data have been normalized against the values for
non-irradiated samples. A clear growth in the 260 nm absor-
bance can be observed almost from the outset and a plateau
value is reached at a light dose of 1600 J cm−2. This indicates
that photodynamic damage to the inner cell membrane occurs in
our system. Leakage of TagRFP from the bacterial cytosol,
measured by fluorescence spectroscopy of supernatant solutions,
was observed only after light exposure and in a light-dose depen-
dent manner, consistent with increasing levels of photoinduced
bacterial membrane damage (not shown).
In a second series of assays we assessed the integrity of the
outer membrane. It is well known that Gram-negative bacteria
are markedly more resistant to photodynamic inactivation than
Gram-positive species, due to the highly organized structure of
its cell envelope.5 Specifically, many studies have shown that the
presence of an additional outer membrane prevents many PSs
from reaching and/or binding to the inner membrane, resulting in
lowered photosensitization efficiency.5 The outer membrane is
thus a typical target in Gram-negative bacteria.27,28 The fluor-
escent probe 1-N-phenylnaphthylamine (NPN), which increases
its fluorescence upon binding to cells with a damaged outer
membrane, was used to this end.26,29 As shown in Fig. 2 (black
Fig. 1 Photokilling effect of TagRFP in E. coli upon irradiation with
green laser light. Panel A: Example of viability results after photo-
dynamic treatments in D-PBS. Each column is a 1 : 10 dilution with
respect to the one on its right. The initial cell density for every sample
was ca. 108 CFU mL−1. Dark control (upper left); 2400 J cm−2
irradiation (upper right) and 3200 J cm−2 irradiation (bottom). Panel B:
Light-dose dependence on bacterial cell death in E. coli transformed
with pET20TagRFPhis or pET20b plasmids.
Fig. 2 Bacterial cell envelope integrity assays after different aPDT
light dose treatments. Red circles: absorbance of supernatants at 260 nm.
Black triangles: fluorescence of NPN. Data are normalized to values
measured for non-irradiated samples.






























































triangles), no increase in NPN fluorescence was observed relative
to dark control suspensions, suggesting that no significant
damage is inflicted on the outer membrane. NPN fluorescence
measurements in water and in lysed cells served as further con-
trols (Fig. S2, ESI‡).
Finally, damage to genomic DNA from E. coli cells was
studied, since some authors have reported photodamage to
genetic material in aPDT.30,31 DNA from irradiated cells was
extracted by standard procedures and electrophoresis of the
extracts was run in a 0.6% agarose gel. As shown in Fig. S3,
ESI,‡ no differences could be observed between samples ir-
radiated at the maximum light dose and dark controls. This indi-
cates that TagRFP-induced photodamage to genomic DNA does
not occur to any measurable extent. Our results are in line with
those of previous studies where it was concluded that DNA
damage is not the primary cause of bacterial cell photoinactiva-
tion.10,32 However, we cannot exclude that a lethal effect may be
produced by localized DNA damage that could not be detected
in our assay.33
Overall, TagRFP photodamage seems to occur mainly in the
inner membrane. No damage of the outer membrane or of
genomic DNA could be observed. These observations are mark-
edly different to those reported for an external photosensitizer.26
Thus, the site where 1O2 is primarily generated proves crucial for
inflicting different types of cell damage. It is relevant to recall
that the latest estimates of the radial diffusion distance of 1O2,
which represents its sphere of activity, are about 155 and 550 nm
in H2O and D2O, respectively.
21 These distances are below the
typical size of a bacterial cell.
In summary, killing of bacteria from purely endogenous 1O2
produced by a genetically-encoded photosensitizing protein has
been demonstrated for the first time. Our work provides insight
into the mechanism of singlet-oxygen mediated photodamage,
namely that cytoplasmic location of a photosensitizer is suffi-
cient for light-induced bacterial cell death. Moreover, this work
supports the potential of genetically-encoded strategies for treat-
ing bacterial infections with photodynamic therapy, which could
be realized by appropriate gene transfer methods.
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Fluorescent proteins as singlet oxygen photosensitizers: mechanistic 
studies in photodynamic inactivation of bacteria 
 
Rubén Ruiz-Gonzáleza, John H. Whiteb, Aitziber L. Cortajarenac, Montserrat Aguta, Santi Nonella, 
Cristina Flors*c 
aInstitut Químic de Sarrià, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain; 
bSchool of Chemistry, University of Edinburgh, Joseph Black Building, The King’s Buildings, West 
Mains Rd, Edinburgh EH9 3JJ, United Kingdom; cMadrid Institute for Advanced Studies in 
Nanoscience (IMDEA Nanoscience), C/ Faraday 9, E-28049 Madrid, Spain 
ABSTRACT   
Antimicrobial photodynamic therapy (aPDT) combines a photosensitizer, light and oxygen to produce reactive oxygen 
species (ROS), mainly singlet oxygen (1O2), to photo-oxidize important biomolecules and induce cell death. aPDT is a 
promising alternative to standard antimicrobial strategies, but its mechanisms of action are not well understood. One of 
the reasons for that is the lack of control of the photosensitizing drugs location. Here we report the use of genetically-
encoded fluorescent proteins that are also 1O2 photosensitizers to address the latter issue. First, we have chosen the red 
fluorescent protein TagRFP as a photosensitizer, which unlike other fluorescent proteins such as KillerRed, is able to 
produce 1O2 but not other ROS. TagRFP photosensitizes 1O2 with a small, but not negligible, quantum yield. In addition, 
we have used miniSOG, a more efficient 1O2 photosensitizing fluorescent flavoprotein that has been recently engineered 
from phototropin 2. We have genetically incorporated these two photosensitizers into the cytosol of E. coli and 
demonstrated that intracellular 1O2 is sufficient to kill bacteria. Additional assays have provided further insight into the 
mechanism of cell death. Photodamage seems to occur primarily in the inner membrane, and extends to the outer 
membrane if the photosensitizer’s efficiency is high enough. These observations are markedly different to those reported 
for external photosensitizers, suggesting that the site where 1O2 is primarily generated proves crucial for inflicting 
different types of cell damage. 
   
Keywords: antimicrobial photodynamic therapy, singlet oxygen, fluorescent proteins, miniSOG, photosensitization, 
TagRFP  
 
1. INTRODUCTION  
Fluorescent proteins are invaluable tools for fluorescence microscopy and related techniques to monitor cellular 
processes in living cells, owing to their ability to be genetically-fused to virtually any protein in a cell. They are mostly 
used as tags, sensors and reporters, but recently other interesting properties of fluorescent proteins are being exploited. In 
particular, their capability to act as singlet oxygen (1O2) photosensitizers is generating increasing interest.1 1O2 is 
produced when a photosensitizer (in this case the fluorescent protein) is excited by light, and transfers its excitation 
energy to molecular dioxygen. 1O2 is highly reactive, and can photo-oxidize substrates such as proteins, lipids and 
nucleic acids, which is relevant in the context of photodynamic therapy (PDT) and chromophore-assisted laser 
inactivation (CALI). 
We have previously shown that some variants from the green fluorescent protein (GFP) family are able to photosensitize 
1O2, although with very low efficiency.2-4 For example, TagRFP photosensitizes 1O2 with a quantum yield (ΦΔ) of 0.004,4 
similar to that of the free GFP chromophore.2 The photosensitizing protein KillerRed,5 although initially thought to 
produce 1O2, is now acknowledged to produce other ROS.6, 7 
Recently, efforts to produce genetically-encodable tags that generate 1O2 have turned to the engineering of flavin 
mononucleotide (FMN)-binding fluorescent proteins, since FMN is an efficient 1O2 photosensitizer (ΦΔ= 0.51).8 
MiniSOG (for “mini Singlet Oxygen Generator”) is a 15 kDa flavoprotein not structurally related to GFP.9 Although its 
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value of ΦΔ  had been initially reported as 0.47, this value has been recently revised to 0.03, still an order of magnitude 
higher than that of TagRFP.10 
 
Owing to the ability to genetically-encode them, fluorescent proteins that are able to photosensitize 1O2 offer an 
advantage in a number of applications where full control of the site for 1O2 generation is important (e.g. chromophore-
assisted laser inactivation, photodynamic therapy, or electron microscopy).1 In this paper, we take advantage of the 
genetic control of the photosensitizer location in mechanistic studies of antimicrobial photodynamic therapy (aPDT). 
aPDT is regarded as a very promising antimicrobial strategy because its mechanism of action involves non-specific 
photooxidation of cellular components, which strongly reduces the likelihood to develop resistance.11 Photodynamic 
action involves the photosensitization of reactive oxygen species (ROS) such as 1O2, superoxide radical anion, hydrogen 
peroxide, or hydroxyl radicals. Almost every cell component is a potential target for these ROS, as they react readily 
with proteins, carbohydrates, cell-membrane components, and nucleic acids.12 
Despite decades of research, the mechanistic details of cell death triggered by these early photochemical steps is poorly 
understood and it is not clear whether bacterial death requires damage to the external wall and/or of inner cell 
components.13, 14 Crucially, it has been difficult to establish the role of the photosensitizer location, and thus the primary 
site of photodamage, since the small size of bacteria precludes the use of fluorescence microscopy techniques due to 
their limited spatial resolution. On the other hand, time-resolved studies of the formation and decay of 1O2 have been 
instrumental in establishing the coexistence of externally-bound and internalized photosensitizer molecules in E. coli.15 
Because the photosensitizer is delivered from the cell exterior it has not been possible so far to separately study the 
contributions of external and internal damage, nor has it been possible to control the location of the photosensitizer. As a 
result, a sound understanding of the role of drug location in the mechanism of cell death has been elusive to date. In this 
paper, we use two different fluorescent proteins, TagRFP and miniSOG, as genetically-encoded 1O2 photosensitizer in 
aPDT. The proteins, which have very different structures and 1O2 photosensitizing efficiencies, are expressed in the 
bacterial cytosol. We quantify the extent of photoinduced cell death inflicted by both fluorescent proteins, and we 
perform mechanistic studies to better understand how photodynamic damage occurs in aPDT. 
 
2. MATERIALS AND METHODS 
2.1 Bacterial expression and culture conditions 
pET20bTagRFPHis1 or pET20b plasmids were transformed into competent E. coli strain BL21 (DE3). The pBAD-Myc-
HisA plasmid encoding miniSOG9 was transformed into E. coli DH5α cells. E. coli were aerobically grown overnight at 
37 ºC in an orbital shaking incubator (250 rpm) in luria-bertani (LB) broth (Fischer Scientific) in the presence of the 
appropriate amount of antibiotic (100 µg/mL disodium carbenicillin; Sigma) to stationary phase. A reinoculum was then 
grown in fresh LB medium at 37 ºC to an OD600 = 0.2 (start of log phase). TagRFPHis expression was induced with 50 
µM solution of isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma) and miniSOGHis expression with 0.1 % arabinose 
for 1 hour at 37°C to an OD600 ≈ 0.6-0.7  The suspensions were then centrifuged (10 min, 5000 rpm) and resuspended 
with sterile PBS or D-PBS at pH 7.4 to ca. 108 colony forming units per milliliter (CFU)/mLfor aPDT experiments. 
   
2.2 Photodynamic inactivation studies 
Cell suspension aliquots were placed in optical non-treated glass plates (Lab-Tek, Nalgene NUNC international, 
Rochester, New York). For Figure 1A, the wells with TagRFP-tagged samples were illuminated from the bottom of the 
plates by means of an expanded CW 532 nm laser beam (Cobolt Samba) at fluences ranging from 0 to 3500 J•cm-2. For 
Figure 1B, the wells containing miniSOG- and TagRFP-tagged bacteria were illuminated from the top by means of a 
LED light source (Sorisa Photocare) using a 35 mW•cm-2 fluence rate either in the green for TagRFP (535 ± 15 nm) or in 
the blue for miniSOG (470 ± 10 nm). No significant temperature increase was observed during the experiments. At 
different time intervals during the illumination, when the desired fluences had been delivered, aliquots were taken from 
the well (the suspensions were thoroughly mixed before sampling to avoid cell settlement). For determination of cell 
viability after treatments, aliquots were serially diluted (1:10 dilutions until single colonies could be observed), streaked 
on nutrient agar, and incubated in the dark for 18-20 h at 37 ºC.  
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2.3 Integrity of cell membrane  
After photodynamic treatments, samples were centrifuged (13000 rpm, 10 min) and the supernatant was monitored by 
UV—vis spectroscopy (Cary, Varian, Palo Alto) in order to measure the absorbance values at 260 nm, which indicates 
leakage of small cellular components due to inner membrane damage.16 To test the integrity of the outer membrane, the 
pellet was resuspended and 1-N-phenylnaphthylamine (NPN; sigma) was added to a final concentration of 15 µM.14, 17 
Fluorescence spectra were readily measured after NPN addition upon excitation at 350 nm (Figure S2). Cell lysate (3 x 1 
minute sonication) was used as a positive control. 
 
3. RESULTS  
3.1 Quantification of photodynamic bacterial inactivation 
When cells expressing TagRFP were irradiated no significant damage was observed for light doses below 750 J·cm-2.18 
However, a population reduction of ca. 4-log10 in colony-forming units (CFU) per milliliter was achieved after a light 
dose of 3200 J·cm-2 in D-PBS suspensions (ca. 2.5-log10 CFU/mL reduction in normal PBS; Fig. 1). It is well known that 
solvent deuteration extends the 1O2 lifetime19, 20 such that the enhancement of oxidative damage upon deuteration has 
long been used as a mechanistic test for the involvement of 1O2. The light dose used is orders of magnitude higher than 
that used in typical aPDT treatments11 but comparable to that in chromophore-assisted light inactivation (CALI) assays,21 
and is consistent with the low quantum yield of 1O2 generation by TagRFP (0.004±0.0001).4 E. coli cells transformed 
with the control pET20b plasmid, devoid of the TagRFP sequence, were tested under the same experimental conditions. 
As shown in Fig. 1, a CFU/mL reduction of less than 0.5-log10 units was observed in all cases. In addition, bacteria 
expressing TagRFP which were not irradiated did not significantly lose viability (data not shown). These negative 
controls confirm that damage is inflicted by a photodynamic reaction, i.e., by the combination of light, oxygen and 
TagRFP acting as photosensitizer. 
 
Our observation of ca.1-log10 population reduction difference between PBS- and D-PBS-suspended cells is consistent 
with a 1O2 lifetime of 3.5 µs in H2O and 65 µs in D2O.20 This agrees also with our previous report that TagRFP is a pure 
1O2 photosensitizer 4 and suggests that cytoplasmic location of a 1O2 photosensitizer is sufficient to induce bacterial cell 
death following light irradiation.  
 































Light dose / J·cm-2A B
Figure 1. A) Photoinactivation of E. coli BL21 (DE3) expressing TagRFP in the cytosol upon irradiation with 532-nm laser light.        
Light-dose dependence on cell death transformed with pET20TagRFPhis in PBS (red circles) or D-PBS (blue triangles). Control 
with only pET20b in PBS (black diamonds) or dPBS (gray squares). B) Light-dose dependence (475 nm LED irradiation) on 
bacterial cell death in E. coli DH5α expressing miniSOG in the cytosol in PBS (red circles) and D-PBS (blue triangles).  
 
A similar experiment was performed with E. coli DH5α cells expressing miniSOG in the cytosol. A population reduction 
of over 1-log10 units was achieved even after a light doses as mild as 2.5 J·cm-2 and up to 3.5-log10 units was observed 
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after 12 J·cm-2 treatment. Such a light dose is orders of magnitude lower than that used in previous aPDT treatments with 
red fluorescent proteins and comparable to the dose of KillerRed.22 As above, an enhancement of photoinduced cell 
death was observed when the experiment was performed in D-PBS.No damage was observed at maximum light dose 
without miniSOG, nor for E. coli BL21 (DE3) transformed with pET20TagRFPhis plasmid (irradiated at 535 ± 15 nm) 
even at doses of 70 J•cm-2. Moreover, no damage could be effected to bacteria expressing miniSOG in the absence of 
light (data not shown). 
 
3.2 Mechanistic studies of photodynamic damage 
In order to obtain further insight into the mechanism of cell death photosensitized by both fluorescent proteins, several 
additional assays were performed. First, we focused on the cytoplasmic cell membrane. Damage to the inner bacterial 
membrane is accompanied by leaching-out of low molecular-weight species and DNA and RNA fragments, which are 
also able to permeate the external membrane. Release of such intracellular components can be conveniently monitored 
by spectroscopic means, and the onset of UV absorption at 260 nm in the supernatant is taken as a strong indication of 
membrane damage.14, 16 The results of this assay are shown in Fig. 2 (red circles), where the 260-nm absorbance of the 
supernatants of irradiated bacteria suspensions is plotted as a function of the light dose. The data have been normalized 
against the values for non-irradiated samples. In both cases, TagRFP- and miniSOG-expressing bacteria, a clear growth 
in the 260-nm absorbance can be observed almost from the outset, which indicates that photodynamic damage to the 
inner cell membrane occurs in both types of cells. 
 
In a second series of assays, the integrity of the outer membrane was assessed. It is well known that gram-negative 
bacteria are markedly more resistant to photodynamic inactivation than gram-positive species, due to the highly 
organized structure of its cell envelope.11 Specifically, many studies have shown that the presence of an additional outer 
membrane prevents many photosensitizers from reaching and/or binding to the inner membrane, resulting in lowered 
photosensitization efficiency.11 The outer membrane is thus a typical target in gram-negative bacteria.23 The fluorescent 
probe 1-N-phenylnaphthylamine (NPN), which increases its fluorescence upon binding to cells with a damaged outer 
membrane, was used to this end.14, 17 As shown in Fig. 2 (blue circles), there is a markedly different behaviour between 
TagRFP- and miniSOG-expressing bacteria. For TagRFP, no increase in NPN fluorescence was observed relative to dark 
control suspensions. However, over 2-fold increase in NPN fluorescence was observed in miniSOG-tagged bacteria. This 
indicates that the more efficient photosensitizing properties of miniSOG result in a significant amount of 1O2 being able 
to reach the outer membrane and inflict damage, which is not the case for TagRFP-tagged bacteria. NPN fluorescence 




















Figure 2. Bacterial cell envelope integrity assays after different aPDT light dose treatments. Red circles: absorbance of 
supernatants at 260 nm. Blue triangles: fluorescence of NPN. Data are normalized to values measured for non-irradiated samples. 
A)TagRFP in E. coli BL21 (DE3), laser irradiation at 532 nm; B) miniSOG in E. coli DH5α. LED irradiation at 475 nm. 
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Finally, damage to genomic DNA from E. coli cells was studied, since some authors have reported photodamage to 
genetic material in aPDT.13, 24 DNA from irradiated cells was extracted by standard procedures and electrophoresis of the 
extracts was run in a 0.6 % agarose gel.  No differences could be observed between samples irradiated at the maximum 
light dose and dark controls (not shown). This indicates that TagRFP- or miniSOG-induced photodamage to genomic 
DNA does not occur to any measurable extent. Our results are in line with those of previous studies where it was 
concluded that DNA damage is not the primary cause of bacterial cell photoinactivation.25 However, we cannot exclude 




Purely endogenous 1O2 produced by genetically-encoded photosensitizing proteins expressed in the bacterial cytosol is 
able to induce bacterial cell death. Photodamage seems to occur mainly in the bacterial membrane, the extent of which 
correlates with the photosensitizing efficiency of the protein. Both TagRFP and miniSOG can induce damage the inner 
membrane, but only miniSOG in the outer membrane. No damage of genomic DNA could be observed. Our observations 
are markedly different to those reported for an external photosensitizer.14 Thus, the site where 1O2 is primarily generated 
proves crucial for inflicting different types of cell damage.  
This work supports the potential of genetically-encoded strategies in mechanistic studies of aPDT, and using appropriate 
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ABSTRACT: Antimicrobial photodynamic therapy (aPDT) is
an emerging treatment for bacterial infections that is becoming
increasingly more attractive because of its effectiveness against
multi-antibiotic-resistant strains and unlikelihood of inducing
bacterial resistance. Among the strategies to enhance the
efficacy of PDT against Gram-negative bacteria, the binding to
a cationic antimicrobial peptide offers the attractive prospect
for improving both the water solubilty and the localization of
the photoactive drug in bacteria. In this work we have
compared a number of free and apidaecin-conjugated
photosensitizers (PSs) differing in structure and charge. Our
results indicate that the conjugation of per se ineffective highly hydrophobic PSs to a cationic peptide produces a photosensitizing
agent effective against Gram-negative bacteria. Apidaecin cannot improve the phototoxic activity of cationic PSs, which mainly
depends on a very high yield of singlet oxygen production in the surroundings of the bacterial outer membrane. Apidaecin−PS
conjugates appear most promising for treatment protocols requiring repeated washing after sensitizer delivery.
■ INTRODUCTION
The global diffusion of new antimicrobial infections as well as
the continuously increasing resistance of pathogens against
many of the commonly used antibiotics imposes a considerable
effort to develop alternative therapies to the use of classical
drugs. In this area antimicrobial photodynamic therapy (aPDT;
also termed photodynamic antimicrobial chemotherapy,
PACT) represents a very promising strategy, particularly for
the treatment of superficial and localized infectious diseases.1
The PDT concept comprises the action of three components: a
photosensitizer (PS), a light source of appropriate wavelength,
and oxygen. The interaction between light and the PS leads to
the generation of reactive oxygen species (ROS), e.g., singlet
oxygen, by two possible mechanisms involving either electron-
transfer (type I) or energy-transfer (type II) reactions.2 These
ROS are highly reactive and can damage a variety of cellular
components, e.g., proteins, nucleic acids, and lipids, resulting in
cytotoxicity.3−5 Advantages of aPDT over traditional antibiotics
include a broad-spectrum activity, also against antibiotic-
resistant species,6 and the lack of development of resistance
mechanisms due to the multitarget process.7,8
Porphyrins, commonly used as PSs in PDT, can efficiently
kill Gram-positive bacteria, whereas only cationic PSs, or
noncationic PSs in combination with agents that permeabilize
the highly organized outer membrane of Gram-negative
bacteria, are able to kill Gram-negative species.9−11 An
alternative approach to improve the susceptibility of Gram-
negative bacteria to the photodynamic action of neutral
porphyrins involves the covalent attachment of the PS to a
polymer molecule containing basic amino groups12 or, as we
recently proposed, to a cationic antimicrobial peptide.13
Cationic antimicrobial peptides (CAMPs) are components of
the innate defense of many organisms, and they are being
considered a promising source of new antibiotics.14 In addition
to exerting direct antimicrobial effects, many studies have
documented their ability to affect various host cell activity and
to have a key modulatory role in the innate immune
response.44,45 Their overall positive charge ensures accumu-
lation at the polyanionic microbial cell surfaces that contain
acidic polymers, such as lipopolysaccharides, and wall-
associated teichoic acids in Gram-negative and Gram-positive
bacteria, respectively. Beyond the presence of several cationic
amino acids, a substantial proportion of hydrophobic amino
acid residues permit most of the CAMPs to fold into an
amphipathic structure, which allows them to insert into the
phospholipid bilayer of the cell membranes. After insertion,
antimicrobial peptides act by either disrupting the physical
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integrity of the membrane or translocating across the
membrane to hit internal bacterial targets. This multitarget
mode of action promises both low susceptibility to antibiotic
resistance and a broad spectrum of activity against a variety of
microorganisms. Among CAMPs, the family of short proline−
arginine-rich peptides attracts particular interest because of
some unique features, such as a higher activity against Gram-
negative bacteria, a relative stability against proteolysis, and a
very low toxicity against mammalian cells.15 Apidaecin 1b, an
insect 18-residue-long peptide belonging to this family, is
effective against a large number of Gram-negative bacteria and a
few Gram-positive bacteria,16 where it acts by a non-pore-
forming mechanism only partially elucidated.17,18 Mutagene-
sis19,20 and structure−activity relationship studies21−24 have
identified the C-terminal half of apidaecin as essential for its
antimicrobial activity, and several studies have shown that the
peptide is able to translocate a fluorescent tag into a bacterial
cell.22,24−26 In a preliminary communication we have shown
that the conjugation of apidaecin to 5-(4′-carboxyphenyl)-
10,15,20-triphenylporphyrin affords a new water-soluble PS (1c
in Figure 1) that, upon light activation, is able to kill both
Gram-positive and Gram-negative bacteria at concentrations at
which the antimicrobial peptide and, on Gram-negative
bacteria, the porphyrin alone are not effective.13 Herein we
report the synthesis, characterization, and phototoxicity studies
against Escherichia coli and methicillin-resistant Staphylococcus
aureus (MRSA) of new conjugates in which apidaecin and its C-
terminal octapeptide were modified at the N-terminus with
neutral or charged porphyrin and porphycene PSs.
■ RESULTS
Synthesis and Characterization of the Conjugates.
Porphyrins 1b and 3b, properly functionalized for the covalent
binding to the peptide, were prepared by established methods
using the Lindsey27 and Adler−Longo conditions,28 respec-
tively. We synthesized three new PS−peptide conjugates in
which the porphycene 2b or the cationic porphyrin 4b was
covalently linked to the N-terminal end of the antimicrobial
peptide apidaecin and 5-(4′-carboxyphenyl)-10,15,20-triphenyl-
porphyrin (1b) to its C-terminal segment (Figure 1). The
trimethylated porphyrin 4b was prepared from 3b by treatment
with an excess of methyl iodide in DMF, whereas alkaline
hydrolysis of the porphycene 2a released the functional group
from the subsequent conjugation. The synthesis of 2a has been
reported elsewhere.29 The side-chain-protected peptide se-
quences were automatically synthesized on a solid phase by the
standard Fmoc protocol,30 and after removal of the N-terminal
amino protecting group, the selected PS (1−4b, 2.5 equiv) was
coupled to the peptide chain using diisopropylcarbodiimide/N-
hydroxybenzotriazole as the activating agent. The yields of the
coupling reactions were in the range of 75−80% (based on
HPLC) except in the case of the cationic porphyrin 4b, which
apparently did not react with the peptide even using different
coupling reagents and reaction conditions. The conjugate
between apidaecin and this cationic PS was obtained from 3c,
side-chain-protected and still attached to the solid support, by
treatment with an excess of methyl iodide. Besides on pyridine
nitrogens, methylation also occurred on the π-nitrogen of the
histidine side chain, which usually remains unprotected during
Figure 1. Structures of the photosensitizers and their peptide conjugates.
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the peptide chain assembly. After cleavage and deprotection
from the solid support, the conjugates 1c, 1d, 2c, and 4e were
purified by reversed-phase HPLC and characterized by
analytical HPLC, electrospray mass spectrometry, and UV−
vis absorption spectroscopy.
Absorption and Fluorescence of the Conjugates. The
spectroscopic and photophysical properties of the PSs and their
conjugates were measured in aqueous and organic media and in
cell suspensions to assess the structural and environmental
effects as well as their correlation with antibacterial activity.
Methanol. Figures 2 and 3 show the absorption and
fluorescence spectra of the free PSs and of their peptide
conjugates in methanol. While the spectra of porphyrins are
essentially insensitive to conjugation (panels A, C, and D), clear
changes can be observed for the porphycene (panel B). In turn,
the fluorescence quantum yield does not change appreciably for
the porphyrins, while it drops by ca. 50% for the porphycene
(Table 1). Finally, all porphyrins show monoexponential
fluorescence decay kinetics, and conjugation does not change
the lifetime values either (Supporting Information, Figure
S1A,C,D). Again, the situation is different for the porphycenes
in that the conjugate 2c shows biexponential kinetics unlike the
free porphycene 2a (Figure S1B), and on average the singlet
state decays faster (Table 1).
Aqueous Solutions (PBS). Porphyrin 4b is water-soluble as a
consequence of its positively and negatively charged groups. It
remains water-soluble after conjugation (4e) with small but
clear shifts in the position of the Soret and Q absorption bands
and changes in their relative intensities (Figure 2E). The
fluorescence spectrum of 4b shows a single, structureless broad
band (Figure 3E), a behavior strikingly different from that in
methanol but in line with that of the related tetracationic meso-
tetrakis(N-methylpyridinium-yl)porphyrin (TMPyP).32 Conju-
gation to the peptide (4e) leads to partial recovery of the two
well-resolved fluorescence bands observed in methanol. The
fluorescence decay kinetics of 4b is monoexponential, albeit
with a lifetime much shorter than that in methanol. For the
conjugate 4e two decay components can be observed, whose
lifetimes are close to those of 4b in methanol and in PBS,
respectively (Figure S1E, Supporting Information, and Table
1). The kinetics is independent of concentration over 3 orders
of magnitude (Figure S2A and Table S1, Supporting
Information).
On the other hand, porphyrin 1b and porphycene 2a are
insoluble in water, and therefore, no fluorescence can be
recorded in this solvent. Conjugation to the peptides (1c, 1d,
and 2c, respectively) renders them water-soluble, but the
spectroscopic and photophysical properties change substantially
relative to those in methanol: the absorption spectra show
broadening of the Soret band and loss of structure in the Q
region (Figure 2F−H), and the fluorescence is dramatically
quenched. In addition, the fluorescence spectra of 1c and 1d
are slightly red-shifted (Figure 3G,H), and the decays are
biexponential (Figure S1G,H, Supporting Information, and
Table 1) and show a clear concentration trend (Figure S2B,C
and Table S1, Supporting Information).
E. coli Suspensions. The conjugate 4e shows in cell
suspensions the same absorption and fluorescence properties
as it does in PBS (Figures 2I and 3I and Table 1). On the other
hand, there are evident changes for conjugates 1c and 1d in cell
suspensions relative to PBS, particularly in the absorption
spectrum and in the fluorescence kinetics, which shows a third
decay component not present in PBS or in methanol (Table 1).
Finally, the porphycene conjugate 2c shows very similar
absorption spectra in PBS and in E. coli suspensions (Figure
2J). However, while we could record no fluorescence in PBS,
we were nevertheless able to observe extremely weak
biexponential fluorescence decay in the cells (Figure 3, Figure
S1J, Supporting Information, and Table 1).
Singlet Oxygen Production and Decay. All free and
conjugated PSs were able to photosensitize the formation of
1O2 in methanol as evidenced by its phosphorescence at 1275
nm. The quantum yields of 1O2 production (ΦΔ) were in the
0.6−0.7 range for the porphyrins and the 0.1−0.3 range for the
Figure 2. Absorption spectra in methanol (A−D), PBS (E−H), and E.
coli suspensions (I−L), normalized to facilitate their comparison. The
concentration is 5 μM for all compounds. Methanol: (A) 4e (red) and
4b (blue); (B) 2c (red) and 2a (blue; dichloromethane as solvent);
(C) 1d (red) and 1b (blue); (D) 1c (red) and 1b (blue). PBS: (E) 4e
(red) and 4b (blue); (F) 2c (red) and 2a (blue); (G) 1d (red) and 1b
(blue); (H) 1c (red) and 1b (blue). E. coli suspensions (green): (I)
4e; (J) 2c; (K) 1d; (L) 1c. Spectra in methanol (red) and PBS (blue)
are given for comparison.
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porphycenes (Table 2). The kinetics of 1O2 production
matched the results of laser flash photolysis experiments for
the triplet PS decay (see the Supporting Information, Table
S2). Likewise, an excellent match was found between the
observed lifetime of 1O2 and the literature values. In PBS, only
porphyrins 4b and 4e retained their high ability to produce
1O2; all other compounds experienced a decrease of the ΦΔ
value by 20−30-fold (porphyrins 1c and 1d) or even 100-fold
(porphycene 2c; Table 2). Inspection of the kinetics of 1O2
(Figure S3, Supporting Information) reveals that production of
singlet oxygen by conjugate 4e is as fast as that by the free
porphyrin 4b (Table 2), yet for the conjugates 1c, 1d, and 2c it
is 1 order of magnitude slower. On the other hand, the lifetime
of 1O2 for all conjugates in deuterated PBS is shorter than the
value expected in this solvent (67 μs),34 which is actually
observed only for the free porphyrin 4b. When E. coli
suspensions were studied, the 1O2 signals showed essentially
the same pattern as that in PBS solutions (Figure S4,
Supporting Information, and Table 2).
Circular Dichroism (CD) Studies. The conformational
properties of the conjugates were investigated by CD
spectroscopy in different environments, including water and
membrane-mimicking solvents, and compared to those of the
parent peptide. As a consequence of the high proline content (6
out of 18 residues), in water apidaecin assumes a prevalently
disordered, extended structure (Figure 4A), and in membrane-
mimicking environments it exists as a mixture of conformers
with a high percentage of nonrepetitive bent structures, most
probably β-turns (Figure 4C,D).23,25 The CD spectra of the
conjugates in water are characterized by a broad negative band
around 200 nm, much more intense for those with the cationic
porphyrin than for those with the neutral PS (Figure 4A).
Moreover, 1c and 2c showed a split Cotton effect in the Soret
band region (Figure 4B), indicating that porphyrins are chirally
oriented and close to one another in space.35 These results
suggest that while 4e can assume in water a fully extended
structure, conjugates 1c and 2c show the tendency to form
aggregates with the peptide chain probably folded over the
hydrophobic porphyrin platform36 and the porphyrins close to
one another to reduce the exposure to the solvent. Aggregation
was confirmed by a change in the UV spectra of these
conjugates moving from methanol to water. In organic solvent
(2,2,2-trifluoroethanol, TFE) and in the presence of SDS
micelles, the CD spectrum of the conjugates is similar to that of
the parent peptide, with a broad band at 202 nm, a shoulder at
220 nm, and comparable intensities (Figure 4C,D). This
suggests that in membrane-mimicking environments the
conformational preferences of the peptide are minimally
affected by the intramolecular interactions with the PS.
Photoinactivation of E. coli. To determine the photo-
sensitizing efficiency of our PSs and peptide−PS conjugates
against Gram-negative bacteria, E. coli suspensions were
incubated in the dark for 60 min with different concentrations
(1.5, 5, 10, and 15 μM) of the agents and then illuminated
(light dose of 36 J/cm2 of red light for 2a and 2c, 13.5 J/cm2 of
blue light for all other compounds) with or without washings.
At the concentrations used, apidaecin alone did not cause any
decrease of E. coli survival,13as did its C-terminal segment 1d, in
both the dark and light conditions (Table S3, Supporting
Information). In addition, neither 1b nor 2a caused any
bacteria photokilling in their unconjugated form. All conjugates
exhibited markedly concentration-dependent abilities to kill E.
coli under illumination with an efficiency that largely depended
on the type of conjugate (Figure 5A). Indeed, considering the
unwashed samples, 4b and 4e caused complete killing of
bacteria at 5 and 10 μM concentrations, respectively, while all
other agents were considerably less potent and at 15 μM
reduced the survival of E. coli by 4 log at maximum. Moreover,
it is interesting to notice that 1c was slightly more efficient than
1d and caused a bacterial mortality similar to that of 2c.
However, when illumination was carried out after three
washings of the cells to remove the unbound PS (Figure 5B;
Figure 3. Emission spectra in methanol (A−D), PBS (E−H), and E.
coli suspensions (I−L), normalized to facilitate their comparison. The
concentration is 5 μM for all compounds. Methanol: (A) 4e (red) and
4b (blue); (B) 2c (red) and 2a (blue; dichloromethane as solvent);
(C) 1d (red) and 1b (blue); (D) 1c (red) and 1b (blue). PBS: (E) 4e
(red) and 4b (blue); (F) 2c (red) and 2a (blue); (G) 1d (red) and 1b
(blue); (H) 1c (red) and 1b (blue). E. coli suspensions (green): (I)
4e; (J) 2c; (K) 1d; (L) 1c. Spectra in methanol (red) and PBS (blue)
are given for comparison.
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Figure S5, Supporting Information), only 1d retained an
efficacy similar to that observed in unwashed samples, while all
other PSs were considerably less potent. In particular, the loss
of efficacy of 4b and 4e in killing bacteria was drastic, with a
decreased killing ability of 6 log at the 10 μM concentration.
On the other hand, 1c and 2c, which were less photoactive
without washings, were less hampered by the washing
treatment. We also studied the photoinactivation of E. coli as
a function of the incubation times and using a concentration of
5 μM for 4b and 4e and 10 μM for all other compounds
(Figure S6, Supporting Information). The results showed that
the time of dark incubation of the cells with the PSs and their
conjugates before irradiation does not affect to a great extent
the photokilling efficiency of E. coli. Incubation times ranging
from 15 to 120 min gave very similar decreases of bacterial
survival when irradiation was carried out leaving the unbound
PS in solution. Only with 4b and 4e was the photoinactivation
ability slightly improved by increasing the incubation time, but
this effect was lost after the repeated washing treatment.
Photoinactivation of MRSA. The photoinactivation of
MRSA was studied by using the same experimental approach
used for E. coli. Contrary to E. coli, both 1b and 4b were highly
photoactive against MRSA; they caused complete killing of
unwashed bacteria at, respectively, 50 nM and 0.5 μM
concentrations (Figure 6A). These findings are in agreement
with the well-known susceptibility of Gram-positive bacteria to
many cationic and neutral PSs. However, the photoactivities of
the two porphyrins were differently affected by the washing
treatments: 1b did not show any appreciable change, while the
potency of 4b was dramatically reduced (Figure S7A,
Supporting Information). Both 1b and 4b lost part of their
activity when conjugated to apidaecin or its C-terminal
segment. In particular, at a 0.5 μM concentration the
unconjugated porphyrins caused complete cell killing, while
4e, 1c, and 1d caused only about a 3 log reduction of survival
(Figure 6A). The washing of S. aureus before illumination did
not appreciably reduce the killing efficiency of 1c and 1d, while
it significantly affected that of 4e, as was observed with E. coli
(Figure S7A). 2a and its apidaecin conjugate 2c were less
effective than the porphyrin counterparts, being active in the
range of 1.5−15 μM, i.e., at 10-fold higher concentrations
(Figure 6B). However, conjugation with apidaecin strength-
ened the action of the PS (Figure S7B). As for E. coli, also with
S. aureus the photoinactivation experiments were performed as
a function of the incubation time, and no major differences in
the efficiency of S. aureus photoinactivation with conjugated
and unconjugated PSs were found by changing the incubation
times from 15 to 120 min (Figure S8, Supporting Information).
Uptake Experiments. Flow cytometry experiments were
carried out to evaluate the interaction of the PSs (free or
conjugated to apidaecin) following incubation with E. coli and
S. aureus cells under the same experimental conditions as in the
photoinactivation experiments. The measurements showed that
1b does not associate with E. coli cells very efficiently. As shown
in Figure 7, after incubation with 5 μM 1b, only a small fraction
of E. coli cells exhibited a fluorescence signal higher than the
basal value in both washed and unwashed cells. On the
contrary, MRSA cells incubated with 1b exhibited a
fluorescence signal whose intensity was orders of magnitude
higher than the background signal, suggesting efficient
porphyrin association/binding either before or after the
washings. The conjugation of 1b to apidaecin or its C-terminal
segment did not affect to a great extent the association of 1b
with MRSA, while it increased the association with E. coli, as
Table 1. Fluorescence Properties of the Peptide Conjugates and Model Compounds in Methanol, PBS, and E. coli Suspensions
(Fractional Amplitudes in Parentheses)
λF,max/nm ΦF τS/ns
compd MeOH PBS E. coli MeOHa PBSb MeOH PBS E. coli
1b 647 nsc 0.040 ns 10.1 ns
1c 647 651 651 0.050 0.006 9.8 10.7 (0.82) 10.5 (0.46)
3.1 (0.18) 7.5 (0.33)
3.1 (0.21)
1d 646 652 652 0.044 0.006 9.8 6.1 (0.61) 5.9 (0.11)
2.6 (0.39) 4.9 (0.48)
2.5 (0.41)
2a 715 ns 0.030d 1.46d
2c 697 0.016 <0.0001 0.9 (0.94) 0.9 (0.75)
9.6 (0.06) 5.2 (0.25)
4b 656 675 0.022 0.008 7.9 4.2
4e 655 660 660 0.024 0.018 8.1 4.2 (0.49) 4.2 (0.48)
7.1 (0.51) 7.1 (0.52)
aCresyl violet as standard (ΦF(methanol) = 0.54).31 bTMPyP as standard (ΦF(PBS) = 0.017).9 cNot soluble. dIn toluene.
Table 2. Kinetics of Singlet Oxygen Production (ΦΔ) and
Decay (τΔ) of the Peptide Conjugates and Model
Compounds in Air-Saturated Methanol, PBS, and E. coli
Suspensions
ΦΔ τΔ/μs
compd MeOHa PBSb MeOHc PBSd E. colie
1b 0.63 nsf 9.8 ns
1c 0.70 0.020 9.8 3.0 2.3
43g
1d 0.66 0.036 9.5 45g
2a 0.26h ns ns
2c 0.14 0.001 9.8 42g
4b 0.69 0.73 9.6 3.6 3.6
60g
4e 0.67 0.89 9.6 3.6 3.6
36g
aTMPyP as standard (ΦΔ(methanol) = 0.74).3 bTPPS as standard
(ΦΔ(water) = 0.69).3 cLiterature value 10.4 μs.33 dLiterature value 3.3
μs in PBS and 67 μs in D-PBS.33 eIn PBS. fNot soluble. gIn D-PBS.
hToluene as solvent.
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clearly shown by the higher fluorescence signals exhibited by a
large fraction of cells incubated with 1c and 1d. Both free and
apidaecin-conjugated 4b did not appreciably interact with E. coli
since only in unwashed cells was the measured mean
fluorescence intensity slightly higher than the background
signal. Similar results were observed with MRSA cells,
suggesting that 4b and its conjugate exhibit a very poor ability
to interact with both Gram-positive and Gram-negative
bacteria.
■ DISCUSSION
In our previous paper13 we have already shown that the
conjugate 1c is endowed with antibacterial activity following
light activation. In this paper we have extended our
investigations to other PS−apidaecin conjugates, containing
either a neutral porphycene or a cationic porphyrin
(respectively 2a and 4b in Figure 1) to assess the effects of
structural modifications. Porphycene, a structural isomer of
porphyrin, was chosen for its larger absorption coefficients in
the red part of the spectrum, where light can deeply penetrate
into tissues.37 Because positively charged PSs are effective in
PDT against Gram-negative bacteria without the addition of
outer-membrane-disrupting agents,38 we hypothesized that a
conjugate between apidaecin and a cationic porphyrin could
further promote the uptake of the PS in Gram-negative
bacteria, thereby reducing the minimum effective dose.
Moreover, to establish whether the antimicrobial peptide is
able to direct the PS against specific bacterial targets, we also
synthesized a conjugate between porphyrin 1b and a short
cationic peptide (PRPPHPRL) corresponding to the C-
terminal segment of apidaecin. Although the mode of action
of apidaecin has not been determined in detail, several points of
evidence suggest that this peptide enters E. coli cells by a non-
pore-forming mechanism and, once inside the cell, interacts
with components of the protein synthesis machinery, impairing
protein synthesis and folding.17,18 The full-length apidaecin
sequence is very important, and the C-terminal octapeptide
does not possess any antibacterial activity,21 nor is it able to
translocate a fluorescent cargo into bacterial cells.24 Thus, most
probably, the conjugate with this cationic peptide (1d) can
effectively bind to the bacterial cell wall without being able to
reach the cytosol.
Efficient PSs for PDT must have appropriate photophysical
properties, such as an intense red-light absorption band and a
high quantum yield of generation of both the long-lived excited
triplet state and cytotoxic ROS, in particular singlet oxygen,
1O2. To establish whether the peptide moiety negatively affects
the PS photosensitizing efficiency, the porphyrin−peptide
conjugates were submitted to a detailed photophysical
characterization. The fluorescence properties and the singlet
oxygen production ability of the peptide conjugates 1c−d and
4e in methanol (Tables 1 and 2) are essentially identical to
those of free PSs, demonstrating that the peptide moiety exerts
no influence on the PS photosensitizing efficiency in this
solvent. Only in the case of porphycene 2a did we observe
changes in the absorption spectrum and a reduction by about
50% of the fluorescence quantum yield of the PS and in 1O2
production after conjugation to the peptide, which may be
ascribed to interactions between the peptide and the macro-
cyclic core. The situation is different in an aqueous environ-
ment (PBS) where the photophysical data change considerably
relative to those in methanol for all conjugates and particularly
for those containing a neutral PS. The decrease in the
fluorescence quantum yield, the concentration dependence of
the fluorescence kinetics, and the slow kinetics of 1O2
production in 1c−d and 2c reveal the presence of
intermolecular interactions, as observed also by CD spectros-
Figure 4. CD spectra of apidaecin and its conjugates in 10% methanol (A, amide region; B, Soret region), TFE (C), and 30 mM aqueous SDS (D).
The peptide concentration is 10 μM.
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copy (Figure 4B). Such interactions account also for the 20-fold
lower production of 1O2 in PBS relative to methanol (Table 2).
Nevertheless, following illumination (with blue light for 1c−
d and red light for 2c), the conjugates were phototoxic against
E. coli cells, inducing a decrease of survival of 3−4 log at a 15
μM concentration (Figure 5). On the other hand, the
unconjugated PS 2a was completely ineffective toward E. coli
(data not shown), consistent with data previously reported for
1b13 and other neutral porphyrins, which are unable to diffuse
through the highly organized outer membrane of Gram-
negative bacteria.39 Peptide conjugates 1c−d and 2c associate
efficiently with E. coli cells, as suggested by the observation that
repetitive washing of bacteria treated with conjugates, before
illumination, caused only a moderate reduction of phototoxicity
(Figure 5B; Figure S5, Supporting Information). In the case of
1c−d this is also supported by the flow cytometry results
(Figure 7). Porphycene was not fluorescent enough for
cytometry studies, but the detection of fluorescence by time-
resolved techniques in the E. coli suspensions, but not in PBS
(Table 1), must be taken as proof of binding. A deeper
understanding of the type of binding/association of 1c−d to E.
coli cells was obtained by analyzing the fluorescence decay
kinetics: unlike PBS or methanol, three decay components were
observed in cell suspensions, which suggest multiple binding
sites (Table 1). The match between two of the three observed
lifetimes with those detected in PBS indicates that one binding
site is located in an aqueous-like environment. Thus, the third
decay component suggests that an additional binding site exists
where the conjugates experience a less hydrophilic environ-
ment.
However, the phototoxicity and the photophysical and flow
cytometry results for the apidaecin conjugate 1c and its
truncated analogue 1d are so similar that it is difficult to
propose a different localization of these conjugates in E. coli
cells. Most probably both conjugates can diffuse through the
outer membrane and localize in different environments, but
since the C-terminal apidaecin fragment is unable to translocate
a PS across the cytoplasmic membrane, we are led to conclude
that the apidaecin conjugate is also not able to reach the
bacterial targets of apidaecin in cytosol.
The conjugate between the cationic porphyrin 4e and
apidaecin possesses a +6 net positive charge, well-distributed
along the whole molecule, that is expected to discourage the
aggregation phenomena observed in conjugates 1c and 2c. In
Figure 5. (A) E. coli photoinactivation with different concentrations
(1.5−15 μM) of 2c, 1c, 1d, 4b, and 4e. E. coli cells were incubated for
60 min with the PS and irradiated with a fixed light dose (36 J/cm2 of
600−750 nm red light for 2c, 13.5 J/cm2 of 390−460 nm blue light for
all other compounds). (B) E. coli photoinactivation with a 5 μM
concentration of apidaecin or the tested PSs. Irradiation with a fixed
light dose, as described above, was carried out without washing (black
bars) or after three washings with PBS (red bars); the asterisk means a
sterile solution.
Figure 6. MRSA photoinactivation with different concentrations of (A) 1b, 1c, 1d, 4b, and 4e (1 nM to 1.5 μM) and (B) 2b and 2c (1.5−15 μM).
MRSA cells were incubated with the PS for 60 min and irradiated with a fixed light dose (36 J/cm2 of 600−750 nm red light for 2b and 2c, 13.5 J/
cm2 of 390−460 nm blue light for all other compounds).
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confirmation of this, the far-UV CD spectrum of 4e in water is
very similar to that of the free peptide and no dichroic signal,
indicative of porphyrin−porphyrin interactions, was detected in
the Soret band region (Figure 4 A,B). Aggregation can also be
ruled out by the lack of concentration effects on the decay
kinetics (Figure S2A and Table S1, Supporting Information). It
can therefore be safely concluded that the major differences
observed between 4b and 4e (Table 1) are due to interactions
between apidaecin and the porphyrin within the conjugate.
Comparison of the fluorescence spectrum, quantum yield, and
kinetics for 4b and 4e reveals that two populations of
conjugates coexist, in which the porphyrin is either exposed
to water or shielded from it by the peptide. This conclusion is
consistent with the well-known solvent-polarity effects on the
fluorescence of tetrapyridinium porphyrins.32 Nevertheless, the
production of 1O2 was very high in PBS, comparable to or even
higher than that in methanol (Table 2). In fact, the conjugate
4e caused total photokilling of E. coli cells at a concentration
(10 μM) at which 1c induced a strong (4 log) but incomplete
reduction of cell survival (Figure 5A). The cationic porphyrin
4b proved to be even more potent than its apidaecin conjugate
4e (Figure 5A). The 1O2 lifetime data in Table 2, particularly in
deuterated PBS, indicate that apidaecin is able to quench 1O2.
Thus, because 1O2 molecules are generated in the vicinity of
apidaecin, some of them will be quenched by the peptide
during their lifetime rather than by cell components.
The washing of the cells before illumination, to remove the
unbound or weakly associated PS, caused a tremendous
reduction of photokilling of E. coli cells, and under these
conditions 4b became the least efficient PS (Figure 5B; Figure
S5, Supporting Information). Flow cytometry measurements
showed that only unwashed cells exhibited red fluorescence
slightly above the background after incubation with these
compounds (Figure 7). Thus, the results indicate that 4b and
4e associate very weakly with E. coli cells and the killing of
unwashed cells is caused mainly by singlet oxygen generated by
the PS molecules not associated with or loosely associated with
the bacteria. Several reports of PDT on Gram-negative bacteria
have pointed out that if singlet oxygen can be generated in
sufficient quantities near the bacterial outer membrane, it will
Figure 7. Uptake of the peptide conjugates and model PSs in E. coli and MRSA. The cells were incubated with the compounds for 60 min and then
analyzed by flow cytometry. Concentrations of the compounds: 5 μM for E. coli and 1.5 μM for MRSA.
Journal of Medicinal Chemistry Article
dx.doi.org/10.1021/jm301509n | J. Med. Chem. 2013, 56, 1052−10631059
be able to diffuse into the cell to inflict damage to the vital
structure.1,40 Our photophysical data thus support this
hypothesis.
Testing the above PS against MRSA reveals a number of
differences relative to E. coli. First, except for the porphycene,
the concentration needed to inactivate bacteria was 1 order of
magnitude lower. Interestingly, the porphycene conjugate was
almost equally active against both kinds of bacteria. The higher
susceptibility of Gram-positive bacteria to photodynamic
damage has long been known for a large number of PSs.41
Second, it is interesting to recall that washings did not
appreciably remove 1b and its conjugates (1c and 1d) from the
cells (Figure 7), nor did it decrease the photodynamic
inactivation of MRSA (Figure S7, Supporting Information).
In addition, the nonconjugated porphyrin 1b was the most
active PS. This probably can be related to its more hydrophobic
character, which helps in penetration of the cell wall and the
cytoplasmic membrane of Gram-positive bacteria. The
porphycene 2a was probably too hydrophobic, and its strong
aggregation in the external medium prevented cell entrance.
Concerning PSs 4b and 4e, the observations are similar to
those of E. coli: the nonconjugated PS 4b is more active than 4e
on account of its lower ability to quench 1O2, and both lose
their activity after washings due to the very poor binding to the
bacterial cells (Figure 7).
■ CONCLUSIONS
The search for more effective antimicrobial PSs has led to a
number of strategies. Among them, binding to an antimicrobial
peptide offers the attractive prospect of enhancing both the
water solubility of the PS and the efficiency of the PDT
treatments through a synergistic effect. In this work we have
compared a number of free and apidaecin-conjugated PSs
differing in structure and charge. Our results confirm previous
findings that the conjugation of per se ineffective highly
hydrophobic PSs to a cationic peptide produces a photo-
sensitizing agent effective against Gram-negative bacteria.
MRSA are even more susceptible to the action of conjugates,
which produce the same reduction of bacterial growth at one-
tenth the concentration. The apidaecin ability to penetrate
Gram-negative bacteria is unfortunately lost after conjugation
to a bulky PS, but the amphiphilic character conferred by the
peptide enforces the binding of the PS to the bacterial outer
membrane. Apidaecin−PS conjugates appear most promising
for treatment protocols requiring repetitive washing after
sensitizer delivery, where the most active cationic PSs, such
as 4b and its apidaecin conjugate 4e, are rapidly washed out.
On the other hand, apidaecin cannot improve the phototoxic
activity of the cationic porphyrin, which is mainly determined
by a very high yield of singlet oxygen production in the
surroundings of the bacterial outer membrane.
■ EXPERIMENTAL SECTION
General Methods. All chemicals were commercial products of the
best grade available, and unless otherwise indicated, they were used
directly without further purification. The starting porphyrins, 5-(4-
carboxyphenyl)-10,15,20-triphenylporphyrin (1b),42 9-(glutaric meth-
ylesteramide)-2,7,12,17-tetraphenylporphycene (2a),29 and 5-(4-car-
boxyphenyl)-10,15,20-tris(4-pyridyl)porphyrin (3b) and its tris-N-
methylpyridinium iodide (4b),28 were prepared according to literature
procedures. 9-Fluorenylmethoxycarbonyl (Fmoc)-amino acids and all
other chemicals for the solid-phase synthesis were supplied by Sigma-
Aldrich. Fmoc-Leu-Wang resin was purchased from Novabiochem
(Merck Biosciences). Analytical HPLC separations were carried out on
a Dionex Summit dual-gradient HPLC instrument, equipped with a
four-channel UV−vis detector, using a Vydac 218TP54 column (250 ×
4.6 mm, 5 μm, flow rate at 1.5 mL/min). Mobile phases A (aqueous
0.1% trifluoroacetic acid (TFA)) and B (90% aqueous acetonitrile
containing 0.1% TFA) were used for preparing binary gradients. All
analyses were carried out under gradient conditions (10−50% B in 20
min, except as otherwise indicated). All crude peptides were purified to
95% or more homogeneity for analytical and other experimental
purposes. Semipreparative HPLC was carried out on a Shimadzu series
LC-6A chromatograph, equipped with two independent pump units, a
UV−vis detector, and a Vydac 218TP1022 column (250 × 22 mm, 10
μm, flow rate at 15 mL/min). Elutions were carried out by the same
mobile phases described above. All the purified peptides were analyzed
again by HPLC and HRMS. Mass spectral analyses were carried out on
a Mariner API-TOF workstation (PerSeptive Biosystems Inc.),
operating with ESI techniques in positive mode. NMR spectra were
recorded on a Varian Gemini 300 spectrometer (300 and 75.5 MHz
for 1H and 13C, respectively). UV−vis spectra were recorded at rt on a
Shimadzu UV-2501PC spectrophotometer or on a Lambda 5
spectrophotometer (Perkin-Elmer), in 0.1 or 1 cm quartz cells.
Chemical Synthesis. 19-Glutaramide-2,7,12,17-tetraphenylpor-
phycene (2b). A 44 mg (0.1 mmol) sample of 2a was dissolved in 14
mL of THF and combined with 14 mL of methanol, and 9 mL of 4 N
aqueous sodium hydroxide was added dropwise with stirring at rt
within 5 min. The reaction was stirred for an additional 45 min,
neutralized, and then precipitated under acidic conditions with the
complete addition of 50 mL of ice-cold 5% acetic acid. The flaky
precipitate was filtered, washed with water and then with water/
methanol (1:1), and dried. The title compound was obtained in the
form of a dark green powder. Yield: 27 mg (70%). 1H NMR (400
MHz, DMSO-d6): δ = 12.10 (br s, 1H), 10.96 (s, 1H), 10.08 (s, 1H),
10.07 (s, 1H), 10.05 (s, 1H), 9.93 (d, J = 12, 1H), 9.91 (d, J = 12, 1H),
9.85 (s, 1H), 9.82 (s, 1H), 8.37 (m, 6H), 7.98 (d, J = 8, 2H), 7.88 (m,
5H), 7.74 (m, 5H), 7.60 (m, 2H), 4.29 (s, 1H), 3.93 (s, 1H), 2.25 (t, J
= 8, 2H), 2.16 (t, J = 8, 2H), 1.72 (q, J = 8, 2H). 13C NMR (100 MHz,
DMSO-d6): δ = 174.1, 171.9, 158.0, 144.7, 143.7, 142.8, 142.7, 141.3,
139.1, 137.7, 135.6, 135.4, 135.3, 134.8, 134.3, 133.3, 132.8, 131.1,
131.0, 130.3, 129.2, 129.2, 129.1, 128.0, 127.4, 127.1, 123.1, 125.0,
124.5, 116.0, 115.5, 113.9, 33.9, 33.06, 19.8. HRMS (ESI-TOF): m/z
calcd for C49H38N5O3 744.2969 [M + H]
+, found 744.2970.
Synthesis of PS−Peptide Conjugates (General Procedure). The
peptide sequences were prepared on an automated Advanced
Chemtech 348Ω peptide synthesizer, on a 0.25 mmol scale, starting
from Fmoc-Leu-Wang (substitution 0.6 mmol/g of resin). The tert-
butyl group and 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl
group were used to protect tyrosine and arginine side chains,
respectively, and the trityl group to protect asparagine and histidine
side chains. Fmoc deprotection was achieved with 20% piperidine in
DMF (5 + 15 min). Couplings were performed in the presence of O-
(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophos-
phate/N-hydroxybenzotriazole/N,N-diisopropylethylamine (reaction
time 45−60 min), using an excess of 4 equiv of the carboxyl
component. After the coupling of the last amino acid and removal of
the Fmoc group, the resin was washed with DMF and CH2Cl2 and
then dried under vacuum. The dried resins containing the protected
amino acid sequences were used in the coupling reaction to the
porphyrin derivatives. The H-peptide-resin (0.025 mmol) was swelled
in DMF for 1 h and then washed with DMF. To the peptidyl resin was
added 600 μL of a DMF−CH2Cl2 (1:1, v/v) solution containing 0.05
mmol of porphyrin (1b, 2b or 3b), 0.05 mmol of diisopropylcarbo-
diimide, and 0.05 mmol of 1-hydroxybenzotriazole. The reaction
mixture was shaken overnight and then filtered to remove the excess of
reagents. The resin was repeatedly washed with DMF and CH2Cl2,
until the filtrate was colorless, and then dried under vacuum. Cleavage
and deprotection was carried out by treatment of the resin with a
mixture of TFA−triisopropylsilane−water (95:2.5:2.5 by volume) for
1.5 h at rt. The resin was filtered and washed with TFA, and the
filtrates were combined and reduced under vacuum to a small volume.
Addition of cold ether yielded a green precipitate, which was
repeatedly washed with ether and dried under vacuum. The conjugates
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1−3c and 1d were purified by semipreparative HPLC (linear gradient
50−80% B in 20 min), and the fractions containing the conjugate were
collected and lyophilized to yield the pure compound. The purity was
≥95% as determined by analytical HPLC (isocratic 10% B for 3 min;
linear gradient 10−90% B in 30 min). The conjugates were
characterized as follows:
(1c) Yield: 75%. HPLC: tR = 22.0 min. UV−vis (methanol): λmax/
nm (log ε/M−1 cm−1) 414 (5.48), 513 (4.05), 546 (3.70), 591 (3.45),
642 (3.35). HRMS: m/z calcd for C140H179N36O24 2748.38 [M + H]
+,
found 2748.39.
(1d) Yield: 80%. HPLC: tR = 24.3 min. UV−vis (methanol): λmax/
nm (log ε/M−1 cm−1) 413 (5.41), 512 (4.02), 548 (3.68), 589 (3.54),
644 (3.34). HRMS: m/z calcd for C91H104N21O11 1666.82 [M + H]
+,
found 1666.84.
(2c) Yield: 50%. HPLC: tR = 30.3 min. UV−vis (methanol): λmax/
nm (log ε/M−1 cm−1) 378 (4.99), 583 (4.40), 628 (4.53), 650 (4.54).
HRMS: m/z calcd for C144H186N37O25 2833.44 [M + H]
+, found
2833.39.
(3c) Yield: 50%. HPLC: tR = 13.7 min. UV−vis (methanol): λmax/
nm (log ε/M−1 cm−1) 413 (5.11), 510 (3.81), 544 (3.30), 586 (3.27),
642 (2.89). HRMS: m/z calcd for C137H176N39O24 2751.37 [M + H]
+,
found 2751.39.
Conjugate 4e. The porphyrin−peptide conjugate 3c (0.02 mmol),
still attached to the solid support, was swelled in DMF, and a 10%
solution of methyl iodide in DMF (2 mL) was added to the peptidyl
resin. The reaction mixture was shaken overnight at rt and then filtered
to remove the excess of reagents. The resin was repeatedly washed
with DMF and CH2Cl2 and then dried under vacuum. After
detachment from the resin, as described above, the conjugate was
purified by semipreparative HPLC (linear gradient 17−30% B in 25
min). Yield: 50%. HPLC: tR = 12.4 min. UV−vis (methanol): λmax/nm
(log ε/M−1 cm−1) 424 (5.15), 515 (3.98), 556 (3.63), 590 (3.51), 647
(3.03). HRMS: m/z calcd for C141H187N39O24 702.615 [M
4+], found
702.874.
Spectroscopic Measurements. Absorption spectra were re-
corded on a double-beam Cary 6000i spectrophotometer (Varian),
equipped with a 110 mm diameter integrating sphere and a high-
performance photomultiplier tube for diffuse transmittance measure-
ments. Absorption coefficients were derived from the slopes of
Lambert−Beer plots. Fluorescence emission spectra were recorded in
a Spex Fluoromax-4 spectrofluorometer. Fluorescence decays were
recorded with a time-correlated single-photon-counting system
(Fluotime 200) equipped with a red-sensitive photomultiplier.
Excitation was achieved by means of a 405 nm LED working at a
10 MHz repetition rate. The counting frequency was always below 1%.
Fluorescence decays were analyzed using the PicoQuant FluoFit 4.0
data analysis software. 1O2 phosphorescence was detected by means of
a customized PicoQuant Fluotime 200 system described in detail
elsewhere.43 Briefly, a diode-pumped pulsed Nd:YAG laser (FTSS355-
Q, Crystal Laser) working at a 10 kHz repetition rate at 532 nm (12
mW, 1.2 μJ per pulse) was used for excitation. A 1064 nm rugate notch
filter (Edmund Optics) was placed at the exit port of the laser to
remove any residual component of its fundamental emission in the
near-IR region. The luminescence exiting from the side of the sample
was filtered by a cold mirror (CVI Melles Griot) to remove any
scattered laser radiation and focused on the entrance slit of a Science
Tech 9055 dual-grating monochromator. A near-IR-sensitive photo-
multiplier tube assembly (H9170-45, Hamamatsu Photonics) was used
as the detector at the exit port of the monochromator. Photon
counting was achieved with a multichannel scaler (Becker&Hickl MSA
300 or PicoQuant’s Nanoharp 250). The time-resolved emission
signals were analyzed using the FluoFit software to extract lifetime
values. Laser flash photolysis measurements were carried out using a
Q-switched Nd:YAG laser (Surelite I-10, Continuum) with a right-
angle geometry and an analyzing beam produced by a Xe lamp (PTI,
75 W) in combination with a dual-grating monochromator (model
101, PTI) coupled to a photomultiplier (Hamamatsu R928). Kinetic
analysis of the individual transients was performed with software
developed in our laboratory. All spectroscopic measurements were
carried out in 1 cm quartz cuvettes (Hellma) at rt. For the
measurements in bacterial suspensions, bacteria were incubated in
the dark at the conditions employed for the photoinactivation
experiments, namely, 5 μM PS for 1 h. When required, the cells
were washed once and resuspended in PBS to a final concentration of
∼1 × 107 cfu mL−1, and 3 mL volumes of the suspensions were
irradiated with 3 million laser pulses at 532 nm under gentle stirring.
CD measurements were carried out on a Jasco-715 spectropolarimeter,
using a quartz cell of 0.1 cm path length. The spectra were recorded at
298 K and were the average of a series of six scans made at 0.1 nm
intervals in the 250−190 and 350−550 nm regions. Sample
concentrations in water (pH 7), TFE, and aqueous 30 mM SDS
were in the range of 10−13 μM. Ellipticity is reported as the mean
residue ellipticity [θ]R (deg cm
2 dmol−1).
Bacteria Culture. E. coli ATCC 25922 and the methicillin-resistant
strain of S. aureus ATCC BAA-44 were purchased from LGC
Promochem (Teddington, U.K.). Cultures were maintained by two
weeks of subcultures in brain heart infusion (BHI; Difco, Detroit, MI)
agar. For spectroscopic measurements we used instead the E. coli ECT
strain, purchased from the Spanish-type cell culture collection.
Bacteria Photoinactivation. For the photoinactivation experi-
ments, the bacteria were grown overnight in BHI at 37 °C, harvested
by centrifugation, washed twice, and resuspended in PBS (10 mM
phosphate, 0.14 M NaCl, 2.7 mM KCl, pH 7.3) at a density of ∼2 ×
107 cells/mL. The cell density was evaluated by measuring the
turbidity of the suspension in a Perkin-Elmer spectrophotometer
(model Lambda 5). The bacteria used in the experiments were
collected from cultures in the stationary phase of growth.
The bacteria were incubated with different concentrations of the
PSs in the dark at rt for 60 min or with a fixed PS concentration for
different times. After incubation, the suspensions were (i) directly
exposed to light with the unbound PS left in the suspension (no
washing) or (ii) centrifuged (10000g for 5 min), the pellet
resuspended in 1 mL of PBS, and washed two additional times with
PBS before illumination (three washings). For illumination, aliquots of
cell samples obtained as described above were transferred into 96-well
plates (200 μL/well). Samples incubated with porphycene and its
conjugate with apidaecin 1b were irradiated with red light (600−750
nm) with the Waldmann PDT 1200 lamp supplied by Waldmann
MedizintechNnik; the cells were illuminated from the top of the plates
with a fluence rate at the level of the samples of 40 mW/cm2, as
measured with an International Light power meter, and for a total light
dose of 36 J/cm2. Bacteria incubated with porphyrins and their
conjugates were irradiated with blue light (390−460 nm, with a
maximum at 420 nm) emitted by a UV 236 lamp supplied by
Waldmann Eclairage SA; the cells were illuminated from the bottom of
the plates with a fluence rate of 15.2 mW/cm2, as measured with the
Waldmann UV-meter, and for a total light dose of 13.5 J/cm2. After
illumination, aliquots of bacteria suspensions were serially 10-fold-
diluted in PBS, and 50 μL volumes of the appropriate dilutions were
plated in duplicate onto BHI agar to determine colony-forming units
(cfu). Treated and untreated cells were incubated overnight at 37 °C
to allow colony formation. Suspensions of bacteria exposed to PSs but
kept in the dark and subjected to the same procedure applied to the
irradiated suspensions were also plated onto BHI agar after the
appropriate serial dilutions. Controls also included bacteria not
exposed to any agent and bacteria exposed to light or peptide only.
Each experiment was performed at least three times with independent
bacterial suspensions.
Flow Cytometry. The interaction of PSs with bacteria was
evaluated by flow cytometry. For these experiments, the bacteria were
subjected to the same treatments used for photoinactivation
experiments, but instead of being illuminated after incubation and
washings, they were analyzed with a FACSCanto II flow cytometer.
Samples were excited with the 488 nm laser, and fluorescence emission
signals were recorded at wavelengths higher than 670 nm. The bacteria
population was isolated from the instrument noise by setting
electronic gates on the dual-parameter dot plots of forward scatter
against side scatter. For each sample, 20 000 events were acquired and
analyzed with the FACSDiva software (BD). Samples not incubated
with the PSs were used to determine the cell background fluorescence.
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ABSTRACT
1 In this study, we report the synthesis and photochemical
behavior of a new family of photoactive compounds to assess
its potential as singlet oxygen (1O2) probes. The candidate
dyads are composed by a 1O2 trap plus a naphthoxazole moi-
ety linked directly or through an unsaturated bond to the ox-
azole ring. In the native state, the inherent great fluorescence
of the naphthoxazole moiety is quenched; but in the presence
of 1O2, generated by the addition and appropriate irradiation
of an external photosensitizer, a photooxidation reaction
occurs leading to the formation of a new chemical entity
whose fluorescence is two orders of magnitude higher than
that of the initial compound, at the optimal selected wave-
length. The presented dyads outperform the commonly used
indirect fluorescent 1O2 probes in terms of fluorescence
enhancement maintaining the required specificity for 1O2
detection in solution.
INTRODUCTION
Reactive oxygen species (ROS) are present and participate in
many biological processes. Among them, singlet oxygen (1O2),
also well known because its use as a synthetic reagent, plays a
key role in the pathological and physiological processes. It can
oxidize various kinds of biological molecules (i.e. proteins, DNA
and lipids), leading to a plethora of deleterious effects that can
result in e.g. cell death or degenerative diseases (1). Over the
years, insight has been gained in the rules that obey its genera-
tion, the characters involved and the energy requirements, which
has led, among others, to the development of 1O2-based therapies
such as photodynamic therapy, in which a drug referred to as the
photosensitizer (PS) produces 1O2 upon exposure to light of the
appropriate wavelength (2). Despite the major progress made, a
better understanding of 1O2 behavior in biological systems is still
needed. Of critical importance, techniques and/or methods able
not only to detect but also to quantify the concentration of 1O2
both in solution and in vivo are still needed (3,4).
Singlet oxygen can be detected through its intrinsic phospho-
rescence with maximum centered at 1275 nm (5). This is a
robust, specific, noninvasive and direct method; but it suffers
from weak sensitivity due to the low efficiency for 1O2 emission,
particularly in biological media, where the lifetime of 1O2 is very
short (3.1 ls) (6) and the phosphorescence quantum yield is very
small, ca 107 (7).
Trapping 1O2 with suitable chemical acceptors is also exten-
sively used, as such traps and/or their oxidation products, can be
monitored more easily through absorption (8,9), fluorescence (3)
or ESR (10,11). Fluorogenic probes that develop a bright fluores-
cence upon reaction with 1O2 have attracted much interest lately
as they offer excellent sensitivity and convenience, given the
widespread use of fluorescence microscopy techniques. Thus, a
two-component system comprised a 1O2 trapping moiety and a
suitable fluorophore covalently bound to it is the current para-
digm underlying fluorogenic 1O2 probes. In their native state, the
luminescence of the emitting moiety is quenched by the trap.
Oxidation of the trap by 1O2 eliminates this quenching channel
and the luminescence of the fluorophore is recovered.
Several probes have been developed following this principle:
DPAX and DMAX (12,13), MTTA-Eu3+ (14) and, more
recently, SOSG (15–17). All use an anthracene moiety as 1O2
trap that quenches the luminescence of the fluorophore by an
electron transfer process. The same concept has been recently
used to develop a near-infrared probe, His-Cy, where anthracene
has been replaced by a histidine and a cyanine is chosen as flu-
orophore (18). A common drawback for all the above probes is
that the fluorescence increases only moderately after reaction
with 1O2, e.g. from less than two-fold for His-Cy (18) to ca 10-
fold for SOSG. Moreover, as electron transfer reactions are
strongly dependent on solvent polarity, false-positive signals
arise that merely reflect location of the probe in a less polar
microenvironment rather than reaction with 1O2, e.g. when the
probe is in hydrophobic pockets of proteins (16). In addition, the
presence of an anthracene moiety in the structure is potentially
misleading as anthracene is itself a 1O2 PS that may autooxidize
the probe, which further complicates its use (19).
We reasoned that the above problems could be overcome by
designing a probe with distinct absorption and fluorescence spec-
tra for the native and oxidized forms. This would allow enhanc-
ing the fluorescence of the oxidized form relative to the native
probe to an unprecedented level. We report herein the synthesis
and characterization of representative members of a new family
of 1O2 fluorescence probes based on furan trapping moieties
linked to naphthoxazole fluorophores (Fig. 1). Four naphthoxaz-
ole derivatives have been synthesized. 2-(2-(Furan-2-yl)ethyl)
naphtho[1,2-d]oxazole, FN-I1, contains a naphthoxazole linked
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to a furan through a saturated ethyl bridge. In 2-(furan-2-yl)naph-
tho[1,2-d]oxazole, FN-I2, the furan moiety is bonded directly to
the position 2 of the oxazole ring, whereas in (E)-2-(2-(furan-2-
yl)vinyl)naphtho[1,2-d]oxazole, FN-4, the naphthoxazole and the
furan are conjugated through an unsaturated ethylidene link. In
the control molecule, (E)-2-(4-methylstyryl)naphtho[1,2-d]oxaz-
ole, FN-7, the furan ring of FN-4 has been replaced by a nonre-
active tolyl group. Two candidates could be used as 1O2 sensors
namely FN-I2 and FN-4, as their fluorescence is boosted by a
factor of ca 135 and 300, respectively, upon reaction with 1O2.
MATERIALS AND METHODS
Materials. Perinaphthenone, new methylene blue (NMB), anthracene and
naphthalene were purchased from Sigma and used as received. All sol-
vents used were UV grade.
(E)-2-(2-(furan-2-yl)vinyl)naphtho[1,2-d]oxazole, FN-4. To a mixture
of 2-methylnaphthoxazole (1 mM, 0.15 mL) and furylcarboxaldehyde
(0.09 mM, 0.075 mL) in 6 mL of dimethyl sulfoxide, 0.15 mL of aque-
ous KOH 50% was added. The mixture was stirred by 12 h at room tem-
perature. Addition of 15 mL of water afforded a yellow precipitate which
was washed with cold water and cold methanol. Recrystallization from
acetonitrile afforded 135 mg of the yellow product, yield 57%,
m.p. = 124–126°C. 1H-NMR (CDCl3); d: 8.51 (d, J = 8.1 Hz, 1H); 7.96
(d, J = 8.1 Hz, 1H); 7.79 (d, J = 9.0 Hz, 1H); 7.69–7.64 (m, 2H); 7.60–
7.53 (m, 3H); 7.08 (d, J = 15.9 Hz, 1H); 6.62 (d, J = 3.3 Hz, 1H); 6.51
(m, 1H). MS(ESI) m/z: 262.11 [M+H]+, 261.11 [M]+.
2-(2-(furan-2-yl)ethyl)naphtho[1,2-d]oxazole, FN-I1. A quantity of
100 mg (0.38 mmol) of (E)-2-(2-(furan-2-yl)vinyl)naphtho[1,2-d]oxazole,
FN-4, in 50 mL of dry methanol, was reduced under hydrogen employ-
ing 50 mg of Pd-C catalyst. The mixture was stirred during 4 h at room
temperature, then, the catalyst was removed by filtration and the solution
concentrated in vacuo. Recrystallization of the solid residue from petro-
leum ether 40–60°C, afforded 32 mg of white crystals, 32% yield,
m.p. = 120–123°C. 1H-NMR (CDCl3); d: 8.49 (d, J = 8.0 Hz, 1H); 7.96
(d, J = 8.1 Hz, 1H); 7.76 (d, J = 9.0 Hz, 1H); 7.64 (d, J = 14.2 Hz, 2H);
7.51 (d, J = 14.2 Hz, 1H); 7.33 (s, 1H); 6.27 (d, J = 3.6 Hz, 1H); 6.07 (d,
J = 3.6 Hz, 1H); 3.38 (d, J = 7.8 Hz, 2H), 3.30 (d, J = 7.9 Hz, 2H); ppm.
2-(furan-2-yl)naphtho[1,2-d]oxazole, FN-I2. A mixture of 1-amino-2-
naphthol (1 mmol), 2-furylcarboxaldehyde (1 mmol) and triethylamine
(2 mmol) in 10 mL of dry ethanol was refluxed 3 h under nitrogen. The
end of reaction was monitored by thin layer chromatography up to disap-
pearance of the aldehyde. After being cooled to room temperature, the
solution was concentrated in vacuo, and the crude product recrystallized
from acetonitrile to obtain 25% of the product, m.p. 134–136°C. 1H-
NMR (CDCl3); d: 8.54 (d, J = 8.2 Hz, 1H); 8.16 (d, J = 8.2 Hz, 1H);
7.98 (d, J = 8.8 Hz, 1H); 7.81 (d, J = 8.9 Hz, 1H); 7.62–7.54 (m, 3H);
6.66 (d, J = 3.6 Hz, 1H); 6.57 (m, 1H). MS(ESI) m/z: 236.09 [M+H]+,
235.09 [M]+.
(E)-2-(4-methylstyryl)naphtho[1,2-d]oxazole, FN-7. A quantity of
0.15 mL (1 mmol) of 2-methylnaftoxazole, 2 mL of KOH 50% aqueous
and 0.11 mL (0.93 mmol) de 4-methyl-benzaldehyde in 6 mL of
dimethyl sulfoxide were stirred at room temperature during 12 h to
obtain of a greenish yellow. Recrystallization from acetonitrile afforded
145 mg, 56% of the product, m.p. = 127–129°C. 1H-RMN (CDCl3); d:
8.51 (d, J = 8.1 Hz, 1H); 7.94 (d, J = 8.1 Hz, 1H); 7.77 (d, J = 9.0 Hz,
1H); 7.77 (d, J = 16.2 Hz, 1H); 7.68–7.63 (m, 2H); 7.55–7.49 (m, 3H);
7.22 (d, J = 7.8 Hz, 2H), 7.13 (d, J = 16.2 Hz, 1H); d 2.38 (s, 3H)
ppm.13C-RMN (CDCl3) d = 162.36, 147.63, 139.86, 138.29, 137.63,
132.61, 131.14, 129.68, 128.58, 127.39, 126.98, 126.29, 126.03, 125.32,
122.07, 113.02, 110.58, 21.44 ppm.































































Spectroscopic measurements. Absorption spectra were recorded on a
Cary 6000i spectrophotometer (Varian, Palo Alto, CA). Fluorescence
emission spectra were recorded on a Spex Fluoromax-4 spectrofluorome-
ter (Horiba Jobin-Ybon, Edison, NJ) or on a PC1 spectrofluorimeter (ISS,
Champaign-Urbana). Fluorescence quantum yields (ΦF) were measured
by the comparative method described by Eaton and Demas (20,21),
using quinine sulfate in 0.1 N sulfuric acid (ΦF = 0.55) or naphthalene
in ethanol (ΦF = 0.21) as references (22). The absorbance of sample
and reference solutions was set below 0.1 at the excitation wavelength
and the fluorescence spectra were corrected using rhodamine G as refer-










where GradX and GradAct are the slope of integrated fluorescence vs
absorbance plots for the sample and the actinometer and gx and gAct are
the refractive index of sample and actinometer solutions respectively. All
measurements were carried out in nitrogen-purged solutions at
(20.0  0.5)°C. Fluorescence decays were recorded with a time-corre-
lated single photon counting system (Fluotime 200; PicoQuant GmbH,
Berlin, Germany) equipped with a red-sensitive photomultiplier. Excita-
tion was achieved by means of a 375 nm picosecond diode laser working
at 10 MHz repetition rate. The counting frequency was maintained
always below 1%. Fluorescence lifetimes were analyzed using PicoQuant
FluoFit 4.0 software. Light irradiations were performed by means of a
SORISA Photocare LED light source applying a power of 25 mW cm2
for every tested wavelength.
Singlet oxygen measurements. The phosphorescence of 1O2 was
detected by means of a customized PicoQuant Fluotime 200 system
described in detail elsewhere (23). A diode-pumped pulsed Nd:YAG laser
(FTSS355-Q; Crystal Laser, Berlin, Germany) working at 10 kHz repeti-
tion rate was used for excitation. A 1064 nm rugate notch filter (Edmund
Optics, UK) was placed at the exit port of the laser to remove any resid-
ual component of its fundamental emission in the near-IR region. The
luminescence exiting from the side of the sample was filtered by two
long-pass filters of 355 and 532 nm (Edmund Optics, York, UK) and
two narrow bandpass filters at 1275 nm (NB-1270-010, Spectrogon, Swe-
den; bk-1270-70-B, bk Interferenzoptik, Germany) to remove any scat-
tered laser radiation. A near-IR sensitive photomultiplier tube assembly
(H9170-45; Hamamatsu Photonics Hamamatsu City, Japan) was used as
the detector at the exit port of the monochromator. Photon counting was
achieved with a multichannel scaler (PicoQuant’s Nanoharp 250). Time-
resolved emission signals St were analyzed using the PicoQuant FluoFit
4.0 data analysis software to extract lifetime (sT and sD) and amplitude
(a) values. Quantum yields for 1O2 production (ΦD) were calculated from
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Perinaphthenone was used as reference for which ΦD = 1 was taken
(24).
The rate constant for 1O2 quenching by the dyads (kq) was determined
by measuring the 1O2 lifetime as a function of the dyad concentration.
1O2 was generated by 50 lM NMB and the concentration of the dyads
was varied in the range (0.1–1 mM). A plot of the reciprocal lifetime vs









where sDº is the
1O2 lifetime in the neat solvent.
RESULTS
Photophysical characterization
FN-4 is a dyad composed by a furan ring linked to a naphthox-
azole moiety through an ethylidene group. The absorption
spectrum is dominated by a main band with maximum at
367 nm and a second weaker band at 314 nm (Fig. 2a) that
compares reasonably well with the values of 387 and 314 nm
obtained from TD-DFT calculations using G09W. The position
of the bands follows no obvious trend with the solvent polarity
(Table S1). The high values of molar absorptivity, ca
3 9 104 M1 cm1 in all solvents except in water, and the
molecular orbital analysis of the minimum energy structure
obtained from DFT calculations, indicate a p, p* transition. A
similar behavior of the absorption properties was observed for
FN-I2 (Table S2), in which the furan ring is linked directly to
the naphthoxazole moiety, and for FN-7, in which a nonreactive
tolyl substituent replaces the furan moiety. When the linker is
saturated (FN-I1) spectral bands shift substantially to the blue
(kmax = 322 nm) and become more structured. These results cor-
relate with the distinct degree of electronic coupling between the
aromatic moiety and the naphthoxazole fluorophore. Similar
trends are observed in the maximum of the fluorescence spectra
(Fig. 2b) consistent with the reports for related benzoxazole
derivatives (25).
Figure 2. Normalized absorption (a) and fluorescence (b) spectra of FN-I1


















































































Aryl oxazoles typically exhibit a very high fluorescence quan-
tum yield (ΦF), in the 0.7–1.0 range (26,27). Among all studied
compounds, this is observed only for FN-I1 ([ΦF = 0.93] in
methanol). In contrast, FN-4 and FN-7 show high ΦF values in
low-polarity solvents only, the quantum yield decreasing by 1–2
orders of magnitude as the solvent polarity increases (Tables S1
and S3). However, for (E)-4-(2-(naphtho[1,2-d]oxazol-2-yl)vinyl)
benzonitrile, an FN-7 analogue in which the methyl group is
replaced by the strong electron-attractor cyano group, the fluores-
cence quantum yields are close to one in all solvents, irrespective
of their polarity (A. L. Zanocco, unpublished). Finally, FN-I2 is
scantly fluorescent even in nonpolar solvents (Table S2). These
results indicate that electron-rich aromatic moieties can act as
effective quenchers of naphthoxazole fluorescence in conjugated
dyads and, particularly, in polar protic environments, likely due
to a charge–transfer interaction. Thus, furyl-oxazole dyads fulfill
the first condition requested for a potential 1O2 probe namely
that the fluorescence is severely quenched in their native form,
thus deserving further scrutiny.
Reactivity toward singlet oxygen
The ability of the dyads to react with 1O2 has been studied by
monitoring changes in their absorption and fluorescence proper-
ties. No changes could be recorded for FN-I1 and FN7, as
expected. In the case of FN-4, reaction with 1O2 in methanol
caused bleaching of the main band at 367 nm and the growth of
a new band in the 325–350 nm region (Fig. 3a). The clear isos-
bestic point at 348 nm suggests a clean transformation to a sin-
gle photoproduct (hereafter FN-4OX). This was confirmed by
HPLC experiments that, after 95% FN-4 (tr = 14.3 min) con-
sumption, show the formation of a main product at tr = 8.3 min
and several minor secondary products (Figure S1). Experiments
to identify reaction products are in progress; however, furan is
well known to selectively react with 1O2 through an endoperoxi-
dation reaction, whereby the primary endoperoxide evolves to
different end products depending on the structure of the furan
derivative and the solvent (28–30). Involvement of 1O2 in the
process was unequivocally demonstrated by the inhibitory effect
of selective 1O2 quenchers (Figure S2). Most effective were
a-terpinene and sodium azide that inhibited the FN-4 photooxi-
dation by ca 90%. DABCO was able to diminish the FN-4 con-
sumption to a lesser extent. A strong fluorescence increase and a
concomitant shift of the fluorescence peak to the blue could also
be observed (Fig. 3c), the excitation spectra of the original and
final fluorescence bands being markedly different, implying that
they correspond to different chemical species (Fig. 3a, inset).
The spectral overlap is minimized at 330 nm, which suggests
that this excitation wavelength should be chosen to maximize the
fluorescence of FN-4OX. As shown in Fig. 4, the fluorescence
intensity at 378 nm is enhanced by more than 300-fold. Com-
pared with SOSG, the fluorescence enhancement of FN-4 is 30-
fold larger.
In a similar fashion to that observed for FN-4, emission of
FN-I2 also increases considerably upon reaction with 1O2 in
methanol (Fig. 3d), concomitant with the bleaching of the low-
energy absorption band at 367 nm (Fig. 3b). Both the absorption
and fluorescence spectra reveal the appearance of new bands
shifted to the blue. The absorption spectra show a clear isosbe-
stic point at 352 nm, suggesting the formation of a single photo-
product as for FN-4. Excitation at 333 nm maximizes the system
emission, which increases by a factor ca 135 at 363 nm (Fig. 4).
The results above demonstrate that the new family of naphth-
oxazole dyads represented by compounds FN-4 and FN-I2
outperform any other fluorescent probe currently available for
monitoring 1O2. The key novelty of the system relies on the fact
that the fluorophore in the photooxidation adduct is different
from that in the initial species. Thus, spectral changes arise that
elicit the selection of optimal excitation wavelengths to enhance
the fluorescence of the photoproducts.
Figure 3. Absorption (a,b) and fluorescence (c,d) spectra of FN-4 (a,c) and FN-I2 (b,d) before (solid line) and after (dashed lines) reaction with 1O2.
The photosensitizer was new methylene blue 1 lM, the irradiation wavelength was 635  15 nm and the experiments were carried out in aerated metha-


















































































The rate constant for 1O2 quenching by the dyads (kq) was
determined by time-resolved detection of 1O2 phosphorescence at
1275 nm (5,23). Increasing concentrations of the dyads enhanced
the decay rate of 1O2 in a linear fashion. The slope of the plots
afforded the kq values, which are collected in Table 1. Interest-
ingly, the value for FN-4 (vinyl bridge) is 20-fold smaller than
that for FN-I1 (ethyl bridge) and for FN-I2 (direct link), and
about 40-fold smaller than for isolated 2-methylfuran:
kq = 9.9 9 10
7
M
1 s1 in methanol (31), which confirms the
strong electronic delocalization of the furan ring across the vinyl
bridge in FN-4. Notice that the fluorescence enhancements do
not correlate with kq. Finally, the low kq value for FN-7 confirms
that naphthoxazole derivatives lacking the furyl substituent are
essentially unreactive toward 1O2.
Self-sensitization of 1O2 by the dyads and reactivity toward
other ROS
A drawback of SOSG is the growth of fluorescence due to self-
sensitization of 1O2 (19). Other dyads lack selectivity toward
1O2
and react also with different ROS. We investigated whether the
naphthoxazole dyads suffered from the same problems. All dyads
sensitized the production of 1O2, although with very small quan-
tum yields (ΦD, Table 1 and Figure S3). Nevertheless, Fig. 4 and
Figure S4 show that the fluorescence of FN-4 does not increase
upon cumulative irradiation in methanol and that of FN-I2 actu-
ally decreases.
Reactivity toward other ROS was also tested for FN-I2 and
FN-4. Negative results for both dyads vs both superoxide (KO2)
and H2O2 were encountered (Figure S5) indicating a high degree
of specificity for 1O2
CONCLUSIONS
FN-4 and FN-I2 are two examples of successful naphthoxazole-
based dyads capable of monitoring 1O2 in solution with unprece-
dented sensitivity. Photooxidation of the trapping moiety leads to
the formation of a new chemical entity whose fluorescence is
spectrally different from that of the nonirradiated conjugate. Flu-
orescence enhancement factors up to 300-fold have been
observed taking advantage of the change in spectral properties
upon photooxidation. Its added selectivity toward 1O2 and the
negligible effects of self-sensitization make naphthoxazole dyads
worth of further development as 1O2 fluorescent probes.
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